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  UNIVERSITY OF SOUTHAMPTON 
 
ABSTRACT 
 
        FACULTY OF MEDICINE 
 
Doctorate of Medicine 
 
THE EFFECT OF TOPICAL NEGATIVE PRESSURE ON MICROVASCULAR 
BLOOD FLOW IN HUMANS 
 
by Salim Ahmed 
 
 
Throughout history wound carers have used a variety of dressings to aid and 
promote wound healing. One of the most recent additions to the plethora of 
dressings used has been Topical Negative Pressure (TNP). This technique 
of wound management allows wounds that have been dressed with foam 
and  sealed  with  an  adhesive  drape  to  be  subjected  to  a  variety  of 
subatmospheric pressures (SAP) either in a continuous fashion or in a timed 
cycle.  
  In a short space of time this technique has enjoyed widespread anecdotal 
success in the management of acute, chronic and difficult to heal wounds 
across  a  wide  range  of  clinical  specialities [1-18], which  suggests  that  its 
application to wounds positively influences the wound healing process. 
  If TNP does benefit the wound healing process, it is important to ask the 
question by what mean(s) it does so.  
  There is however a paucity of studies investigating the mechanism(s) of 
action  of  TNP,  particularly  in  human  experimental  situations.  Although 
several investigators had evaluated the effect of TNP on blood flow in animal 
studies,  at  the  beginning  of  this  thesis,  no  studies  in  humans  evaluating 
blood flow could be found. 
  This  thesis  was  therefore  aimed  at  investigating  the  effect  of  TNP  on 
microvascular blood flow in humans, and in particular three subatmospheric 
pressure (SAP) setting/ cycles.  
  Having investigated these SAP regimes an attempt was made at describing 
the macroscopic forces evident during TNP application (to intact skin and 
predominantly two-dimensional wounds), and the effect of these forces on 
tissues  was  visualised  in  a  small  number  of  healthy  volunteers  using 
Magnetic Resonance Imaging (MRI). 
  It  was  envisaged  that  by  describing  the physical  forces  involved  in  TNP 
application  a  greater  understanding  of  how  TNP  might  effect  changes  in 
microvascular blood flow might become apparent.  
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1  Introduction – A History of Wound Dressings 
 
 
Throughout history dressings have been used in the management of wounds 
with a number of objectives in mind. These include cleansing the wound, 
stemming  bleeding,  protecting  the  wound  from  the  external  environment, 
absorbing exudate and more recently attempting to beneficially modify the 
wound environment. 
Using a variety of dressings progress has been made and hindered by a 
number of key individuals. Early in the history of wound care, simple and 
non-irritant dressings predominated and were recommended by individuals 
such  as  Celsus,  whose  concepts  of  wound  care,  especially  in  the 
management of acute and chronic wounds, are similar to those in practice 
today. 
Following Galen’s theory of laudable pus, however, wound carers began to 
use complex irritant dressings in an effort to induce suppuration, as it was 
thought mistakenly, that the formation of pus was a necessary part of the 
wound healing process. Surprisingly this concept dominated wound care for 
the next fifteen hundred years, and was finally laid to rest by the Pasteur and 
Lister in the 19
th century. Their work led to a return to the use of simpler, 
non-irritant and ultimately sterile dressings. 
In the last century has there been a move away from the traditional role of 
wound dressings with the emphasis now being on attempting to beneficially 
modifying the wound environment particularly in the chronic wound, where 
dressings such as growth factors, protease modifying dressings and Topical 
Negative  Pressure  (TNP)  are  now  being  used  to  redress  some  of  the 
biochemical  disturbances  that  characterise  these  types  of  wounds.  This 
introduction aims to give a brief overview of how dressings and the concepts 
of wound care that they reflect have evolved throughout history, and why one 
of these dressings TNP is worthy of further investigation. 
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1.1  Ancient Egypt  
 
 
‘Thou should bind it with fresh meat the first day and treat afterwards with grease honey and 
lint everyday until he recovers’ 
 
The management of ‘a wound in the head penetrating to bone’ as recommended by the 
Smith’s Papyrus [30] 
 
 
Probably our oldest record of wound care comes from the Smith’s Papyrus. 
These  written  records  were  found  in  Luxor  and  were  named  after  the 
American Egyptologist Edwin Smith.  Although they date to the 16
th century 
BC they are in fact thought to be a copy of an older text that dates back to 
2500 BC [31, 32] and therefore provide an insight into the care of wounds in 
ancient Egypt. 
Contained within the Papyrus are forty-eight case reports of wounds, with the 
text containing details of treatment, prognosis and a detailed description of 
wound dressings used in each case[30].  
The Papryus would seem to suggest that Egyptian wound carers appreciated 
that closed wounds healed faster than open ones [31, 32] . As a result linen 
bandages would be cut into strips and dipped in gum, before being applied to 
wound  edges  in  an  attempt  to  bring  them  together.  When  this  was  not 
possible open wounds would be dressed with medicaments, which were held 
in  place  with  bandages  that  also  served  to  protect  the  wound  from  the 
external environment. The use of simple dressings on these open wounds 
predominated with fresh meat, grease, lard honey and lint being the most 
commonly used, but the Egyptians were also known to use gall of ox, fly 
blood and minerals such as green copper derived from malachite [30, 32]. 
Nevertheless  religious  superstition  also  played  a  significant  role  in  wound 
care with religious incantations also being prescribed in an attempt to heal 
wounds [32]. 
The  use  of  honey  is  an  interesting  example  of  wound  dressing  that  is 
currently  receiving  renewed  interest.  A  complex  mixture  of  substances, 
honey  predominantly  consists  of  fructose  and  sucrose.  Its  high  osmotic     23 
pressure and low pH are thought to create an unfavourable environment for 
bacterial growth [33]. 
 
 
1.2  Ancient India 
 
Detailed  descriptions  of  wound  dressings  are  also  contained  within  the 
Samhita, an ancient Hindu text that is ascribed to Sushruta (600 BC). 
The Samhita provides details of suitable dressings for use in open wounds 
including cloth manufactured from plants, cotton, wool, silk, the inner bark of 
trees,  as  well  as  lint,  honey,  butter  and  grease[30].  Bandages  were 
commonly  used,  once  again  to  hold  medicaments  in  place,  and  up  to 
fourteen different types are described [30], with Sushruta recommending that 
wound carers learn the art bandaging by using full sized dolls! 
The dressing of ulcers provides a good example of the intricacy of wound 
dressing provided in the Samhita. Sushruta recommended that ulcers should 
be dressed with the lint, which was saturated with honey and clarified butter. 
On top of this medicinal dressing the leaves or the bark of trees would be 
placed and then pressed firmly with linen bandages [30]. These bandages 
would be wrapped around the limb and tied making sure that the knot was 
not over the seat of the ulcer, so as not to cause undue pain to the patient 
[30]. 
It is not unreasonable to propose that the aims of this three layer bandage 
would  have  been  to  promote  healing  through  the  use  of  the  medicinal 
dressing, prevent soiling by the absorption of exudate (through the use of 
leaves  and  bark),  and  provide  protection  of  the  wound  from  the  external 
environment. 
 
1.3  Ancient Greece and Rome 
 
This degree of sophistication in wound dressings does not appear to have 
been practiced in ancient Rome or Greece, but nevertheless a number of     24 
concepts of wound care were to emerge from these civilisations, principally 
because of the writings of three individuals, Hippocrates, Celsus and Galen. 
Early Greek references to wound care, however are found in the Iliad. This 
text dates to circa 800 BC and contains descriptions of one hundred and 
forty seven war wounds [34]. As in ancient Egypt, the treatment of these war 
wounds, relied on a combination of dressings and religious superstition, with 
wounds on the battlefield being cleansed with water, dressed with bandages 
and  religious  incantations  being  chanted  over  them  in  order  to  promote 
healing [31]. 
 
1.3.1  Hippocrates 
 
A move away from the use of religious mysticism in wound care was to be 
offered by the teachings of Hippocrates (circa 460-377 BC), who sought to 
explain disease, its treatment and prognosis through observation, reasoning, 
and importantly independent of religion [30, 31, 34]. 
Works attributed to him survive in the Corpus, a collection of sixty or so texts 
that were gathered in the library of Alexandria in 250 BC[34]. Hippocrates 
often cleansed open wounds with water, wine or vinegar, which would be 
applied to the wound either directly or as soaks [31]. 
Wine and vinegar may have been used because they were widely available, 
however  both  are  known  to  have  antiseptic  properties.  For  example  wine 
contains a number of polyphenols, some of which have antiseptic properties 
thirty  times  greater  than  carbolic  acid  [31],  which  Lister  used  nearly  two 
millennia later.  
Having cleansed the wound, Hippocrates preferred to expose wounds to the 
open air, which was in contrast to treatment in Ancient India and Egypt [30, 
31].  
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1.3.2  Celsus 
 
Although Celsus (25BC- 50 AD) was not a physician he contributed to the 
understanding  and  treatment  of  wounds  through  his  encyclopaedia  ‘De 
Medicina’  [34].  Like  Hippocrates  before  him  he  preferred  to  dress  open 
wounds using simple dressings, such as lint, honey and sponges soaked in 
wine and vinegar [30], but it is not his dressings that stand out from this text, 
rather it is Celsus concepts of wound care. 
Celsus  appreciated  that  there  maybe  a  difference  between  fresh  (acute) 
wounds,  which  he  advised  should  be  cleansed  and  sutured,  and  wounds 
which  were  contused,  contaminated  and  chronic  in  nature[31].  Celsus 
recognised  that  these  wounds  might  need  further  intervention, 
recommending  that  they  be  cleaned  and  debrided  in  an  effort  to  convert 
them  back  to  fresh  wounds[31].  In  addition  Celsus  also  gave  the  first 
description of the cardinal signs of inflammation: ‘Notae vera inflammationis 
sunt quattor, rubor et tumor cum calore et dolore’[31].  
This appears to demonstrate that Celsus had a detailed understanding of 
wound management, and its complications, but importantly he knew that if 
tended,  to  with  simple  dressings,  acute  wounds  would  heal  predictably, 
particularly if sutured, but chronic wounds often required further intervention. 
It  is  therefore  not  surprising  that  future  wound  carers  were  to  align 
themselves  with  Celsus  and  rediscover  his  principles  of  wound  care. 
However despite some of Celsus’ principles of wound care being with us to 
the current day, it was to be Galen’s concept of laudable pus, that was to 
dominate wound care for the next fifteen centuries, and lead to the use of 
complex wound dressings primarily aimed at irritating the wound. 
 
1.3.3  Galen 
 
Claudius Galen (circa 129-216 AD) of Pergamon (now in Turkey) dedicated 
himself  to  medicine  at  an  early  age  and  is  known  to  have  travelled     26 
extensively  in  the  pursuit  of  knowledge,  including  to  Egypt  [34].  His 
prominent position firstly as surgeon to the gladiators and then as physician 
to the Emperor of Rome, together with a prolific pen (with over three hundred 
and fifty texts ascribed to him), resulted in a long lasting influence on wound 
care and wound dressings [34]. 
Galen proposed the concept of ‘pus bonem et laudabile’ or that of laudable 
pus [31]. He believed that the formation of pus was a necessary part of the 
wound healing process and as such used a variety of irritant dressings to 
actively  promote  suppuration.  Galen  himself  used  dressings  of  cobwebs, 
writing ink and Lemnian clay to irritate the wound, personally venturing to the 
island of Lemnos to collect the clay himself [31]. 
Perhaps  surprisingly  his  concept  of  wound  care  was  to  become  widely 
accepted and largely unopposed for more than fifteen hundred years. This 
led  to  a  move  away  from  dressings  being  simple  and  predominantly  non 
irritant in nature, to the use of complex irritant dressings whose purpose was 
to  actively  induce  suppuration,  as  this  was  felt  to  be  a  necessary  part  of 
wound healing. 
 
1.4  Middle Ages 
 
During the middle ages the art of surgery and suturing diminished, with little 
if  any  major  changes  in  wound  management  occurring.  Galenic  teaching 
prevailed, dominating wound care, with increasingly bizarre wound dressings 
being used in an attempt to cause suppuration [32].  
Paulus Aegineta’s (607-669 AD) seven volume epitome summarised medical 
knowledge after Galen [32] and provides details of dressings consisting of 
copper ore, chalk, snails, radish, and pigeon’s blood. Islamic medicine with 
its widespread use of cautery in wound care was also influenced by Galenic 
principles. For example, possibly the most prominent Arab surgeon of his 
time Albucasis (Abdul Qasim Al Zarawhi) (936-1013AD) used irritants such 
as quicklime, pigeon’s blood and incense to manage wounds[32]. 
Only  a  few  individuals  and  institutions  were  to  offer  any  dissent  to  the 
‘established  practices’.  These  included  the  universities  of  Bologna  and 
Montpellier  in  the  13
th  and  14
th  century  [32],  and  individuals  such  as     27 
Paracelsus, Wilhelm Fabry, and Ambrose Pare in the 15
th and 16
th [30] [34, 
35].  However  their  concerns  regarding  Galenic  teaching  largely  went 
unheard and certainly did not result in any sweeping or widespread change 
in  practice,  rather  it  appears  that  they  were  only  to  influence  the 
management of wounds locally or regionally, if at all.  
 
1.4.1  Voices of dissent 
 
 
Theodoric  of  Lucca,  near  Bologna,  (1205-1296  AD)  was  adamant  that 
suppuration was contrary to nature and that the complicated dressings used 
by the followers of Galen were actually responsible for prolonging healing 
[35]. He preferred simple dressings advocating keeping open wounds dry. In 
1257 he stated in his text, Chirurgia, that: 
 
‘As all modern surgeons profess, pus should be generated in wounds. No 
error can be greater than this. Such a practice is indeed to hinder nature, to 
prolong the disease and to prevent the consolidation of the wound’.  [35] 
 
Such opinions were also adopted by Henri de Mondeville (1260-1310 AD), 
Theodoric’s pupil whilst at Bologna, who took up a seat at the new school of 
medicine in Montpellier, and by Henri’s successor Guy de Chauliac (1300-
1368)[32] whose principles of wound management in many ways resembled 
Celsus’s  practices.  These  included  the  removal  of  foreign  bodies  from 
wounds, leaving contused wounds open, the reapproximation of separated 
parts of wounds if at all possible and the treatment of complications [32]. 
 
1.4.2  Paracelsus and Ambrose Pare  
 
Paracelsus  (1493-1542),  meaning  surpassing  Celsus,  was  the  name 
adopted  by  Theophrastus  von  Hohenheim[34].  Unlike  Theodoric  and  his 
students, Paracelsus’ medical education was far from traditional and resulted     28 
in  him  abandoning  the  conventional  dogma  surrounding  wound  care, 
returning  to  the  principle  of  learning  through  observation.  He  rejected 
Galen’s principles, stating that his ‘shoebuckles contained more wisdom than 
Galen’ [34] and instead returned to simple dressings such as resin, wine, 
water and lint, claiming that wounds had a natural tendency to heal. 
Ambrose Pare (1510-1590) re-evaluated his following of Galen principles but 
through misfortune rather than design, and for a very specific type of wound 
– the gunpowder wound. Gunpowder had been introduced to the battlefields 
of Europe as far back as the 14
th century, but by the mid 16
th century and 
during  the  French  religious  wars  firearms  were  in  common  use.  These 
‘wounds of fire’ were feared for a number of reasons but primarily because it 
was felt that the gunpowder itself was exceptionally poisonous (this is not 
surprising  considering  the  tissue  loss  and  destruction  that  must  have 
resulted  from  their  use,  not  to  mention  potential  complications  such  as 
tetanus and gas gangrene). Treatment of these wounds was aggressive but 
based firmly on Galenic principles with boiling hot oil and cautery being used 
to destroy the poison and induce suppuration [30, 32, 35]. 
Pare was a keen follower of this form of treatment but during a particularly 
fierce battle his stock of oil ran out and he was forced to treat a number of 
soldiers  with  dressings  of  egg  yolk,  rose  oil  and  turpentine.  When  he 
examined his patients the next day he discovered that those treated with the 
latter dressing had fared far better being in less pain and afebrile, as a result 
he  resolved  never  again  to  use  boiling  oil  in  the  management  of  those 
wounded by gunshot [35]. 
Pare subsequently went on to great fame and dominated the surgical history 
of the 16
th century, as such he probably had the reputation to cause a wide 
change in practice, however despite his condemnation, Pare continued to 
use a variety of irritant dressings in other wounds, as did unfortunately his 
peers. 
 
1.5  The Renaissance  
 
Questions  regarding  Galenic  principles  continued  to  be  asked  during  the 
seventeen century. Caesar Magatus like Paracelsus believed in the natural     29 
tendency  of  wounds  to  heal,  claiming  that  the  formation  of  cicatrise 
depended on nature [30]. As such he would use simple lint to dress wounds. 
The  famous  German  authority  Lorenz  Heister  (1683-1758)  also  used  lint, 
giving  detailed  descriptions  of  its  use  in  his  influential  text  the  General 
System of Surgery [30]. The lint would be made up in various forms either as 
strips,  pledgets  and  dossils  (like  olive  stones)  and  would  be  used  for  a 
variety of purposes including covering the wound and protecting it from the 
external  environment,  stemming  bleeding,  drying  the  wound  and  lastly  to 
hold the two edges of a wound open, and thus allow the passive drainage of 
any collections [30]. 
Other prominent surgeons were also advocating a move away from the use 
of  complicated  irritant  dressings  including,  La  Peyronie  (1678-1747)  (who 
used  dressings  of  lint  and  plaster,  whilst  Pibrac,  before  the  Academy  of 
Surgery in Paris in 1768, advocated the use of simple dressings and the 
gentle treatment of wounds [30]. 
As  these  voices  grew,  wounds  began,  or  rather  once  again  began  to  be 
treated more humanely with fewer dressings and fewer irritants being used. 
As such the more bizarre wound dressings began to be consigned to history 
and  there  was  a  greater  reliance  by  wound  carers  to  use  dressings  of 
grease,  honey,  wine,  vinegar,  eggs,  rose  oil  etc  and  of  wool,  linen,  lint, 
bandages  and  plaster  [30].  In  essence  a  return  to  the  simpler  wound 
dressings that had been used in pre-Galenic times, an appreciation that most 
wounds  had  a  natural  tendency  to  heal  and  a  return  to  learning  through 
direct observation rather than the rigid adherence to ancient authorities. 
The use of ‘older’ methods was part of the general rebirth of surgery, the 
sciences and medicine that was taking place and which was occurring for a 
variety  of  reasons  including  the  establishment  of  a  number  of  new 
universities, the introduction of the printing press and a relaxing by theocratic 
leaders on the practice of human dissection [35], which led to an increased 
understanding of the anatomy, physiology and pathology of the human body.  
From this Renaissance emerged the surgeon-anatomist who armed with a 
far greater appreciation of the human body than ever before were able to 
push the frontiers of surgery forward. 
     30 
1.6  19
th Century 
 
Despite  these  advances  in  surgery  and  the  re-emergence  of  the  art  of 
suturing during the renaissance, healing of wounds by primary intention was 
unusual,  with  the  majority  of  wounds  healing  by  secondary  intention  [30]. 
Dressings used in hospitals were either produced on site or purchased from 
external suppliers and had a tendency to be used and then reused, not only 
on grounds of economy but because materials such as linen became softer 
with reuse and were therefore less painful to the patient in application [30]. 
However this practice inevitably led to suppuration, sepsis, the breakdown of 
sutured wounds and a real risk of death. 
In direct contrast to Galenic thinking, the prevailing opinion now was that 
suppuration  was  a  complication  of  the  healing  process  rather  than  a 
necessary step in wound healing and therefore wound carers were at pains 
to  prevent  and  manage  the  formation  of  pus;  however  the  cause  of 
suppuration  was  as  yet  not  fully  understood.  Two  individuals  in  particular 
would be instrumental in changing this, Lister and Pasteur. 
 
 
 
1.6.1  The age of antisepsis and asepsis 
 
Joseph Lister or Lord Lister (1827-1912), as he was to become was, like his 
contemparies dismayed by the mortality associated with surgical sepsis [35]. 
Throughout the ages wound carers such as Albucasis, Paracelsus, Lorenz 
Heister etc had all warned of the ‘injurious’ effect of exposing wounds to air 
and in many ways Lister shared this opinion.  This is not surprising when one 
considers Lister’s surgical practice, which allowed him to observe that open 
bone fractures invariably became infected in contrast to closed fracture. 
Only when he had read the elegant experiments of Louis Pasteur, a French 
Chemist, which proved that putrefecation was due to bacteria, did he realise 
that it was not the air itself but rather the ‘floating particles’ i.e. bacteria in air, 
that were responsible for suppuration [30].     31 
Lister  therefore  set  about  to  apply  a  dressing  to  wounds  ‘capable  of 
destroying  the  life  of  floating  particles’  [30].  After  experimenting  with  a 
number of dressings and antiseptic substances, Lister began using carbolic 
acid, which was being used effectively in the purification of sewage. 
In 1867 he reported eleven cases of compound fractures, in which undiluted 
carbolic  acid  had  been  applied  to  all  aspects  of  the  wound  and  then  the 
wound would be dressed with lint (soaked in carbolic acid) and covered with 
tin foil to prevent exposure [30, 35]. 
 There  were  no  infective  complications  in  his  series,  and  only  one  death 
(from  laceration  of  the  femoral  artery  by  a  sharp  bone  fragment).  These 
results  were  unheard  of.  Using  his  antiseptic  techniques,  mortality  from 
managing compound fractures fell from 46 % to 15 % in his institution [35]. 
Lister  also  attempted  to  introduce  an  antiseptic  atmosphere  in  which 
operations  and  dressing  changes  could  take  place,  by  the  means  of  a 
carbolic  spray  and  through  filtering  air  through  a  barrier  of  cotton  wool 
soaked in carbolic acid[35].  
 
 
 
 
 
Figure 1 A plaque outside the Glasgow Royal Infirmary Hospital, Glasgow, UK 
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1.6.2  Other antiseptics 
 
The antiseptic properties of iodine and chlorine were also realised during this 
period and as such solutions containing these elements began to be used in 
wound  management.  For  example  Semmelweis  (1818-1865)  used  a 
chlorinated solution as a hand wash, which resulted in a significant reduction 
in  puerperal  sepsis  in  his  institution  [32,  35],  whilst  Labbraque  was  to 
cleanse wounds with a chlorinated soda solution [32]. The widespread use of 
chlorinated  antiseptics  began  some  time  later  when  in  1912  hypochlorite 
antiseptic  solution,  as  Eusol  (Edinburgh  University  solution)  became 
available, with Dakin’s solution following soon after in 1915 [32]. 
Iodine solutions also began to be applied to wounds, especially during the 
American civil war (1861-1865) [32] and its use continues until the current 
day, as does the practice of impregnating dressings with antiseptics, which 
began at about the same time. 
A number of metallic antiseptics also began to be used during this period 
including  silver,  which  would  be  applied  to  ulcers  for  example,  as  lunar 
caustic,  a  pencil  containing  silver  nitrate  with  potassium  nitrate  [32].  The 
early users of silver probably did not recognise its anti-microbial activity, but 
by the late 19
th century, Credé (1819-1892) was using colloidal silver to treat 
eye infections [32]. Credé’s son continued his father work and together with 
Beyer investigated the antibacterial actions of silver, which resulted in the 
production  of  two  silver  salts  for  the  treatment  and  prevention  of  wound 
infection [36].  
More recently silver sulphadiazine (beginning in 1958), has been used as a 
dressing in burn management where silver’s anti-pseudomonal activity would 
prove particularly useful [37]. 
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1.6.3  Asepsis 
 
Some of Lister’s contemparies were to also stress the value of scrupulous 
cleanliness. Lawson Tait (1845-1899) produced similar results to Lister, by 
practising what would now be considered as aseptic techniques in wound 
management [35].  
Other individuals began to sterilise their dressings and surgical equipment, 
having been spurred on by the work of bacteriologists such as Koch and 
Wolhegel [32] who had investigated the effect of wet and dry heat on micro-
organisms as early as 1881[38]. 
The work of the individuals mentioned in this section (and many more) led to 
a widespread change in the practice of wound care. The cause of wound 
infection  had  been  elucidated  and  no  longer  was  it  being  encouraged  in 
wound  care.  Instead  it  was  actively  being  prevented  using  simple 
cleanliness, aseptic techniques, sterilisation of equipment including wound 
dressings, and the use of bactericidal antiseptics either applied directly on 
wounds or in combination with dressing materials. The Galenic shackles of 
wound care had finally been dispelled.  
 
 
 
1.7  20
th century  
 
Surgical  techniques  improved  significantly  during  the  20
th  century, 
particularly in reconstructive surgery and this allowed for a widening in the 
goals of wound management such that it was no longer necessary to dress a 
wound until it epitheliased. Instead dressings could be used to prepare a 
wound bed until it was amenable to reconstruction with, for example, skin 
grafting or flaps. 
In  addition  debridement  of  necrotic  and  contaminated  wounds  came  into 
mainstream  practice  once  a  number  of  army  surgeons,  including  Antoine 
Depagé (1862-1925), had shown that the excision of devitalised tissue in war 
wounds resulted in reduced infection rates [39] (although this practice had     34 
been recommended by Celsus nearly two thousand years before Depagé 
[31]).  
The discovery of penicillin by Alexander Fleming led to a further reduction in 
infection rates, particularly when it became widely available in the Second 
World War [32], and paved the way for use of systemic and topical antibiotics 
in the treatment of wound infection. 
Despite  these  advances  the  materials  used  to  dress  wounds  in  the  both 
world  wars  were  little  changed  from  those  had  been  used  for  centuries. 
Dressings of lint, cotton, cotton wool, Gamgee (a highly absorbent composite 
dressing) and gauze were in common use, often in combination with Tulle 
gras, an open weave cloth coated with soft paraffin wax (which was placed in 
between these traditional dressings and the wound surface) [30].   
In  many  respects,  their  roles,  were  also  unchanged,  namely  to  stem 
bleeding, absorb exudate, hold medicaments in place and protect the wound, 
but there was also a tendency, up to and including the 1950s, to keep the 
wound as dry as possible, primarily because it was assumed that this would 
reduce infection [33]. This concept of letting wounds ‘dry out’ was however to 
be challenged by a number of investigators including George Winter [40]. 
Collectively  their  work  led  production  of  a  host  of  new  wound  dressing 
materials,  that  as  well  as  fulfilling  the  traditional  roles  of  dressings,  now 
offered the possibility of beneficially modifying the wound environment and 
potentially accelerating healing.   
 
 
 
 
1.7.1.1 Moist Wound Healing 
 
In  1962  Winter  established  the  concept  of  moist  wound  healing  when  he 
demonstrated that wounds, (acute partial thickness skin wounds in pigs) kept 
moist by an occlusive polythene film, healed twice as fast as those exposed 
to air [40]. 
Winter  postulated  that  these  results  were  due  to  the  fact  that  occlusive 
dressings provided a moist environment that facilitated epithelial migration 
from  adnexal  structures  whilst  the  scabs  that  formed  as  a  result  of  air     35 
exposure, provided a physiological barrier to epithelial migration [40]. He was 
therefore able to establish that a simple change in physical conditions at the 
wound surface could have significant effects on epithelisiation and therefore 
wound  healing  rates.    His  results  were  subsequently  confirmed  in  acute 
wound models [41-43] and in healthy human volunteers [44, 45]. 
This  work  directly  led  to  the  introduction  of  a  number  of  new  wound 
dressings whose aims were to modify the wound environment and exploit the 
benefits of a moist wound healing environment. These occlusive dressings 
included adhesive drapes, foams, hydrocolloids, hydrogels and alginates.    
 
 
 
1.7.1.1.1   Adhesive drapes 
 
The  first  type  of  moist  wound  dressings  to  be  produced,  were  the 
semipermeable adhesive drapes of which a number are currently available 
including Opsite
©, Bioclusive
© and Tegaderm
© [33, 46]. 
These dressings are transparent and have on their wound contact surface an 
adhesive that allows them to be applied to the wound edge [46] creating a 
closed, warm, moist wound environment [33] but also having a number of 
other  properties  including  being  impermeable  to  bacteria  and  durable  in 
nature [46]. 
One of the main advantages of these dressings is claimed to be their ability 
to permit the passage of excess exudate away from the surface of the wound 
and  to  the  external  atmosphere  in  the  form  of  water  vapour  [33,  46].  
However even with the most permeable of the adhesive drapes significant 
volumes of wound fluid can collect under the drapes, potentially leading to 
loss of adhesion, skin maceration and bacterial contamination [47]. This has 
led a number of individuals to aspirate excess fluid from underneath these 
dressings by use of a syringe [33]. 
 
1.7.1.1.2  Foams 
 
Although there are currently a wide range of foam dressings available, the 
first two to be introduced into wound management were Silastic foam and     36 
Lyofoam in the 1970s, which differ significantly in their application. Silastic 
foam is a two component product that vulcanises at room temperature [33]. 
The two components are mixed together prior to being poured directly into a 
wound cavity, where they react together to form an open cell foam. 
Whilst Lyofoam is an open cell polyurethane foam that comes in sheets and 
as such can be cut to fit the dimensions of a wound. When placed in the 
wound, the cells of the foam that are in contact with the surface of the wound 
actually collapse, due to the effects of heat and pressure, which allows the 
foam to take up wound fluid by capillary action [33]. 
Newer additions to these original products include polyvinyl alcohol foams, 
which are available as sheets, and foam based dressings that incorporate an 
adhesive drape. The drape adheres to the skin surrounding the wound and 
holds the foam in place.  
Foams in general provide a moist wound environment, are thermal insulators 
[33,  48],  have  high  absorbency  and  are  less  painful  on  removal  than 
traditional dressings [49]. 
 
 
1.7.1.1.3  Hydrocolloids 
 
Hydrocolloids  are  based  upon  the  gel  forming  agents, 
carboxymethylcellulose, and gelatin, which in many products are combined 
with elastomers and adhesives. This composite is then applied to a carrier 
usually  a  polyurethane  foam  or  film  to  form  an  absorbent,  self  adhesive 
waterproof wafer [50]. 
In the presence of wound fluid these products, of which Granuflex
© was the 
first to become available in the 1980s, absorb liquid and form a gel, which 
depending  on  the  formulation  is  either  cohesive  and  retained  within  the 
dressing or viscous and mobile. 
These dressings provide a moist wound environment and are claimed to be 
able to cope with wounds with ‘low to medium exudate levels’ [50].  
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1.7.1.1.4  Hydrogels 
 
Hydrogels  consist  of  insoluble  polymers  and  up  to  90  %  water  [46].  The 
polymers contain hydrophilic sites, which interact with aqueous solutions and 
can  therefore  absorb  exudates.  By  nature  of  their  water  content  these 
dressings create a moist wound environment and are said to be able to non-
surgically debride and deslough wounds [33]. 
They are available as sheets or amorphous forms, with examples including 
Vigilon
© and Intrasite
© [33].  
 
 
1.7.1.1.5  Alginates 
 
These biodegradable dressings are derived from brown seaweed and are 
available as either brittle gels, when they contain a high mannuronic acid 
content or as more flexible fibres, when guluronic acid predominates [51]. 
Once in place they absorb exudate to form a hydrophilic gel over the wound 
and as such create a moist wound environment. Alginates therefore rely on 
the  absorption  of  exudates  for  their  activity.  In  addition  by  being  able  to 
donate calcium they also have haemostatic capabilities [52]. 
Commercially available products include Sorbosan
© and Kaltostat
©. 
 
1.8  Recent Developments 
 
Since Winter’s work there has been extensive study of the biochemical and 
cellular processes involved in both acute and chronic wound repair, which 
has  not  only  influenced  wound  care  as  a  whole  but  has  resulted  in  the 
emergence of a number of new topical agents / wound dressings. 
As a result of this research we know now that wound healing is a complex 
process involving interactions between a variety of cell types, plasma derived 
proteins, structural proteins and the extracellular matrix, with many of these 
interactions being conducted by an array of growth factors and cytokines. In 
addition a number of impediments to wound healing, both local and systemic 
have been identified and are listed in Figure 2     38 
 
 
Local and systemic factors that impede wound healing 
 
 
 
Local factors   Systemic factors  
• Inadequate blood supply   • Advancing age and general immobility  
  • Obesity  
• Increased skin tension   • Smoking  
• Poor surgical apposition   • Malnutrition  
 
• Deficiency of vitamins and trace 
elements  
• Wound dehiscence  
• Systemic malignancy and terminal 
illness  
• Poor venous drainage   • Shock of any cause  
• Presence of foreign body and 
foreign body reactions   • Chemotherapy and radiotherapy  
 
• Immunosuppressant drugs, 
corticosteroids, anticoagulants  
• Continued presence of 
microorganisms  
• Inherited neutrophil disorders, such as 
leucocyte adhesion deficiency  
• Infection  
• Impaired macrophage activity 
(malacoplakia)  
• Excess local mobility, such as 
over a joint  
 
 
 
 
 
 
Figure 2  Factors impairing wound healing [68] 
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1.8.1   Acute Wound Environment 
 
In acute wounds, i.e. wounds that heal in a timely fashion, the wound healing 
process progresses unimpeded through a number of phases that have been 
arbitrarily defined as 
 
 
1.  Coagulative phase – which achieves haemostasis 
2.  Inflammatory phase- necessary to achieve debridement of the wound  
3.  Proliferative  phase  –  involving  angiogenesis,  matrix  synthesis  and 
deposition and fibroplasia 
4.  Remodelling  –  which  results  in  a  reduction  in  vascularity  and  an 
increase in the tensile strength of the wound 
 
A summary of these processes is given in Figure 3. 
 
These wounds tend to be characterised by high mitogenic activity, low levels 
of inflammatory cytokines, low levels of proteolytic enzymes in the wound 
fluid milieu and mitotically competent cells [51], and as a result they heal in a 
predictable manner (unless complications arise), a fact observed by Celsus 
nearly two thousand years ago. 
Celsus treated acute wounds by cleansing them with wine, debriding any 
contused/ necrotic tissue, removing foreign bodies, reapproximating wound 
edges where possible (for he knew that closed wounds healed faster than 
open wounds), and finally dressed the wound with simple dressings of lint, 
honey etc [31].  
The modern management of acute wounds is little changed, however in a 
holistic approach any cause of impaired wound healing should be identified 
and  attempts  made  to  minimise  or  reverse  this  problem,  for  example 
inadequate  or  poor  nutrition  will  delay  healing,  particularly  if  the  patient’s 
protein intake is low [31] therefore efforts should be made to improve dietary 
intake.  The  management  of  the  wound  itself  however  follows  in  many 
respects Celsus’s principles. 
Antiseptics  have  replaced  the  use  of  wine.  Debridement  still  plays  an 
important role in decreasing the necrotic burden of the wound [53]. When     40 
primary closure is possible, sutures are used to reapproximate wound edges. 
When this is not possible wounds can be left to granulate and epitheliase or 
alternatively a number of reconstructive options including split skin grafting 
can be used to achieve wound closure.  
Depending on which option is chosen the resultant wounds are commonly 
dressed with no dressings, a modern equivalent of tulle gras and gauze, or 
occlusive dressings (with the aim of accelerated epitheliasation), although in 
practice acute wounds in healthy individuals will normally heal by 21 days 
[51] irrespective of the dressing used.   
 
 
 
 
Figure 3 Wound healing ‘phases’ and the characteristic cells that are seen in 
the healing wound at that time[69] 
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1.8.2   Chronic wounds  
 
In chronic wounds, i.e. wounds that heal in a longer time than expected or 
fail  to  heal,  there  is  a  disturbance  of  the  normal  wound  healing  process. 
These type of wounds of which diabetic, venous and ischaemic ulcers are 
examples, can not only pose serious clinical problems as a result of being 
difficult  to  heal  and  potentially  refractory  to  treatment  but  also  have  a 
detrimental effects on patient’s quality of life [54]. The financial burden alone 
to the National Health Service, is thought to be in the region of £1 billion/ 
year in the UK [55].  
There has therefore been considerable effort to develop new and effective 
treatments  for  chronic  wounds,  which  has  been  aided  significantly  by  our 
increased understanding of the chronic wound environment. 
 
1.8.3  Chronic wound environment 
 
A  number  of  factors  are  known  to  play  a  role  in  the  formation  of  chronic 
wounds. Local factors including infection, ischaemia, the presence of foreign 
bodies  and  tissue  maceration,  and  systemic  factors  such  as  malnutrition, 
advancing  age  and  renal  disease  have  all  been  implicated  in  impaired 
healing in chronic, and for that matter acute wounds [55] (a detailed list of 
factors impairing healing are contained within Figure 2). 
The wound milieu of chronic wounds is also known to be characterised by 
several  features  which  are  distinct  from  acute  wounds,  these  include  a 
prolonged inflammatory phase, low mitogenic activity, low levels of growth 
factors, an imbalance between the levels of proteolytic enzymes and their 
inhibitors  in  the  wound  fluid  environment,  and  the  presence  of  senescent 
cells  which  have  impaired  responsiveness  to  growth  factors  [55]  [51].  Of 
these features, the wound fluid environment is thought to play a central role 
in  the  pathogenesis  of  chronic  wounds  and  as  a  result  it  has  received 
interest from a number of investigators [56-59]) 
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1.8.4  Chronic wound fluid constituents 
 
The chronic wound fluid environment is now known to consist of a number of 
deficiencies  and  imbalances  that  are  not  only  detrimental  to  the  wound 
healing  process  but  which  distinguish  it  biochemically  from  acute  wound 
fluid.  This  is  clearly  demonstrated  by  the  fact  that  acute  wound  fluid 
stimulates cellular proliferation in vitro, whereas chronic wound fluid actually 
inhibits this process [59].  
The fluid of chronic wounds is known to contain high levels of inflammatory 
cytokines  compared  to  acute  wound  fluid  [51].  For  example  the  levels  of 
Tumour Necrosis Factor Alpha (TNF-A) and Interleukin 1 (IL-1) peak after a 
couple of days and then return to very low levels in acute wound healing 
however in chronic wounds they are persistently elevated [51]. 
Chronic wound fluid contains considerably reduced levels of growth factors 
involved  in  cell  proliferation,  for  example  Platelet  Derived  Growth  Factor 
(PDGF), Interleukin 6 (IL-6), TGF-A and Tumour Growth Factor Beta (TGF-
B) have all been found in lower concentrations in chronic wound fluid than in 
acute wound fluid [51]. 
In addition chronic wound fluid contains low levels of glucose and heightened 
proteolytic activity when compared to acute wound fluid [51]. The heightened 
proteolytic  activity  is  mainly  attributed  to  high  levels  of 
metallomatrixproteinases (MMPs) [55]. These proteinases are implicated in 
all phases of wound repair and have been shown to play an important role in 
controlling tissue /extracellular matrix degradation. As a result their levels are 
usually tightly regulated by Tissue Inhibitors of Metalloproteinases (TIMPs) 
[60]. An imbalance between MMPs and their inhibitors in chronic wound fluid 
can  therefore  result  in  abnormal  degradation  of  the  extracellular  matrix, 
corruption of matrix materials necessary for re-epitheliasation [51] and lead 
to the degradation of growth factors and cytokines. 
The  constituents  of  chronic  wound  fluid  can  therefore  have  a  significant 
impact on wound healing. As a result the management of chronic wound fluid 
has become central to the treatment of chronic wounds.  
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1.8.5  Chronic Wound Management 
 
Nearly  two  millennia  ago  Celsus  recognised  that  there  was  a  difference 
between acute and chronic wounds. He believed that chronic wounds should 
be converted into acute wounds in an attempt to promote their healing and to 
achieve this he used to debride the chronic wounds that he treated [32]. The 
concept of managing chronic wounds today is very similar, however initially, 
and as for acute wounds, any possible impediments to healing either local or 
systemic  (as  mentioned  previously)  should  be  identified.  For  example 
pressure offloading footwear in patients with diabetic neuropathy[61], the use 
of compression bandages and stockings in patients with venous ulceration 
[62], and the treatment of complications such as infection. 
 A  number  of  measures  can  then  be  used  to  convert  the  chronic  wound 
environment into an acute one. Debridement was used by Celsus to promote 
healing in chronic wounds, and this practice is still used today. In addition 
several  new  dressings  and  topical  agents,  that  aim  to  modify  the  chronic 
wound fluid environment, such as growth factors, protease modifying matrix 
and Topical Negative Pressure (TNP) are also increasingly being used, in an 
effort to convert the chronic wound into an acute one. 
 
 
 
1.8.5.1 Modifying the wound environment 
 
 
1.8.5.1.1  Debridement 
 
Debridement involves the removal of devitalised and non-viable tissue from 
the wound bed. This can be achieved through a variety of means. Sharp 
debridement using a scalpel is the quickest and most effective method, and 
its  use  has  been  shown  to  increase  the  healing  rates  of  some  chronic 
wounds [63], however several newer methods are available. 
Enzymatic  debridement  through  the  topical  application  of  exogenous 
enzymes can be used instead or together with surgical debridement. Several 
agents  are  available  such  as  Fibrolysin/  Dnase  which  breaks  down  fibrin,     44 
inactivates  fibrinogen  and  dilates  blood  vessels,  and  in  addition  bacterial 
collagenases as well as papain derived compounds, which liquefy fibrinous 
debris [51]. 
Mechanical debridement can be achieved by using high pressure streams of 
water  or  wet-dry  gauze  dressings  that  result  in  the  separation  of  necrotic 
tissue when the dressing is removed [51]. 
The  sterile  larvae  of  Lucilia  sericata  are  also  being  used  to  biologically 
debride  chronic  wounds.  These  larvae  produce  an  enzyme  capable  of 
breaking  down  necrotic  tissue  without  affecting  healthy  granulation  tissue 
[51]. 
 
 
1.8.5.1.2  Growth Factors 
 
Growth factors have a number of functions in the wound healing process 
including  attracting  various  cell  types  into  the  wound,  stimulating  cellular 
proliferation,  promoting  angiogenesis  and  regulating  the  turnover  of  the 
extracellular matrix [55].  
Exogenous applied growth factors such as PDGF (which is chemotactic for 
polymorphnuclear cells and macrophages), EGF (which supports the growth 
of  keritanocytes  as  well  as  the  migration  of 
keratinocytes/fibroblasts/endothelial  cells)  and  TGF-B  (which  stimulates 
fibroblasts and keritanocytes to grow as well stimulating collagen production) 
[51], have all been applied to wounds in an attempt to redress the low levels 
of growth factors that seem to characterise some wounds, although PDGF is 
the only currently licensed product in the United Kingdom [64]. 
However  it  is  important  to  consider  that  role  of  growth  factors  in  wound 
healing is complex, with many of the factors emerging at different stages of 
the healing process and so theoretically single agent therapy may not be 
effective  in  promoting  wound  healing  [51].  High  protease  levels  may  also 
render any topically applied growth factor inactive, so it seems imperative 
that protease levels are managed in the chronic wound either through their 
inactivation or removal. 
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1.8.5.1.3  Protease Modifying Dressings 
 
Promogran
© is an oxidised regenerated cellulose and bovine collagen matrix. 
This dressing has the capability to physically, absorb, bind and inactivate 
proteases,  such  as  neutrophil  elastase,  plasmin  and  MMPs,  whilst  at  the 
same time bind growth factors such as PDGF, but importantly release these 
back into the wound in an active state [65].  
This  ability  to  modify  the  chronic  wound  environment  by  selectively 
inhibiting  proteases  and  removing  them  from  direct  contact  with  the 
wound bed is an exciting new development in the management of chronic 
wounds,  however  Promogran
©  is  not  currently  in  widespread  use  and 
therefore its efficacy empirically or otherwise (outside specialist centres) 
needs to be established. 
 
 
 
 
 
1.8.5.1.4   Topical Negative Pressure 
 
Topical Negative Pressure is a recently introduced wound dressing, which 
consists  of  an  occlusive  dressing,  of  foam  and  adhesive  drape,  and  a 
portable suction system [2, 66]. Wounds are typically debrided prior to the 
application of TNP (to remove necrotic tissue) [2, 66] and then the foam, 
which may be either polyvinyl alcohol or polyurethane in nature, is placed in 
contact  with  the  wound  surface  and  sealed  with  an  adhesive  drape.  This 
drape extends beyond the margin of the wound to adhere to dry normal skin. 
A  non-collapsible  tube  then  connects  this  dressing  to  a  programmable 
suction pump, which houses a canister that collects wound exudate Figure 4. 
Together  the  foam  and  adhesive  are  able  to  create  a  moist  wound 
environment, whereas the suction system allows wounds to be subjected to 
a controlled closed sub-atmospheric pressure environment. This is claimed 
to remove excess wound fluid [2, 66], preventing pooling under the occlusive     46 
dressing and therefore problems such as loss of adhesion of the drape and 
skin maceration.  
Although  introduced  initially  as  a  treatment  for  either  chronic,  difficult  to 
manage, infected wounds, or in use in those unfit for surgery [2], TNP has 
also gained wide acceptance in the management of acute wounds [4, 11, 12, 
67]. In both acute and chronic wounds clinical observation has suggested 
that TNP accelerates the rate of granulation tissue formation [4, 16, 66]. This 
mirrors the findings from experimental situations [16, 18]. 
The observed acceleration of the wound healing process, is believed to be 
multimodal,  through  mechanisms  already  mentioned,  as  well  as  by 
decreasing the bacterial load of the wound [16], mechanically loading the 
wound [25], and increasing blood flow [16, 26-28]. 
Blood flow in particular, has been shown by Morykwas & Argenta [16], the 
inventors  of  a  patented  TNP  system  known  as  Vacuum  Assisted  Closure 
(VAC)
©,  to  be  influenced  by  the  degree  of  suction  applied,  i.e.  the  sub-
atmospheric pressure (SAP) applied. They showed that a 125mmHg SAP 
applied continuously or in an intermittent manner (applied for 5 minutes and 
switched off for 2 minutes) were the most efficacious in terms of increasing 
blood flow.  The investigators believed that the immediate increases in blood 
flow  seen  in  their  experiments  were  as  a  result  TNP  ability  to  remove 
oedema, but clinical experience suggests that this removal of oedema is in 
itself not immediate. 
Nevertheless Morykwas & Argenta’s [16] results have formed the basis of 
the SAP settings used in clinical practice and are to be supplemented with a 
further  SAP  regime  in  the  next  generation  of  VAC
©  pumps,  known  as 
pressure profiling (KCI
© –Ferndown UK). This pressure regime will consist of 
applying a 150mmHg SAP for three minutes and then applying a 100mmHg 
SAP for 3 minutes in a repeating cycle. However to date none of these SAP 
had been investigated in human experimental situations, with regards to their 
effect  on  microvascular  blood  flow.  Nor  has  there  been  any  attempt  to 
understand  the  macromechanical  forces  present  during  TNP  application 
which may shed light on how changes in blood flow may occur.  
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Figure 4  A commercial TNP system known as Vacuum Assisted Closure
© (VAC
©). 
This image shows the programmable suction pump known as the VAC-ATS
©. In 
this  system  the  collection  canister  is  seen  housed  within  the  pump.  In  the 
foreground polyurethane foam dressing sits on adhesive drape that is used to seal 
the wound. On top of the foam lies a TRAC
© pad (Therapeutic regulated accurate 
care) that connects the dressing to the connection canister and thus the pump. 
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1.9  Aims of Thesis 
 
This thesis has been set to address whether any of these SAP actually increase 
microvascular blood flow in humans, either in human skin or in wounds. In contrast 
to existing studies [16, 26-28] this thesis investigates changes that occur in blood 
flow under the foam aspect of the dressing (Chapters 5 and 6) . The aim of the 
thesis is to also attempt to describe the physical forces that are present under the 
foam  aspect  of  the  dressing  and  by  doing  so  appreciate  mechanisms  by  which 
presumed changes in blood flow may occur whether that be by removal of oedema 
or other mechanisms. A concept of mechanical forces is proposed and investigated 
using Magnetic Resonance Imaging (chapter 7).  
It  is  hoped  that  the  findings  of  chapter  7  may  help  to  understand  the 
macromechanical changes evident under the foam aspect of a TNP dressing, and 
provide insights as to whether there is a physical basis for these forces to produce 
changes in blood flow or to effect the actual measurement of blood flow. 
 
 
1.10  Null Hypothesis 
 
The hypothesis being tested in this thesis is that application of the following SAP 
regimes  to  a  TNP  dressing  does  not  increase  blood  flow  in  human  skin  and 
wounds. 
 
1.  The Continuous application of a 125mmHg SAP. 
 
2.  The  Intermittent  application  of  a  125mmHg  SAP  (5  minutes  on:  2 
minutes off), in a repeating cycle. 
 
3.  The profiled application of a 150mmHg and 100mmHg SAP (3 minutes 
at 150mmHg: 3 minutes at 100mmHg) in a repeating cycle.     49 
2  Literature Review 
 
2.1  Terminology 
 
Various terms are used in the literature to describe the application of suction to a 
wound  that  has  already  been  dressed  with  foam  and  sealed  with  an  adhesive 
drape. These include vacuum sealing technique, [3], vacuum assisted closure [2, 
16], subatmospheric pressure dressing [70] and negative pressure wound therapy 
[71]. However for the purposes of this thesis the generic term Topical Negative 
Pressure (TNP) [72] will be used wherever possible. 
 
2.2  Methods 
 
A Medline search was performed using the terms Topical Negative Pressure and its 
various synonyms. Only English language articles up to and including May 2008 
were selected. 
 
2.3  History of TNP 
 
The  application  of  suction  to  wounds  is  in  itself  not  a  new  concept,  and  was 
probably  first  used  by  Heaton  in  1898 [73],  when  he  used  a  modified  Sprengel 
pump to aid the drainage of abdominal wounds Figure 5. 
However,  the  application  of  suction  forces  to  a  wound  that  has  already  been 
dressed with foam and sealed with an adhesive drape, is a new concept in wound 
care, and was first described by Fleischmann in 1995 [3] (nearly a century after 
Heaton), and subsequently by Argenta and Morykwas in 1997 [16].   
Their individual versions of TNP were very similar but varied in two main respects. 
Firstly in the type of foam that they used and secondly in the nature of their suction 
/ vacuum delivery systems.     50 
 
 
Figure 5 Heaton’s apparatus. (A)- Reservoir: (b)- Tube: (C)- upper limb of Sprengel 
pump: (c)- side tube of pump, connected by (D) a second piece of tubing to (E), a 
perforated glass bulb placed in the wound. The pump generated a suction force 
through a falling stream of water, allowing wound fluid to be evacuated through the 
perforations of the bulb and into a collection bucket. BMJ 1898  
 
The various components of Fleischmann’s TNP system consisted of white open cell 
polyvinyl  alcohol  foam  (PVA),  with  a  pore  size  of  60-270  microns,  an  adhesive 
polyurethane drape, perforated non-collapsible drainage tubes and vacuum bottles.  
The wound would be filled up with layers of foam that already been trimmed to fit 
the dimensions of the defect. Two 16 gauge Redon drainage tubes would then be 
placed along the long axis of the wound but in between the layers of the foam. 
These tubes would be drawn out through the skin adjacent to the wound (as a 
result  dressing  changes  were  invariably  performed  under  general  anaesthetics), 
and the entire area would be sealed with the adhesive drape. The tubing would 
then be connected to pre-vacuumed bottles [3]  
In  reporting  this  technique  in  1995  Fleischmann  described  TNP  use  in  the 
management  of  a  variety  of  wounds,  claiming  that  it  lead  to  the  ‘complete 
evacuation of fluids and a high pressure (80kpa -approximately 600mmHg)’ at the 
wound foam interface, resulting in the ‘rapid formation of sound granulation tissue’. 
The technique was predominantly used as an ‘intermediate measure’ [3] prior to 
wound closure with a variety of secondary operative procedures.     51 
Two years later Argenta & Morykwas [2] described their TNP system, its use in a 
series of patients, and animal experimental studies [16], which tried to determine 
the  mechanism(s)  through  which  TNP  might  beneficially  modify  the  wound 
environment . 
Their system consisted of black polyurethane ester foam, with a pore size of 400-
600  microns,  an  adhesive  polyurethane  drape,  a  non-  collapsible  drainage  tube 
containing  side  ports,  a  collection  canister  that  acted  as  a  reservoir  for  wound 
exudate, and a programmable suction pump. 
Its application to wounds was very similar to Fleischmann’s technique but because 
of the design of their system patients could have dressing changes at the bedside, 
which gave it a distinct advantage over Fleischmann’s TNP system. 
In essence the black polyurethane foam would be cut to fit the wound being treated 
and the non-collapsible tubing would be placed on the foam and allowed to exit 
parallel to the skin surface. Adhesive drape would then seal the site, extending 
some 5cm beyond the margins of the wound to adhere to adjacent intact skin. The 
proximal  end  of  the  tubing  would  then  be  connected  to  the  collection  canister, 
which was housed within the programmable suction pump. 
This  pump  allowed  a  variety  of  suction  forces,  i.e.  a  variety  of  sub-atmospheric 
partial pressures (SAP) to be applied to the wound, either in a continuous manner 
or, intermittently in a timed cycle. In addition sensing devices were incorporated 
within the pump so that warning alarms would sound when either the canister was 
full or if there was a leak in the TNP dressing. 
They claimed that their system ‘increased the rate of granulation tissue formation’ 
in  both  acute  and  chronic  wounds  and  used  the  technique  primarily  to  prepare 
wound beds prior to closure with a secondary procedure. They also used TNP to 
achieve wound closure through epitheliasation, in patients unfit for surgery [2]. 
Unlike  Fleischmann  they  patented  their  system  as  ‘a  wound  treatment  requiring 
reduced pressure’, gained FDA approval for its use, and licensed their system to 
Kinetic  Concepts  Incorporated  (KCI
©)  from  whom  it  is  now  available  as  the 
patented Vacuum Assisted Closure System (VAC
©). To illustrate the application of 
a VAC
© system figures 6-10 demonstrate the various steps involved. 
 As  a  result  of  Argenta  &  Morykwas’  clinical  and  experimental  work [2,  16],  the 
safety features of their TNP system and the ability to perform dressing changes 
without the need of general anaesthetics, VAC
© has become a widely accepted  
means of applying TNP to wounds. 
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Figure 6  Black polyurethane dressing cut to the dimensions of the wound and applied to its 
surface 
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Figure 7  Application of an adhesive dressing 
 
 
Figure 8  An aperture is cut in the adhesive aspect of the dressing once the wound is sealed 
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Figure 9  A TRAC
© pad is applied over the aperture so as to be in contact with the foam 
 
 
Figure 10 Tubing that extends from the TRAC
© pad (the plastic circle seen in the middle of the 
foam) connects to a programmable suction pump via a collection canister. When a SAP is 
applied the foam collapses as seen      55 
 
2.4  Clinical uses of TNP 
 
2.4.1  Acute wounds 
 
2.4.1.1  Descriptive series 
  
In their 1995 paper Fleischmann [3] described the use of TNP in 63 acute wounds 
(group A) and 47 acute infected wounds (group B), prior to definitive management 
with  delayed  primary  closure,  split  skin  autografts,  flap  transfer  and  ‘open 
treatment’ [3]. 
Both these groups were treated with TNP. White PVA foam and vacuum bottles 
being  used  to  deliver  SAP  of  80kpa  to  the  wound,  in  a  continuous  fashion.  All 
dressing changes were performed under general anaesthetics and although it is not 
clear from the paper, the nature of the wounds being treated suggests that they 
were debrided prior to the initial application of TNP. 
Wounds were treated for a mean period of 14.7 (group A) and 12.4 days (group B), 
with  dressing  changes  on  average  every  2.5  and  2.3  days  respectively.  No 
complications  of  the  use  of  TNP,  nor  any  complications  in  the  definitive 
management of these wounds, such as flap failure, were reported. 
In this series they observed that TNP stimulated the development of ‘healthy and 
tense  granulation  tissue’  and  that  with  its  use  one  could  ‘achieve  secure  rapid 
wound healing’. Neither of these claims however was objectively substantiated. 
In their clinical series Argenta &Morykwas [2] treated 94 sub-acute wounds defined 
as being open for more than 12 hours but less than 7 days (group A) and consisting 
of dehisced wounds and open wounds exposing orthopaedic metalwork.  
In addition 31 acute wounds, defined as being open for less than 12 hours (group 
B), and including contaminated wounds, ‘evacuated abscesses’, and haematomas 
were treated. All of these wounds were debrided and then TNP was applied using 
their VAC
© system, until ‘a healthy bed of granulation tissue’ had formed, at which 
stage the wound was closed by delayed primary closure, split skin autografting or 
local flap transfer.     56 
A SAP of 125mmHg was applied to the wound continuously for the first 48 hours 
(which they thought aided the removal of oedema), and then a sub-atmospheric 
pressure of 125mmHg was applied intermittently in a repeating timed cycle (i.e. 
applied for five minutes, and then switched off for two minutes). Dressings were 
changed every 48 hours. 
In group A, all patients ‘were successfully treated’ with TNP. In group B, one patient 
died  of  pulmonary  embolism  otherwise  all  other  patients’  were  ‘managed 
successfully’. Unfortunately successful outcomes were not defined clearly in this 
paper as evident by two patients in group A, developing ‘late’ infection.   
In their series Argenta & Morykwas [2] also observed a ‘ rapid rate of granulation 
tissue formation’, but once again this was not objectively measured.   
Mullner  [4] treated 12 acute soft tissue defects, with an average size of 20cm
2  
(range 6-80cm
2). Wounds were debrided prior to the application of TNP, (the TNP 
system consisting of using PVA foam and vacuum bottles). The sub-atmospheric 
pressure delivered to the wound was not stated. Dressing changes were performed 
every 4-7 days, with a mean treatment period of 16 days.  
All 12 wounds ‘responded to treatment’, with 9 wounds being closed with split skin 
autografting and the remaining 3 closing by epitheliasation. 
No complications were encountered. The authors concluded that TNP facilitated 
the formation of granulation tissue formation whilst maintaining a ‘clean wound bed’ 
and as result TNP shortened the time period needed to achieve healing in these 
wounds, despite not providing any corroborative evidence to support these claims. 
Although the results from these clinical series and others [70], [9, 11, 13, 14, 74-
78], [79],  in which TNP has been used in the management of acute wounds, have 
been promising they remain predominantly descriptive in nature and lack matched 
control groups. A few exceptions exist and are presented below.  
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2.4.1.2  Studies with controls  
 
2.4.1.2.1  Retrospective studies 
 
This  literature  review  has  only  identified  five  comparative  clinical  studies  with 
historical  controls,  in  which  TNP  has  been  used  in  the  management  of  acute  / 
acutely infected wounds and compared to ‘conventional’ wound dressings [12, 20, 
80] [1, 81]. All five of these studies, were retrospective in nature, with four relating 
to the use of TNP in managing infected median sternotomy wounds. 
Deep sternal infection in median sternotomy scars is a rare complication of cardiac 
surgery with an incidence of 0.15-5 % [82, 83]. However, despite improvements in 
surgical technique and treatment of infection, mortality over the last two decades 
still remains at 10-20 % [82] [84] [11, 12]  
‘Conventional’  treatment  of  this  complication  has  involved  surgical  debridement, 
antibiotics,  dressing  the  wound  with  a  variety  of  surgical  packs,  and  delayed 
closure of the wound with or without flap transfer. More recently TNP has been 
used  to  manage  the  wound  instead  of  surgical  packing  and  prior  to  definitive 
closure [11, 14, 15, 85]. 
In  the  most  recent  and  largest  comparative  study  Fuchs  [12]  performed  a 
retrospective analysis of 68 patients who developed sternal wound infection in their 
institute over a five year period. The time interval from sternal infection to freedom 
of microbiological cultures, rate of C- Reactive protein (CRP) decline, in hospital 
stay  and  survival  were  compared  between  35  patients  who  had  TNP  and  33 
patients who had their wounds managed with surgical packs (the exact type and 
frequency of dressing change is unclear from the paper). TNP was applied using 
VAC
©,  with  continuous  SAP  of  between  75-150mmHg  being  used.  Dressing 
changes were performed every 3-7 days. 
There  were  no  significant  differences  between  the  demographics,  comorbidities, 
and  baseline  blood  results  of  these  two  patient  groups  at  the  time  of  sternal 
infection diagnosis, nor of the number of antibiotics prescribed between the two 
groups.  
Freedom from microbiological cultures was achieved significantly earlier in the TNP 
group, 16  (Interquartile  range  (IQR  10-26)  vs  26  (IQR  19-51)  days,  CRP  levels 
declined significantly more rapidly with TNP (p<0.01) and median inhospital stay     58 
was significantly shorter , 25 days vs 34 days (p<0.01). No significant difference in 
mortality rates could be demonstrated in this study. The authors concluded that 
TNP improved the outcome of patients but conceded that their results need to be 
confirmed in randomized controlled prospective studies. 
 
 
2.4.1.2.2  Prospective studies 
 
Only  one  controlled  prospective  study  evaluating  the  efficacy  of  TNP  in  acute 
wounds has been identified by the literature review. Genecov  [19] studied the rate 
of epitheliasation in split skin autograft donor sites using TNP and compared it to a 
control of Opsite
© adhesive drape. 
15 patients who needed split skin autografting to a variety of primary defects took 
part in the study. Using a dermatome two donor sites, of uniform thickness, were 
created in each patient. In each individual one of the donor sites was dressed with 
Opsite
©  whilst  the  other  was  subjected  to  TNP,  using  the  VAC  system  at  a 
continuous setting of 125mmHg SAP. 
Both the Opsite
© and the TNP dressings were changed after 4 and 7 days, at which 
stage 6mm punch biopsies were harvested. After being histologically prepared the 
slides were evaluated by a pathologist, blinded to the treatment regimes, as to the 
degree  of  epitheliasation  and  maturation  of  the  epidermis  on  a  scale  of  0  (no 
evidence of re-epitheliasation) to 4 (complete, mature appearing epithelium). 
In the 10 patients who completed the study 7 patients re-epitheliased faster with 
TNP than with Opsite
© by day 7, in two patients there was no difference rate of re-
epitheliasation, whilst in the final patient Opsite
© was superior. The scored data 
suggested  TNP  significantly  increased  the  rate  of  epitheliasation  in  donor  site 
wounds.  
Despite the promising results seen with the use of TNP in acute / acutely infected 
wounds to date, it is difficult to make an evaluation of its efficacy when compared to 
‘conventional’  wound  dressings  based  on  the  literature  at  the  moment.  This  is 
primarily because insufficient controlled studies and, no randomised control trials 
(RCT), currently exist evaluating its use solely in acute wounds. Although Genecov 
’s [19] study suggests that rate of epitheliasation is improved by TNP, very few 
wounds in clinical practice heal purely by re-epitheliasation, partial thickness burns 
and split skin autograft donor sites being exceptions.      59 
There is a need for future prospective, randomised, controlled studies to evaluate 
anecdotal  reports  that  TNP  results  in  an  increase  rate  of  granulation  tissue 
formation in acute wounds [3], [2, 4] and that it reduces the time to achieve wound 
healing/ closure [4]. 
There is however evidence, from acute wound models, that TNP increases the rate 
of granulation tissue formation when compared to saline moistened gauze [18], and 
that  this  rate  is  affected  by  both  the  sub-atmospheric  pressure  delivered  and 
whether it is applied either continuously or intermittently [16, 17]. 
 
2.4.1.3  Animal Studies 
 
 
Several authors have investigated by the rate of granulation formation in acute 
wound models [16-18, 86]. 
Morykwas    [16]  were  the  first  to  do  so  in  1997.  In  this  study  two  full  thickness 
wounds were created on the dorsal spine of five pigs. TNP was applied to one of 
these wounds, using VAC
© and a continuous SAP setting of 125mmHg, whilst the 
second  wound  acted  as  control  and  was  dressed  with  saline  moist  gauze. 
Dressings were changed at 48 hours and then daily until granulation tissue was 
flush with the skin surface. Volume changes in the wounds were calculated using 
alginate impressions. 
 A  similar  protocol  was  used  to  assess  the  effect  of  intermittent  pressure  on 
granulation  tissue  formation  in  a  further  five  pigs,  using  a  SAP  of  125mmHg 
(5minutes on: 2min off).  
The authors claimed the diameter of wounds did not change during their study and 
so any differences in volume were accounted for by increases in granulation tissue 
formation alone. Their results showed that continuous TNP increased the rate of 
granulation  tissue  formation  by  (mean  ±  standard  deviation)  63.3%±26.1% 
(P<0.01) as compared to saline soaked gauze controls whilst intermittent pressure 
did so by 103.4.4 ± 35.3% (p<0.01). 
A subsequent study by Morykwas [17] evaluated whether the SAP setting had any 
effect on granulation tissue formation (using the same animal wound  model) in n=4 
pigs. 
Three  pressures  (which  were  continuously  applied)  were  investigated.  Wounds 
treated with TNP at a SAP of 125mmHg granulated significantly quicker (p<0.0001)     60 
than  the  other  two  SAP  evaluated,  filling  with  granulation  tissue  equal  to  the 
surrounding tissues by day 8, with only (Mean ± standard deviation) 21.2 ± 6.7 % 
granulation tissue filling at SAP of 25mmHg, and 5.9 ± 13.8% filling with a SAP of 
500mmHg.  
Fabian  [18] further evaluated the efficacy of intermittently applied TNP (125mmHg 
SAP 5 minutes on: 2 off), against a control dressing of foam and adhesive drape. 
Using  an  acute  wound  model  in  rabbit  ears,  they  measured  granulation  tissue 
formation  histologically  using  a  lens  micrometer  and  demonstrated  significantly 
greater (p<0.002) granulation tissue (maximum vertical height of granulation tissue 
seen) in wounds treated with TNP at 10 days post injury. Miller  [86] however could 
demonstrate  no  difference  in  the  extent  of  granulation  tissue  formation  in  acute 
porcine wounds treated with TNP (125mmHg SAP continuous), saline wet to dry 
dressings or a ventilated adhesive drape at either 4, 7, 9 days post injury. In this 
study  rather  than  directly  measure  the  amount  of  granulation  tissue  using  a 
micrometer, the granulation was graded by a histopathologist on a scale of 0 – no 
granulation to 5 – severe granulation.  
 
2.4.2  Chronic wounds 
 
 
A number of descriptive clinical series have reported the ‘successful’ use of TNP in 
chronic  wounds  [3]  [4-6,  8,  16,  87],  but  these  have  tended  to  lack  comparative 
controls. There has recently however been an immergence of RCT evaluating the 
efficacy of TNP against ‘conventional’ wound dressings [88-92], which have begun 
to suggest that TNP may offer significant wound healing benefits over traditional 
wound dressings. However the methodological shortcomings of most of these RCT 
means that their conclusions should be treated with caution.  
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2.4.2.1 Descriptive series  
 
Argenta  &Morykwas  [2]  treated  175  chronic  wounds  defined  in  their  series  as 
wounds that had been ‘open for greater than one week but that had exhibited no 
progress towards normal healing’ (141 pressure ulcers, 31 vascultic ulcers, 3 ‘other’ 
wounds. They claimed that ‘many were non surgical candidates’ or patients that 
had failed multiple surgical procedures in the past. All wounds were debrided of 
necrotic  tissue  prior  to  the  application  of  TNP.  SAP  of  125mmHg  were  used, 
applied continuously, however in the case of vasculitic ulcers and when using the 
125mmHg SAP setting they noticed that patients complained of pain when suction 
was switched on. They therefore used a reduced SAP of 50-75mmHg initially and 
then ‘gradually’ increased up to a SAP of 125mmHg.  
Treatment continued until the wounds had decreased significantly in size (although 
this  was  not  measured  objectively)  and  the  wound  could  be  closed  by  delayed 
primary closure, split skin autografting or local flap transfer. 
Their  results  showed  that  the  ‘vast  majority’  of  wounds,  171/175  ‘responded 
favourably’ to TNP. They observed the ‘rapid formation of granulation tissue’ but 
claimed that it formed at a slower rate than in the acute / sub-acute wounds in their 
series. In addition they claimed that TNP removed the oedema surrounding their 
chronic wounds, stating that the surrounding tissues became ‘more pliable’ as a 
result. Neither of these observations was measured objectively. 
Amstrong [6] treated 31 diabetic patients with TNP following surgical debridement 
of their foot wounds. The mean ± standard deviation duration of foot wounds prior 
to  treatment  was  25.4±  23.8  weeks.  TNP  was  applied  continuously  using 
125mmHg SAP, with dressing changes every 48 hours. Treatment was continued 
until wound beds were covered with 100 % granulation tissue, with no exposed 
tendon, joint capsule or bone. 
Using TNP they recorded that 28/ 31 of their patients (or 90.3 %), healed at the 
level of their initial debridement, i.e. they did not require more proximal surgical 
procedures such as below knee amputation to achieve wound healing. Complete 
coverage of the wound beds took a mean treatment period of 4.7 ± 4.2 weeks. 
They  concluded  that  their  data  supported  the  judicial  use  of  TNP  in  the 
management of diabetic foot wounds.  
Mendonca [87] treated 15 patients with 18 chronic non- healing wounds on the foot 
and  ankle,  using  TNP.  Ten  patients  were  diabetic.  The  period  of  time  that  the     62 
wounds  existed  prior  to  treatment  was  not  mentioned,  however  all  wounds  had 
failed to heal with previous debridement and the use of ‘conventional’ dressing prior 
to applying TNP. 
In their series Mendonca [87] surgically debrided their wounds and then packed 
them with proflavin (an iodine based dressing). At 24-48 hours after surgery the 
wound would be treated with TNP, initially at 125mmHg of continuous SAP for 48 
hours and then 125mmHg intermittent SAP (5 minutes on: 2 off). 
‘Satisfactory healing’ which avoided the need for further debridement or amputation 
was achieved in 13/18 wounds in a mean of 2.5 (range 1-6) months. Treatment 
failed  in  5  patients  of  whom  3  were  non  compliant  with  treatment.  Wound  size 
decreased  from  a  mean  of  7.41cm
2  prior  to  TNP  to  a  mean  of  1.58cm
2  after 
treatment (the area was estimated by calculating the length * breadth of wounds). 
No statistical analysis of results was provided in this paper. 
 
2.4.2.2 Randomised Controlled Trials  
 
A number of authors have performed RCT to evaluate the efficacy of using TNP in 
the management of chronic wounds [88], [21, 89-92]. Although four out of the initial 
five  initial  trials  found  that  TNP  had  significant  wound  healing  benefits  over 
‘conventional’ dressings they suffered from having small numbers of patients, (the 
Egington [92] study only having six patients), and methodological shortcomings in 
their design [93], [94]. More recently, however Amstrong [22] have published a well-
designed,  large  multi-center  randomized  control  trial  that  indicates  that  TNP  is 
superior to ‘conventional’ dressings in the management of patients with diabetic 
foot wounds.  
The  two  initial  RCT  were  performed  by  Joseph  [95]  and  McCallon  [89].  Joseph  
reported data from 24 patients with 36 chronic wounds including pressure sores, 
venous and radiation ulcers. Patients were randomized to receive either TNP, with 
continuous suction at 125mmHg SAP and dressings changed every 48 hours, or 
wet to wet/ wet to moist gauze dressings changed three times a day. Wounds with 
necrotic debris underwent sharp debridement within 48 hours of treatment starting. 
The percentage change in volume of the wounds was measured at three and six 
weeks,  using  impression  moulds.  This  study  showed  a  significantly  (p<0.038) 
greater reduction in wound volume at six weeks using TNP, 78 % vs 30% (it is not     63 
clear from the paper whether these are mean or median values). Time to complete 
healing was not stated as it was deemed an ‘unrealistic endpoint’ in the study. 
The  Mccallon  study  [89,  94]  contained  10  patients  with  diabetic  foot  ulceration. 
Patients were randomized by flipping a coin initially and then by alternating groups. 
All wounds were debrided prior to having their wounds dressed. Five patients had 
TNP  with  continuous  suction  at  125mmHg  SAP  for  48  hours  and  from  then  on 
intermittently at 125mmHg SAP, whilst the remaining five, had saline moistened 
gauze dressings. The TNP dressing was changed every 48 hours whilst the saline 
dressings twice a day. 
Wound area measurement using tracings and planimetry were performed every 48 
hours and were recorded along with the number of days to ‘satisfactory healing’. 
This was defined as the number of days to wound closure either by the use of split 
thickness  autografts,  flap  transfer  or  delayed  primary  closure,  or  wound  closure 
through the process of epitheliasation. 
‘Satisfactory healing’ was achieved in a mean ± SD, of 22.8±17.4 days in the TNP 
group, as opposed to 42.8 ± 32.5 days in the control group. Whilst there was a 28.4 
± 24.3% decrease in wound surface area in the TNP group versus a 9.5 ± 16.9% 
increase in the control group during the treatment period. The authors stated that 
the small sample size n=10, ‘precluded statistical significance’. 
However despite the findings in both these trials the Cochrane systematic review 
conducted  by  Evans&  Land  [93]  identified  methodological  shortcomings  in  their 
design,  which  question  the  validity  of  their  conclusions.  For  example  because 
Joseph [95] used a between patient design, it was inappropriate to treat individual 
wounds on patients with multiple wounds as separate from each other. Patients 
and providers were not blinded to the treatment used (although it can be argued 
that it is difficult to blind patients to which treatment their wounds are dressed with). 
Whereas McCallon [89] did not use a valid method of randomization and it was not 
clear  whether  patients,  clinicians  or  outcome  assessors  were  blinded  to  the 
treatment given. 
Evans& Land [93] therefore concluded that although these studies suggested that 
TNP  increases  healing  rates  in  chronic  wounds  compared  to  saline  gauze 
dressings, their small size and methodological flaws meant that the findings should 
be ‘interpreted with extreme caution.’  
Similar  shortcomings  have  been  identified  [96]  in  two  subsequent  RCT  by  Ford  
[90] and Wanner  [91].      64 
More  recently  Vuerstaek  [21]  and  Armstrong    [22]  have  performed  larger    RCT 
assessing the efficacy of TNP in the management of chronic wounds.  
Vuerstaek  [21] evaluated the efficacy of TNP in the management of patients with 
chronic (present for   6months) lower limb ulcers of either arterial, venous or mixed 
arterial/ venous origin. Patients became eligible for the study when 6 months of 
outpatient  management  had  failed  to  reduce  the  size  of  their  ulcer  (this 
management  included  multilayer  bandaging,  debridement,  daily  or  weekly 
cleansing with tap water and the use of non- adherent wound dressings). Strict 
exclusion criteria are provided in the study. 
Patients were randomized by computer program. An intention to treat analysis was 
performed. All patients underwent sharp debridement of their ulcers followed by 
either  TNP  using  PU  foam  and  a  125mmHg  continuous  setting  or  multi-layer 
bandaging  and  the  use  hydrogel  or  alginate  dressing  (the  frequency  of  TNP  or 
conventional dressing changes is unclear). 
A wound was considered to be prepared when 100% of the wound surface was 
covered by granulation tissue. When this was the case secondary closure of the 
wound was attempted with the use of ‘punch grafts’ taken from the thigh. 
It does not appear from the paper that the wound evaluators were blinded to the 
intervention patients received. Wounds were reviewed twice weekly as an in-patient 
and at 3, 6 and 12 months after discharge. 
Primary outcome measures included wound bed preparation - time from surgical 
debridement to ‘punch’ grafting and time to complete healing (time from surgical 
debridement  to  complete  epitheliasation).  Patients  were  only  discharged  after 
complete healing. 
30 patients were randomized to TNP, 30 to conventional therapy. Four patients, 
two  from  the  TNP  group  and  two  from  the  conventional  therapy  arm  failed  to 
complete the treatment protocol.  
TNP therapy resulted in a significantly shorter wound bed preparation time (p = 
.005). The median preparation time was 7 days (95% Confidence Interval, 5.7 to 
8.3) in the TNP group vs 17 days in the control group (95% Confidence Interval,  
10 to 24) and time to complete healing times- 29 days (95%Confidence Interval, 
25.5 to 32.5) in the TNP group compared with 45 days (95% CI, 36.2 to 53.8) in the 
control group (P = .0001).      65 
As  a  result  they  recommended  that  TNP  should  be  the  treatment  of  choice  for 
recalcitrant chronic lower limb ulcers, despite at one year follow up having a 52% (n 
= 12) recurrence rate compared with 42% (n = 10) in the control group (p = .47). 
Faster rates of healing were also demonstrated by Amstrong in a robust multicentre 
RCT that suggests TNP has a significant role in the management of diabetic foot 
wounds. 
Armstrong  [22] evaluated he use of TNP on diabetic foot wounds in a multicentre 
study. 
Wounds of the feet are a common and complex sequela of diabetes [97], and are 
often difficult to heal, with high rates of complications such as infection [22, 98]. 
Treatment is complex and often involves the eradication of infection, establishing 
whether any associated ischemia is amenable to revascularization, debridement, 
‘conventional’ wound dressings and pressure offloading [99] however if this fails to 
achieve wound healing amputation is often required [100]. 
Healing can often be slow and delayed in these amputation wounds because of 
their complex nature, many containing exposed bone and tendons, and because of 
the compromised healing capacity of diabetics [22, 101]. 
Armstrong  [22], in their RCT, investigated whether TNP improved the proportion 
and rate of healing in these types of wounds in a multicentre trial of 162 patients.  
The  study  was  performed  over  a  16-week  period  and  compared  TNP,  ‘using 
standard treatment guidelines’ (no pressures stated) and dressing changes every 
48 hours, against a control group of patients who received ‘moist wound therapy’ 
with alginates, hydrocolloids, foams or hydrogels. The attending clinician made the 
choice of which moist dressing to use. Dressings changes in the control group were 
performed at least daily unless the attending clinician recommended otherwise. 
Both inclusion and exclusion criteria were clearly stated in this study. Patients were 
appropriately randomized to receive either TNP (n=77) or control dressings (n=85). 
Neither  patients  nor  investigators  were  blinded  to  the  treatment  assignment.  
Outcomes measured included, the proportion often wounds that were completely 
closed,  defined  as  100%  re-epitheliasation  without  drainage,  and  rate  of  wound 
healing.  These  were  assessed  using  photographs  of  the  wound  (taken  using  a 
standardized  protocol),  wound  tracings,  planimetry,  and  an  estimation  of  the 
amount of granulation cover of the wound based upon as scale of 0-25%, 26-50%, 
51-75%, 76-100%, taken at clearly defined times during the treatment regimes.      66 
The  planimetry  was  performed  by  individuals  blinded  to  the  treatment  regime 
patients received. 
Concordance between the wound investigator and assessment of the planimetry, 
was taken as confirmation of wound closure being achieved. In all but two patients 
there was concordance. 
 An intention to treat analysis based upon detecting a difference of 20 % difference 
between the groups was performed in this study. This yielded a minimum sample 
size of 122, which they exceeded by approximately 30 %. 
Their results showed that a significantly greater proportion of patients in the TNP 
group achieved wound closure than in the control group, 56%vs33%, and that the 
TNP group healed in a significantly shorter period of time. 
In  addition  they  also  assessed  the  proportion  of  individuals  who  had  0-10% 
granulation at the beginning of treatment (19 TNP, 15 control) and achieved 76-
100% granulation. The time to reach this endpoint was significantly faster in the 
TNP group, a median time 42 days IQR (40-56) vs 84 days IQR (57-112) . 
They accepted that there was potential for bias in their study but argued that it was 
difficult to conceal group allocation from patients and experienced caregivers/ and 
wound  investigators,  but  tried  to  minimize  this  bias  by  having  a  masked 
assessment of wound closure.  
 
 
2.5  Miscellaneous uses of TNP 
 
As  well  as  being  used  in  the  management  of  open,  partial  thickness  and  full 
thickness wounds, including burns [102], TNP has also been used as a ‘bolster’ to 
secure skin grafts [103] and Integra [104] (an artificial dermal substitute), in the 
management of degloving injuries [105] and in the treatment of ‘open abdomens’ 
[106, 107].  
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2.6  Mechanisms of action of TNP 
 
 
There  are  several  mechanisms  of  action  by  which  it  is  proposed  that  TNP 
beneficially  modifies  the  wound  environment  and  in  doing  so  promotes  wound 
healing. The evidence to support these claims is discussed in this section. 
 
 
 
 
2.6.1  Creation of a moist wound environment 
 
In using foam to dress the wound and by applying an adhesive drape to seal the 
wound, TNP is believed to create a moist, warm wound environment [72]. Foam 
dressings are known to be both absorbent and insulating in nature [33], whereas 
polyurethane  adhesive  drapes  are  known  to  be  able  to  create  a  moist  wound 
environment by the trapping of wound fluid, but at the same time allow excess fluid 
to evaporate as water vapour [33]. 
Although there is a lack of studies investigating the effects on wound healing when 
both  foams  and  adhesive  drapes  are  used  in  combination,  it  is  reasonable  to 
assume that together they would create a warm, moist wound environment, which 
in  numerous  studies  been  shown  to  promote  epitheliasation  in  acute  partial 
thickness and acute full thickness wounds [108] [109-113]. Whether the physical 
properties  of  the  foam  and  the  adhesive  drape  change  when  suction/  SAP  is 
applied, however is not known. 
 
2.6.2  Exudate management 
 
The removal of chronic wound fluid and the inhibitory factors it contains away from 
the wound bed, has been suggested by several authors [2, 16, 24] as a means by 
which TNP might positively influence the chronic wound environment.  
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However only one study could be identified that has investigated levels of cytokines 
in patients with chronic wound treated by TNP [114]. 
Stechmiller at al [114] performed a pilot study in n=6 adult patients with pressure 
ulcers  to  investigate  the  hypothesis  that  TNP  altered  levels  of  ‘proinflammatory’ 
cytokines as well as MMPs and TIMPs.  
Wound fluid was collected prior to TNP therapy (day 0) and on days 1, 3 and 7 
following TNP therapy.  
Differing  methods  were  used  to  collect  the  wound  fluid.  Prior  to  TNP  therapy 
wounds were dressed with a polyurethane occlusive dressing and fluid was allowed 
to collect for ‘1-2 hours’. Whilst during TNP therapy fluid was collected directly from 
the TNP system tubing. The length of collection time was not stated. 
Their study showed a statistically significant decrease in Tumour Necrosis Factor 
Alpha (TNF  ) from day 0 to day 1(p<0.05), a decrease that was sustained at day 3 
and 7. No statistically significant differences could be seen in the levels of the other 
cytokines measured (IL1 ) or the proteases or anti-proteases measured (MMP2, 
MMP3, TIMP1) when either compared to Day 0 or between the other collection 
days. 
They  suggested  that  in  chronic  wounds  such  as  pressure  ulcers  there  was  a 
persistent inflammatory state characterised by high levels of cytokines such as TNF 
 . They claimed that the reduction in TNF   seen during TNP therapy could explain 
in  part  the  success  of  TNP  therapy  ‘in  treatment  of  chronic  wounds,  which  are 
typically chronically inflamed’. Although they suggested further studies would need 
to be performed to confirm this finding, they did not discuss the possible effects on 
their results of differing collection methods, nor did they correlate changing levels of 
TNF   with the clinical success of using TNP.  
Fluid  from  acute  wounds  has  been  studied  by  Wackenfors  et  a  [27]  who  have 
analysed PCO2  , PO2, HCO3
- , pH and lactate levels in fluid collected from acute 
wounds. In this study median sternotomy scars were created in twelve pigs. In six 
pigs the sternotomy scar was dressed with TNP, and a 75mmHg SAP was applied 
continuously. Wound fluid was collected before TNP was applied at 30 minutes and 
1 hour after therapy. In the remaining six pigs wound fluid was collected, at the 
same time intervals, from a tube inserted substernally in the superior aspect of the 
wound. 
In wounds treated with TNP, significant changes occurred in PO2 and PCO2 levels, 
PO2  increasing and  PCO2  decreasing after 60 minutes of TNP therapy,      69 
 
 
but remained unchanged in the control group. Lactate increased significantly after 
30 minutes and an hour, but was unchanged in the control. Bicarbonate and pH 
levels remain unchanged in both TNP and control groups. 
They  suggested  that  the  changes  in  PO2  and  PCO2  could  be  explained  by 
increases in blood flow to the wound, and that the increased lactate levels rather 
than being produced by anaerobic glycolysis were a result of aerobic glycolysis in 
cells such as neutrophils, macrophages and fibroblasts [27].    
 
 
 
2.6.3  Removal of oedema 
 
One of the main mechanisms of action of TNP is thought to be the active removal 
of excess tissue fluid from the tissue surrounding treated wounds [2, 3, 11, 16, 28, 
79,  115],  with  Fleischmann    [3]  suggesting  that  fluid  is  ‘sucked’  away  from  the 
wound bed by the system. However even though significant volumes of wound fluid 
have been collected from wounds using TNP [2, 79] there is at the moment no 
objective quantative evidence to support the claims that TNP reduces oedema. 
 
 
 
2.6.4   Reduction in bacterial colonization 
 
In an acute porcine wound model, Morykwas and Argenta [16] created two wounds 
on the dorsal spine of 5 pigs, which in 3 pigs were inoculated with a human isolate 
of  staphylococcus  aureus,  whilst  in  a  further  2  pigs  a  porcine  isolate  of 
staphylococcus epidermis was used. 
One wound in each animal was treated with TNP using a SAP of 125mmHg applied 
continuously whilst the second wound was dressed with foam and adhesive drape 
used in TNP but with no suction / SAP applied. Dressings were changed on a daily 
basis,  during  which  stage  3mm  punch  biopsies  were  harvested  in  a  ‘rotational’     70 
fashion  from  the  base  of  the  wound.  This  continued  for  2  weeks.  The  biopsied 
tissue was homogenized, diluted in saline and incubated on the surface of an agar 
plate.  Colonies  were  counted  and  the  number  of  organisms  per  gram  of  tissue 
calculated. 
For TNP treated wounds there was a significant reduction (p<0.05) in organisms 
from an inoculum of 10
8 to less than 10
5 organisms/gram tissue between days 4 
and 5, whereas in the control group levels of bacteria fell below 10
5 after a mean of 
11 days. 
They suggested that these reductions were as a result of TNP increasing blood 
flow to the wound [16] and that this resulted in enhanced resistance to infection, but 
they did not seek to explain why bacterial levels dropped in their control group. 
This  work  has  led  to  TNP  being  used  in  infected  wounds  invariably  following 
debridement and in conjunction with the administration of antibiotics [2],[4, 116] and 
especially in the management of infected median sternotomy scars [11, 12, 14, 15, 
20, 75, 77, 85].  
As  mentioned  previously  Fuschs  [12]  has  demonstrated  that  TNP  results  in 
freedom  from  positive  microbiological  cultures  significantly  quicker  than 
‘conventional’  dressings  in  their  study  of  infected  median  sternotomy  scars. 
However despite these encouraging results a recent RCT, discussed below, has 
failed to demonstrate a significant difference in bacterial load between TNP treated 
wounds and those managed with ‘moist wound dressings’ [117]. 
Fifty  four  patients  with  wounds  that  could  not  be  closed  directly  because  of 
infection, contamination or with chronic wounds were included in this study and 
randomized  to  receive  either  TNP  at  a  continuous  SAP  of  125mmHg  or  ‘moist 
gauze therapy’, with moistening agents antiseptics such as 1 % acetic acid, 2 % 
sodium hypochloride, and 0.2 % nitrofuralam (the choice of which, was based on 
the preference of the attending physician as well as the bacterial species cultured). 
TNP  dressings  were  changed  every  48  hours  whilst  the  moist  gauze  dressings 
were changed at least twice a day. All wounds were debrided prior to dressing 
application. 
Wound biopsies were taken at the beginning of treatment and continued until the 
end  of  therapy.  These  were  processed  and  cultured  in  a  similar  manner  to  the 
Morykwas& Argenta study [16]. The total number of colony forming units per disk 
and the number of colony forming units per species were calculated per gram. This 
was done by a microbiologist blinded to the treatment regimes.     71 
In addition the number of days taken to achieve a ‘clean, red, granulating wound 
bed’ i.e. a wound ‘ready for surgical therapy’ was recorded as well as wound size 
measurements (using tracing and planimetry) immediately after debridement and 
after therapy. Both these were performed by clinicians not blinded to the treatment 
regimes.  
The total quantative bacterial load did not significantly change in either the TNP or 
the control group during this study.  
When  the  most  common  bacterial  isolates  were  analysed  further,  Moues  [117] 
showed that there was a significant decrease in the nonfermentative negative rods 
and a significant increase in Staphylococcus aureus during therapy TNP therapy. 
The reduction in the number of nonfermentative negative rods was expressed as a 
negative mean regression of -0.15 ± 0.07 (p < 0.05). In conventional therapy no 
significant effect was observed (-0.06 ±0.16; p = 0.72). Comparing both therapies, 
no significance was found (p =0.53).  
During TNP therapy an increase was seen in the number of Staphlycoccus aureus, 
expressed as a positive mean regression of 0.26 ±0.11 (p < 0.05) vs. 0.03 _ 0.14 (p 
= 0.80) in conventional treated wounds. Comparing both therapies, no significance 
was found (p=0.23). 
No significant difference in the median number of days required to achieve a wound 
bed  that  was  ‘ready  for  surgical  therapy  was  evident  between  the  two  groups, 
median± SEM, 6 ± 0.52 days in the TNP group and 7 ± 0.81 days in the control. 
However the wound surface reduction was significantly larger in wounds treated 
with TNP than with ‘conventional’ dressings, 3.8 ± 0.5 percent/ day compared to 1.7 
± 0.6 /day (mean ± SEM) (p<0.05). 
Therefore although TNP has been shown to reduce bacterial load in animal studies 
and in a comparative controlled study, this RCT would suggest that TNP can result 
in improved wound healing, independent of a reduction in bacterial load.  
 
2.6.5   Mechanical Forces 
 
Several authors have suggested that the application of TNP to wounds results in 
the  creation  of  mechanical  forces,  firstly  on  the  wound  bed  resulting  in  cellular 
proliferation, angiogenesis, and increased rates of granulation tissue formation [24,     72 
25], and secondly on the surrounding tissues causing them to stretch and tissue to 
be gained in a process akin to tissue expansion [24].  
Certainly cells are known to be able to proliferate in vivo if they are exposed to 
soluble mitogenic factors and allowed to stretch, either through the adherence to 
‘stiff’  substrate  that  is  capable  of  resisting  cell  contraction  (produced  by  the 
cytoskeleton) or by the application of external mechanical forces [118-121]. Cells 
that do not stretch undergo apoptosis [122, 123]. 
With this in mind Saxena  [25] have attempted to define the micro- mechanical 
forces that might be evident at the foam/ wound interface of wounds treated with 
TNP, using finite element analysis.  
Finite  element  analysis  is  a  computer  modeling  system,  which  in  essence  is  a 
numerical technique that gives approximate solutions to problems arising in physics 
and  engineering  [124].  However  it  has  also  been  adapted  to  other  disciplines 
including medicine, in such areas as burn heat transfer [125], ‘dog ear’ formation 
[126] and craniofacial surgery [126, 127]. 
In finite element analysis a problem defined in geometrical space is subdivided into 
a finite number of smaller regions [124]. This is done by breaking the system up 
into  simple  discrete  elements  and  setting  boundary  conditions,  which  are 
constraints  to  the  system  and  based  upon  known  or  assumed  mechanical 
properties of the discrete elements [124].  
Saxena  [25] hypothesized that the application of TNP could induce wound healing 
by  creating  micro-mechanical  forces  sufficient  to  induce  cell  proliferation  and 
angiogenesis, and investigated this hypothesis using a finite model analysis. 
The discrete elements of Saxena’s study were the pores within the polyurethane 
foam used in VAC therapy. The boundary of each discrete element was formed 
where  the  foam  was  in  contact  with  the  wound.  This  boundary  they  termed  as 
‘struts’. They assumed that the pores were symmetrical. 
The  model  predicted  the  microscopic  forces  that  could  theoretically  exist  at  the 
foam/  wound  interface,  showing  that  wound  tissue  would  be  stretched  into  the 
pores of the foam in between struts, deforming/ stretching the tissue. The strain on 
the tissue in their model was in the region of 5-20 % which is similar to the levels 
shown in vivo to stimulate cellular proliferation [25, 123]. 
In  the  same  study  Saxena  also  took  biopsy  specimens  of  five  clinical  wounds 
treated  with  TNP  therapy  for  4-7  days.  They  claimed  that  the  cross  sectional     73 
histological  specimens  showed  a  ‘striking  resemblance’  to  their  finite  element 
analysis. 
 This  study  therefore  provides  a  theoretical  basis  for  how  TNP  may  stimulate 
granulation  tissue  formation,  by  examining  the  forces  evident  at  a  microscopic 
level.  However  in  doing  so  it  makes  a  number  of  assumptions,  including  the 
‘strutting’ of the foam, which is central to the model, and said to create the levels of 
strain seen. 
 
 
2.6.6  Enhancing Blood Flow 
 
Several investigators have evaluated the effect of TNP on blood flow surrounding 
acute animal wounds. More recently and during the writing of this thesis Timmers  
have reported on the effect of TNP on cutaneous blood flow underneath the foam 
aspect of the TNP dressing. 
 
 
2.6.6.1  Morykwas&Argenta study 
 
Morykwas&Argenta [23] used laser Doppler needle probes (Moors
© instruments, 
Devon, UK) to investigate blood flow in acute experimental wounds. In n=5 pigs 
Morykwas  created  two  circular  2.5cm
2  defects  down  to  the  deep  fascia  of  the 
muscle over the dorsal spine. Laser Doppler needle probes were then inserted, via 
the wound, and into the surrounding subcutaneous tissue and deep muscle of the 
back  (approximately  1-2mm  from  the  wound  edge-  personal  communication 
Morykwas 2005 TNP symposium –Salisbury). The number of probes used is not 
specified in the paper. 
TNP was applied to one of the wounds continuously using SAP of between 0- 400 
mmHg (at increments of 25mmHg) for 15-minute intervals. 
Morykwas  &  Argenta  summarized  their  findings  claiming  that  the  application  of 
suction / SAP caused an immediate rise in laser Doppler measured blood flow in 
both the subcutaneous tissue and muscle. Blood flow responses were described as 
being ‘bell shaped’ in nature, with maximal increases in blood flow seen at a SAP of 
125mmHg. At this SAP blood flow increased 4 fold relative to baseline (it is not     74 
clear how long baseline recordings were taken for). However these increases only 
lasted 5-7 minutes and then gradually declined. 
Blood flow measurements were immediately depressed below baseline when SAP 
of 400mmHg or above was applied.  
Following  these  experiments  the  needle  probes  were  taken  and  placed  in  the 
second full thickness wound, which was used to determine the effects of applying 
intermittent  SAP,  in  a  timed  cycle.  The  period  of  time  during  which  SAP  was 
applied,  the  ‘on  cycle’,  ranged  from  1-10  minutes  whilst  the  ‘off  cycle’  ranged 
between 1-5 minutes. During the off cycle the pressure returned from a SAP to 
atmospheric pressure i.e. 760 mmHg.  
Intermittent  application  of  SAP  resulted  in  an  increase  in  blood  flow  to  the 
subcutaneous tissue and muscle that fitted a square wave, such that blood flow 
increased immediately from baseline during an ‘on cycle’, and returned immediately 
to baseline when the SAP was removed, i.e. during the ‘off cycle’. Peak levels were 
seen during application of 125 mmHg SAP (4 fold increase relative to baseline) 
Figure 11, and depressed levels were seen when the SAP was 400mmHg or higher. 
Furthermore the peak increases in blood flow, seen during the ‘on cycle’ actually 
decreased when the ‘off cycle’ intervals were greater than 2 minutes. The mean 
and standard deviation of blood flow during baseline periods, and periods when 
SAP was applied were not given in this study, nor was any statistical analysis of the 
data given. 
As a result of their findings Morykwas& Argenta [23] recommended that a SAP of 
125 mmHg applied continuously or a SAP of 125mmHg applied intermittently (5 
minutes on: 2 minutes off) be used clinically. 
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Figure 11 Laser Doppler tracing of the effects of applying intermittent 125mmHg SAP 
[23] 
 
 
In  explanation  of  their  results  Morykwas&  Argenta  [23]  suggested  that  chronic 
wounds  and  to  a  lesser  extent  acute  wounds  were  characterised  by  localized 
peripheral oedema. They postulated that the immediate rises in blood flow seen 
after the application of SAP were due to the active removal of oedema or excess 
interstitial fluid from the tissues immediately surrounding wounds. This removal of 
oedema they claimed resulted in decompression of previously compromised blood 
vessels and therefore the restoration of blood flow in them. 
The means by which TNP might remove excess interstitial fluid was not explained 
in  this  study.  Nor  were  any  explanations  offered  as  to  why  blood  flow  returned 
immediately to baseline when SAP was switched off. 
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2.6.6.2  Wackenfors  studies 
 
In a series of more detailed studies Wackenfors [26, 27] have investigated changes 
in  blood  flow  to  the  tissues  surrounding  acute  inguinal  and  acute  median 
sternotomy  wounds  in  pigs.  In  both  studies  the  effect  of  TNP  on  blood  flow  at 
various distances from the wound were evaluated. 
In the first of their studies Wackenfors [26] created bilateral inguinal cavity wounds 
(dimensions  15cm  long  by  10  cm  deep)  in  7  pigs.  These  were  filled  with 
polyurethane  foam,  1.5  times  broader  than  the  dimensions  of  the  wound  and 
sealed with adhesive drape that extended 5cm beyond the wound margin. TNP 
was applied to one of these wounds whilst the second wound acted as a control, 
with  no  suction  being  applied  to  the  dressing  (although  no  results  from  these 
wounds are presented in the paper). Core temperature was recorded throughout 
the experiment and maintained at 35-37°C. 
To measure blood flow changes they used a multichannel Periflux
© 5000 Laser 
Doppler (Perimed
©, Sweden) that was capable of recording measurement from a 
number of needle filament probes. 
In  their  experiments  the  laser  Doppler  filament  probes  were  inserted  into  the 
subcutaneous tissue and deep muscular tissue surrounding the wound, in 0.5 cm 
increments up to 4.5cm from the wound edge. A skin probe was placed 10cm from 
the wound. 
SAP of 50mmHg, 75mmHg, 100mmHg, 125mmHg, 175mmHg and 200mmHg were 
applied  randomly  and  laser  Doppler  measured  blood  flow  responses  were 
recorded. Once all distances and pressures were evaluated, the effect of applying 
an intermittent cycle of 125mmHg SAP was investigated in the area immediately 
surrounding  the  wound  (i.e.  0.5cm  from  the  wound  edge),  but  only  in  the 
subcutaneous tissue. 
In summarising their results they observed that 
 
 
1.  In the immediate proximity of the wound, blood flow decreased immediately 
following  the  application  of  SAP.  This  occurred  in  both  the  muscle  and 
subcutaneous tissue. 
2.  This hypoperfused zone was larger (i.e. the distance to which it extended 
beyond the wound edge was further) when increasing SAP were used. In     77 
addition the hypoperfused zone was more prominent in the subcutaneous 
as compared to the muscular tissue. For example 
 
 
 
 
 
 
 
 
Table 1 The distance hypoperfused areas extended from wound edge in Wackenfors  
[27] 
 
 
 
The differences given in table  
Table 1 between SAP and between the two tissues were statistically significant 
(p<0.05). 
 
3.  Beyond  this  hypoperfused  zone  the  application  of  SAP  caused  an 
immediate rise in blood flow that was seen up to 4.5cm from wound edge 
(i.e.  the  maximum  distance  they  measured)  in  muscle  and  3.5cm  in  the 
subcutaneous tissue. 
4.  This increase in blood flow became more prominent with increasing SAP in 
both subcutaneous and muscular tissue. 
5.  Peak increases in blood flow occurred closer to the wound edge in muscle 
compared  to  subcutaneous  tissue  (for  example  at  75mmHg-  1.5cm  in 
muscle vs 3cm in subcutaneous tissue (p<0.05)) 
6.  No change in the skin probe took place (10cm from wound edge) at any 
stage. 
 
 
The hypoperfused zones were investigated further, by inserting a single probe 
0.5cm from the wound edge. Intermittent SAP of 125mmHg was applied. The on 
 
SAP 
 
Subcutaneous tissue 
 
Muscle 
50mmHg  1.8 cm  1cm 
200mmHg  2.5cm  1.7cm     78 
periods during which SAP was applied ranged from 1 to 15 minutes. The off 
periods were not mentioned. 
 
 
They observed that 
 
1.  When the SAP was applied blood flow decreased immediately. 
2.  When  the  SAP  was  switched  off,  blood  flow  increased  to  a  level 
approximately 40-50% above baseline levels. 
3.  The peak flow after the SAP was switched off was not affected by the length 
of the ‘on periods’. 
4.  However increasing the length of the ‘on periods’ resulted in significantly 
longer lasting blood flow increases (an ‘on period’ of 10 minutes resulted 
was optimal in ensuring the longest blood flow increases). 
 
In Wackenfors [27] second study, midline sternotomy wounds were created down 
to  and  including  the  pericardium.  Wounds  were  subjected  to  TNP  in  a  similar 
protocol  to  their  2003  study.  They  observed  changes  in  blood  flow  that  were 
consistent to the pattern of changes mentioned above.  
In essence these studies have showed that in the cavity wounds treated with TNP, 
there is hypoperfusion immediately adjacent to the wound edge. Further away and 
up to a distance of 4.5cm from the wound edge increases in blood flow were seen. 
These  changes  in  blood  flow  were  not  only  dependent  on  the  degree  of  SAP 
applied but also varied according to tissue being treated. As Morykwas&Argenta 
[16]  had  previously,  these  authors  believed  that  increases  in  blood  flow  were 
secondary  to  removal  of  oedema  from  the  surrounding  tissues.  They  also 
suggested that the differences in blood flow observed in muscle and subcutaneous 
tissue, were due to ‘pressure being transduced’ differently in ‘soft and dense tissue’ 
from the application of SAP. 
In offering this explanation Wackenfors [27] did not seek to define these pressure/ 
forces, how they were created or clearly define what effect these forces might have 
on the tissues they measured blood flow in. However they did suggest that the SAP     79 
might collapse subcutaneous tissue more readily than muscle claiming that a lower 
SAP, for example 75mmHg, might lead to less collapse of subcutaneous tissue. 
They did not clearly explain the area of hypoperfusion seen, but suggested that 
increases in blood flow seen in the hypoperfused zones when suction was switched 
off, was due to hyperaemia.  
These  detailed  studies  [27,  128]  have  demonstrated  that  there  are  consistent 
changes  in  laser  Doppler  measured  blood  flow  in  the  tissues  surrounding  TNP 
dressings, and that changes in blood flow are dependent on the distance from the 
wound edge, the tissue in which blood flow is measured , the SAP applied, and the 
manner in which it is applied ( i.e. in an intermittent cycle). 
 
2.6.6.3  Timmers  study 
 
This study was published in December 2005, after all experiments performed in this 
thesis.  Prior  to  its  publication  the  effect  of  TNP  on  blood  flow  in  human 
experimental situations had not been evaluated. 
In their study Timmers [29] evaluated the effect of TNP on cutaneous blood flow in 
the healthy intact forearm skin (volar) of n=10 volunteers (Mean age 22.1 years, 
range 20-27), using both PU and PVA foam types. 
The forearms of each volunteer were dressed with a single piece of nominally sized 
foam  (10*15  cm).  Skin  blood  flow  was  measured  using  3  filament  probes 
(Perimed
©,  Sweden)  that  were  incorporated  into  holders  and  placed  within  the 
foam, as shown in Figure 12 (personal communication Dr Jukema Salisbury TNP 
Symposium 2005). 
 
 
 
 
 
 
 
Figure 12 Schematic of black PU foam containing 3 probe holders (red) for Perimed 
filament laser Doppler probes (black line), in Timmers  study 
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One forearm was randomised to receive experimental SAP at varying levels from, 
whilst the contralateral arm was used as a control and received a fixed SAP of 
25mmHg. 
After a thirty minute ‘acclimatisation’ period recording of laser Doppler measured 
blood flow began and lasted for twenty minutes. 
The  mean±  SD  of  blood  flow  was  calculated  in  this  period  and  acted  as  the 
baseline blood flow to which any changes were relative to. Following this 20 minute 
period,  successive  SAP  of  100mmHg,  200mmHg,  300mmHg,  400mmHg  and 
500mmHg  were  applied  for  20  minutes  each,  with  no  breaks  in  between  the 
successive rises. 
By not measuring blood flow in between these SAP rises the authors assumed that 
changes in blood flow during the various periods occurred independent of each 
other. Any change in blood flow was therefore deemed to be relative to the baseline 
period (i.e. when a 25mmHg was applied).  
Although blood flow was measured throughout each 20 minute period, in which the 
100mmHg, 200mmHg, 300mmHg, 400mmHg and 500mmHg SAP were applied, 
only data from the last 5 minutes was used to calculate the mean± SD blood flow. 
The  authors  justified  this  by  claiming  that  only  after  10  minutes  of  raising  the 
pressure, did measured blood flow reach a ‘steady state’. However they did not 
elaborate on how blood flow changed prior to reaching a ‘steady state’ or how the 
overall results of the study would change if this data were included. 
Both PVA and PU foams were investigated in each volunteer on separate days. 
Baseline recordings were significantly higher with the use of PU foams than with 
the use of PVA foam.  
Blood flow in the ‘control arm’ did not significantly change during the course of the 
experiment 
 In  the  experimental  arms,  statistically  significant  improvements  in  laser  Doppler 
measured blood flow were observed up to a SAP of 300mmHg, in PU foam, mean 
± SD, 5.6 ± 3.32 fold increase relative to baseline (p<0.009). Further rises were 
seen between SAP of 300-500mmHg however these changes in blood flow were 
not statistically significant.  
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In contrast to Morykwas [16] Timmers  did not seen any decreases in blood flow. 
The authors did not discuss the mechanisms by which they felt these increases in 
blood flow occurred. 
This  study  therefore  suggests  that  cutaneous  blood  flow  increases  significantly 
when SAP of up to 300mmHg are applied (relative to a baseline SAP of 25mmHg). 
However  the  method  of  successively  increasing  the  SAP  applied  during  the 
experiment assumes that each proceeding SAP does not prejudice the measured 
blood flow. In addition the authors only use the data from the last 5 minutes of each 
period, ignoring the first 15 minutes, and do not make clear how this data could 
influence  the  overall  results  of  the  study.  It  is  however,  to  date  the  only  study 
investigating  blood  flow  in  human  volunteers,  under  the  foam  aspect  of  the 
dressing. 
 
 
2.6.6.4  Schao-Zeng Chen  study  
 
Schao-Zeng  Chen  [28]  have  investigated  the  microcirculation  in  tissues 
surrounding acute full thickness wounds in rabbits. In n=8 rabbits, they evaluated 
changes  in  blood  velocity,  capillary  calibre,  capillary  density  and  capillary 
morphology following TNP application. 
In  preparing  the  animals  they  created  2cm  round  full  thickness  wounds  on  the 
dorsal ear, down to perichondrium. One wound was created on each ear of the 
rabbit. 
On the third postoperative day (after the wounds had been created), the left ear 
wound of each animal was dressed with TNP polyurethane foam and an adhesive 
drape was used to seal the area extending 5-6cm beyond the wound margin. SAP 
was  applied  to  the  dressing  according  to  the  experiment  protocols.  The  second 
wound in each animal was dressed with petrolatum gauze and absorbent gauze 
and  acted  as  a  control.  At  different  times  and  at  a  distance  of  0.5cm  from  the 
wound  edge,  a  1cm  diameter  hole  was  cut  in  the  adhesive  drape,  forming  a 
‘detection window’.     82 
A  microcirculation  microscope  (WX-753  Hongda
©  Optic-Electric  Instrument  Co, 
China) and an image analysis system (Dongfang Institute of Blood disease) were  
used  to  detect  blood  velocity  and  capillary  calibre.  SAP  of  38mmHg  (5kpa), 
76mmHg  (10kpa),  113mmHg  (15kpa),  and  150mmHg  (20kpa)  were  applied 
‘continuously’ to the TNP wounds for 20 minutes. Blood flow velocity and capillary 
calibre were measured before therapy began and every 2 minutes (up to the 20 
minutes  after  each  SAP  was  applied).  These  were  not  recorded  in  the  control 
group. No reason for this was given. 
In  terms  of  blood  velocity,  their  results  showed  that  when  SAP  of  greater  than 
75mmHg were applied, blood velocity increased immediately from a baseline of 
approximately  0.8mm/s  to  reach  a  peak  within  4  minutes  (range  of  peak  blood 
velocity  approximately  1-1.2mm/s).  These  increases  were  significant  (p<0.01). 
There was also a tendency for these velocities to fall back to baseline through the 
course of the experiment, see Figure 13.  
Capillary calibre increased significantly at SAP of 113mmHg and 150mmHg 
compared to pre-treatment levels, for example at a SAP of 150mmHg, mean ± SD 
capillary calibre increased from 12.43 ± 1.88 to 13.86 ± 1.96 mm. It is not clear at 
what time during the 20 minute application of SAP this was measured or whether it 
represents results from a single capillaries or multiple ones.   
 
 
Figure 13 Change in blood velocity from Schao-Zeng Chen study[28]  
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With  regards  to  capillary  density  Schao-Zeng  Chen  applied  TNP  at  SAP  of 
113mmHg to the wound for 8 hours each day. No explanation for this period of time 
was given. At 6 hours, and at 1,3,6 and 9 days after the wounds were created the 
capillary density, defined as ‘intercrossed capillary number/ mm ’ was calculated in 
four random fields and averaged. This was done both in the TNP group and the 
control group. 
At 6 hours, 1, 3, and 6 days the capillary density in the TNP group was significantly 
higher than in the control group. No difference was seen between the two groups 
on day 9.  
The increased blood velocity they suggested was as a result of’ blood surging’ to 
the wound from the surrounding tissue’s capillaries, and that this ‘surge’ of blood 
‘opened  capillary  beds’,  increasing  capillary  calibre  and  ultimately  resulting  in 
higher capillary density. This suggests that these changes would occur in tandem 
however  it  is  not  possible  to  assess  whether  this  occurred  because  of 
discrepancies in the time intervals that blood velocity, capillary calibre (time interval 
of presented data not given), and capillary density were measured.  
Schao-Zeng  Chen  [28]  also  harvested  skin  and  subcutaneous  from  the  wound 
edge of wounds treated with TNP, at a SAP of 113mmHg, and from control groups. 
Tissue  was  harvested  at  2,  10  and  20  minutes  and  also  at  3  and  6  days  after 
wound creation. 
In describing the morphology of the histological sections, they claimed that before 
TNP  therapy  capillaries  ‘looked  flat’  and  that  their  cell  bodies  projected  into  the 
lumen, the basement membranes were not integral and endothelial spaces were 
wide with few cell junctions. Two minutes after TNP therapy, capillaries became 
round and the basement membrane integral. 10 minutes afterwards the capillaries 
appeared elliptical and were ‘dilated significantly’, with endotheliocytes flat. After 30 
minutes capillary buds appeared on the surface of observed capillaries. At 9 days 
the capillary morphology returned to normal. 
In  the  control  group  1  day  after  wound  creation  the  capillary  lumina  were  still 
stenosed, with no capillary buds emerging until the third day and the basement     84 
membrane  still  not  integrated.  It  is  not  clear  from  the  study  known  how  many 
capillaries these subjective observations were based on. 
 
Such methodological discrepancies and the lack of a suitable control in this study, 
makes drawing any conclusion from these observations difficult (an adhesive drape 
or foam/adhesive drape control would have been more suitable).   
 
 
 
2.7  Conclusions 
 
2.7.1  Clinical studies 
 
•  TNP involves the application of suction forces to a wound that has already 
been dressed with foam and sealed with an adhesive drape [2]. 
•  Typically wounds are debrided prior to the application of TNP. 
•  Since  its  introduction  in  the  mid  1990s  TNP  has  enjoyed  widespread 
success and acceptance in the management of acute, chronic, difficult to 
manage and infected wounds. 
•  Although  it  is  used  primarily  to  prepare  the  wound  bed  prior  to  wound 
closure by a variety of means, it exact indications for use have not been 
established. 
•  Experimentally  TNP  has  been  shown  to  increase  the  rate  of  granulation 
tissue formation compared to control dressings. 
•  The  vast  majority  of  literature  regarding  its  clinical  use  comes  from 
retrospective case reports/ series that are observational in nature and lack 
objective outcome measures. 
•  There is a paucity of controlled clinical studies regarding the use of TNP. 
•  This  literature  review  could  not  identify  any  randomized  controlled  trials 
(RCT) regarding the use of TNP in acute wounds solely.     85 
•  Several RCT have emerged regarding the use of TNP in chronic and difficult 
to manage wounds. 
•  Although a number of studies have shown that TNP is superior to a variety 
of  ‘conventional’  dressings  the  methodological  flaws  of  these  studies 
suggests that their conclusions be treated with caution.  
•  More recently a multicentre RCT by Amstrong  (2005) investigated the role 
of TNP in managing partial amputation wounds in diabetics. This showed a 
greater rate of wound closure, and quicker healing in the TNP treated group 
 
 
2.7.2  Mechanisms of action  
 
•  Despite  its  widespread  use  the  exact  mechanism(s)  of  action  of  TNP, 
through which it might beneficially modify the wound environment, remain 
poorly understood and little investigated. 
•  TNP is thought to 
  
1.  Create a moist wound environment- both foams and adhesive drapes 
are known to do this. 
2.  Remove  oedema-  although  this  literature  review  could  find  no 
quantative evidence to support this 
3.  Decrease bacterial load – the evidence from an experimental data 
and a recent RCT is conflicting however. 
4.  Mechanically load the wound-, which in a theoretical finite element 
analysis has been shown to produce strains similar in magnitude to 
those that can accelerate cell division in-vivo. 
5.  Increase blood flow 
 
•  Several  studies  have  investigated  the  effect  of  blood  flow  in  acute 
experimental wounds 
•  3/ 4 of the studies have used laser Doppler to assess microvascular blood 
flow.  Only  one  study  has  used  a  microcirculation  microscope  to  assess 
changes in blood velocity.     86 
 
 
•  In the dorsum of pigs, TNP was shown to increase blood flow, in the muscle 
and  subcutaneous  tissue,  surrounding  acute  wounds  immediately  after 
suction was switched on [23]. 
•  The magnitude of increase was affected by the SAP applied. 
•  Maximum increases were seen at 125mmHg SAP. The increases lasted 5- 
7min 
•  By  applying  a  125mmHg  intermittently  (5  min:  2  off)  the  investigators 
maximized blood flow increases. 
•  In acute experimental cavity wounds, i.e. median sternotomy and inguinal 
wounds  in  pigs  [26,  27],  TNP  has  been  shown  to  create  a  zone  of 
hyperperfusion  adjacent  to  the  wound,  immediately  after  suction  was 
switched on. This zone of hypoperfusion was affected by the degree of SAP 
applied  and  in  addition  there  was  a  discrepancy  on  its  effect  between 
muscle  and  subcutaneous  tissue.  Beyond  this  zone  TNP  immediately 
increased blood flow in muscle and subcutaneous tissue, as soon as suction 
was  switched  on.  This  increase  was  affected  by  degree  of  SAP  applied. 
There was a discrepancy between the effects of TNP on muscle and the 
subcutaneous tissue. 
•  More  recently  Zhoa-Chen  [28]  has  shown  that  TNP  increases  the  blood 
velocity in capillaries surrounding acute experimental wounds in rabbit ears. 
This occurs immediately after suction is switched on. 
•  All  investigators  [16,  26-28]  suggest  that  the  increases  in  blood  flow  are 
secondary to the removal of oedema by TNP. 
•  In  explaining  the  discrepancies  in  blood  flow  changes  in  muscle  and 
subcutaneous  fat,  Wackenfors  [27]  suggest  that  the  different  SAP  may 
cause collapse of fat more than muscle. 
•  They  suggest  that  this  ‘pressure  transduction’  to  the  surrounding  tissues 
may be an important factor in choosing SAP setting. 
•  However despite this the most commonly used SAP settings clinically tends 
to be the 125mmHG continuous or intermittent settings recommended by 
[17, 23]. 
•  Which is to be supplemented by a new profiling pressure regime in the nest 
generation of a commercially available TNP system.     87 
•  Prior to the last month of this thesis and after the experimental work was 
finished,  these  pressure  settings  had  not  been  evaluated  in  human 
experimental situations. Nor had blood flow been evaluated underneath the 
foam aspect of the foam dressing, during TNP application.  
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Blood Flow Studies 
 
 
 
Human  skin  is  a  multifunctional  organ,  which  provides  protection,  sensation, 
participates  in  temperature  homeostasis,  and  fulfils  a  number  of  biochemical, 
metabolic  and  immune  functions  [129].  As  with  other  tissues  its  structural  and 
functional integrity relies upon the skin microcirculation being intact, and perfusion 
being at least commensurate to metabolic demand. 
Structurally the skin consists of two layers, an outermost avascular layer known as 
the  epidermis,  predominantly  consisting  of  keratinocytes,  and  serving  as  an 
impervious protective barrier, and the dermis [130]. The dermis consists largely of 
collagen,  but  also  contains  fibroblasts,  mast  cells  and  histiocytes,  as  well  as 
structures such as hair follicles, sweat and eccrine glands [130]. It is often referred 
to in two layers, an upper papillary dermis that sends protrusions into the epidermis 
known as dermal papillae, and the lower reticular epidermis that abuts the subcutis 
[129]. 
In  contrast  to  the  epidermis,  the  dermis  has  a  very  rich  blood  supply  that  is 
organised into an upper horizontal plexus, situated in the papillary dermis and from 
which  the  nutritive  capillary  loops  of  the  dermal  papillae  arise,  and  a  lower 
horizontal plexus, which is located at the dermal-subcutis border [131]. The lower 
plexus,  is  fed  by  perforating  blood  vessels  from  the  underlying  muscles  and 
subcutaneous fat, and communicates with the upper horizontal plexus through a 
series of arterioles and venules[131]. 
Irrespective  of  the  cause  when  this  blood  supply  becomes  compromised  or  is 
disrupted,  critical  ischaemia  of  the  skin  can  ensue  leading  to  necrosis,  further 
disruption of the vasculature and ultimately wound formation.  
As discussed in chapter 1 the normal response to this type of insult is the well 
orchestrated, and progressive process of acute wound healing[132]. Apart from the 
most superficial type of wounds this relies on angiogenesis, the complex process 
by which blood flow is restored to tissues after injury, through the reparation of 
damaged blood vessels and the formation of new blood vessels (from pre-existing 
ones) [132]. 
Although angiogenesis occurs concurrently with the formation of granulation tissue, 
and becomes clinically apparent at approximately four days post injury [132], it is     90 
preceded by the appearance of capillary buds as early as the first day [133]. These 
new vessels either fuse across the gap of a primary closed wound or in healing by 
secondary  intention  they  join  adjacent  ones  to  form  the  capillary  network  of 
granulation tissue [133]. Unlike the pattern of blood vessels in organised tissues, 
the  vasculature  of  granulation  tissue  is  non-uniformly  distributed,  branches 
irregularly and does not confer to the normal hierarchical pattern of blood vessels 
seen elsewhere [134]. 
Despite this, the aim of these new vessels remains the same as those in organised 
tissues, namely the provision of sufficient nutrients, in particular oxygen, and the 
removal of waste products; thus ensuring that the anabolic processes of wound 
repair are supported and healing progresses in a timely fashion [133]. Only later, 
once this role is fulfilled does vascular remodelling and involution of blood vessels 
occur [132]. 
However  in  situations  in  which  blood  flow  to  the  wound  is  impaired,  such  as 
peripheral  ischaemia  or  venous  insufficiency,  delayed  wound  healing  can  occur 
[135]. Wound carers therefore use a variety of methods to improve blood flow (and 
as a result oxygen delivery) to these types of wounds, including revascularisation in 
ischaemic  lower  limbs,  venous  compression  stockings  in  venous  hypertension, 
hyperbaric oxygen therapy [51]and more recently TNP[2]. 
As we have seen a number of investigators [16, 26-28] have demonstrated that 
TNP  application  increases  blood  flow  in  the  tissues  surrounding  acute  animal 
wounds. In particular the study by Morykwas [16] has formed the basis of the SAP 
regimes used in clinical practice. 
To date however the effect of these SAP settings has not been evaluated in human 
experimental situations. Therefore in the following sections a series of preliminary 
studies are performed investigating the effect of TNP on blood flow in non-wounded 
skin and wounds.  
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3  Equipment 
 
 
3.1  Blood Flow measurement 
 
 
There is currently no universally accepted gold standard for the measurement of 
blood  flow  [136],  however  techniques  used  include  videomicroscopy  [137],  H2 
clearance  [138],  Xenon  washout  [139],    plethysmography  [140-142]  fluroscene 
tracer [142]), temperature [143] as well as indirect measurements such as tcPO2 
[144].  
The invasive nature as well as the inability of some of these methods to be used in 
both on skin and within wounds (i.e. under a foam TNP dressing), makes them 
inappropriate  choices  for  use  in  this  thesis.  Laser  Doppler  however  offers  a 
sensitive, continuous, real time and potentially non-invasive method of monitoring 
microvascular blood flow [136], which can be used on skin and within wounds [145-
147] and which correlates well with other methods of blood flow assessment [148]. 
It  currently  exists  in  two  forms  Laser  Doppler  Imaging  (LDI)  [149]  and  Laser 
Doppler Flowmetry (LDF)[145]. 
LDI is able to create a two -dimensional blood flow map of tissue perfusion [149] 
Unlike  LDF  it  is  non-contact  method  of  blood  flow  measurement  .In  one 
embodiment  LDI  consists  of  a  laser  beam  that  scans  the  tissue  in  a  step-wise 
manner, by means of a computer controlled mirror system, which is housed in a 
camera-like scanner head [149]. This scanner is positioned about 10-30 cm above 
the tissue surface [149].  
In contrast to LDF, LDI is able to measure blood flow over large areas[149], but the 
laser  beam  is  unable  ‘scan’  through  the  foam  aspect  of  a  TNP  dressing,  and 
therefore LDF was chosen for current study.  
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3.1.1  Laser Doppler technique 
 
LDF  is  an  optical  technique  that  relies  on  the  Doppler  effect  to  measure 
microvascular blood flow [145]. In this method a beam of laser light is transmitted 
from a base unit, via an optical fibre to a probe that is usually placed on the tissue 
surface[145]. 
When the monochromatic and coherent (same wavelength and unscattered) laser 
light is emitted by the probe, transmission, absorption and scattering of light occurs 
within the tissue [145],Figure 14. Any backscattered light from the tissues will consist 
of light that has been spectrally broadened by moving red blood cells, as a result of 
the  Doppler  effect,  and  of  light  that  is  backscattered  from  stationary  structures, 
whose wavelength will remain unchanged [136, 150].  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14 Diagram of laser Doppler probe consisting of a single transmitter of laser light 
and two receivers of backscattered light.  
 
 
Both these forms of backscattered light are received by the laser Doppler probe 
and returned to the base unit, where they are transferred to a photodetector for 
processing and converted into a voltage output [145]. This voltage output is related 
to the concentration and speed of the moving red blood cells responsible for the 
Doppler  shift  [150]  and  has  arbitrarily  been  defined  in  relative  units  known  as 
Perfusion Units (PU) or units of Blood Flux (BF) [136].     93 
LDF is therefore best used to monitor dynamic changes in microvascular blood flow 
in response to physiological stimuli [151], such as increasing the local temperature 
[152], occluding blood supply using a tourniquet [153], or in the case of this thesis 
the application of SAP to a TNP dressing. Rather than being able to measure over 
a large area, LDF measures blood flow in a single spot, and from a sample volume 
of approximately 1mm
3 [26, 145, 154]. 
An example of LDF recordings is shown in Figure 15, which illustrates the two major 
components of the received signal. The individual peaks reflect heart beats, whilst 
the sinusoidal pattern, known as vasomotion are though to occur as a result of 
rhythmical  diameter  changes  in  the  vasculature  [155],  and  occur  at  a  rate  of 
between  cycles  per  minute  4-10/minute  [131,  156].  Whilst  these  variations  in 
microcirculation  occur  over  short  periods  of  time,  i.e.  over  seconds,  further 
variations in perfusion such as slow drifts and stochastic changes can also occur 
[136], over a period of minutes.  
 
 
Figure 15 A thirty second LDF trace, illustrating heart synchronous beats and 
vasomotion. Time on X axis and Perfusion Units or Flux on Y axis 
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3.1.1.1   Laser Doppler System and Probe 
 
 
The  volume  of  tissue  in  which  LDF  measures  blood  flow  is  claimed  to  be 
approximately  1mm
3  [26,  145,  154],    however  this  will  depend  on  a  number  of 
factors. These include laser wavelength [148], as this will determine the depth of 
penetration of the laser light in a given tissue, the probe geometry [136, 157] and 
the optical properties of the tissue being measured. 
For the purposes of this study a Periflux
© LDPM – P5010 base unit (Perimed
©, 
Sweden) will be used throughout, Figure 16. This has a diode 780nm (1 milliwatt) 
laser and measures blood flow at a frequency of 32 Hz, i.e. the base unit measures 
the blood flow thirty-two times every second. 
 
 
 
 
Figure 16 The Perimed P5010 base unit 
 
To minimise the presumed effect on blood flow that insertion of an invasive laser 
Doppler probe would produce, a non-invasive surface probe will be used in this 
study.  
Although a variety of surface probes are supplied by Perimed
© these tend to be 
bulky in nature. As a result, and after consultation with Perimed
© Sweden a wafer 
thin  probe  was  designed  and  manufactured  specifically  for  thus  study.  The 
dimensions  of  this  new  probe  were  1cm  by  0.8cm  by  2mm,Figure  17.  It  was 
envisaged that this probe would allow blood flow to be measured without perturbing 
the TNP system itself or the application of a variety of SAP. 
     95 
 
 
 
 
 
 
 
 
 
                                        
 
 
 
Figure 17 The specially designed Perimed Probe 
 
3.2  TNP system 
 
 
The TNP system used for this thesis was the VAC
© ATS
© system, Figure 18. As 
previously described this consists of PU foam, adhesive drape, a TRAC
© pad that 
allows the dressing to be connected to a collection canister, and an ATS
© suction 
pump that houses the collection canister. The pump used was a specially modified 
VAC
© ATS
© pump (modified by KCI
© Ferndown), whose software allowed the three 
different cycles that are being compared in this thesis, to be applied to the dressing 
on demand. 
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Figure 18 VAC
© ATS
© TNP System capable of applying the three SAP pressure 
regimes being tested in this thesis 
 
 
3.3  Temperature Probe 
 
Skin  /  wound  blood  flow  can  be  significantly  influenced  by  surface  temperature 
[153, 158, 159], which is dependent primarily on the local and room temperature 
changes. 
From  research  within  our  laboratory  it  is  known  that  the  foam,  because  of  its 
insulating nature causes a rise in surface temperature of skin, in the order of 2.6ºC 
(mean  2.6°C  +/-0.6SD),  with  similar  rises  seen  in  wounds  of  1.13ºC  (1.13  +/- 
0.92SD). 
This may well result in rises in blood flow, however as the current study primarily 
investigates whether the application of SAP to a TNP dressing influences blood 
flow, the intention is to monitor the temperature under the foam dressing using a 
Datalogger 1000
© (DCPmicro
© Uk),Figure 19, with a 2mm thermister probe, and only 
begin blood flow recordings when the temperature, under the foam dressing, has 
plateaued.  
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Figure 19 Datalogger 1000
©  
 
The ambient room temperature in addition can have significant effects on the skin/ 
wound  surface  temperature  [159,  160],  and  therefore  skin/  wound  blood  flow, 
however  at  an  ambient  temperature  of  between  20-25ºC,  in  a  draught  free 
environment cutaneous measure blood flow is relatively stable [153]. 
The room temperature was monitored and controlled, in this study, to be between 
20-25ºC using a central heating thermostat. The room was draught free. In addition 
the effect the ambient temperature had on skin temperature was monitored in a site 
adjacent to the experimental area (using a second Datalogger
© probe). 
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4  Sources of Variation and Validation 
 
 
4.1  Sources of Variation 
 
A number of factors were considered when initially writing a protocol for this study. 
These were factors that were known to significantly influence blood flow or have 
significant effects on the measurement of blood flow using LDF. Broadly they were 
divided into, patient factors, environmental factors and equipment factors, which 
are  discussed  below.  Further  sources  of  variation,  which  could  lead  to 
misinterpretation of results in blood flow studies were considered and examined in 
a  series  of  experiments,  which  are  presented  and  discussed  from  section  4.2 
onwards.  
 
4.1.1  Patient/ Volunteer factors 
 
Patient/ volunteer factors known to influence laser Doppler measured blood flow 
include  
 
 
1.  Patient  position  and  limb  position  which  are  both  known  to  affect  LDF 
measured blood flow. For example mean values of LDF measured blood 
flow, in the lower limb, have been reported to be higher in healthy volunteers 
when the individual is supine rather than standing [161], whilst lower values 
have been seen on dependency [162]. 
  
2.  Significant  patient  movement,  which  cannot  only  cause  movement  of 
surface probes but can also result in high amplitude artefacts on the LDF 
recording [151]. 
 
3.  Physical  activity.  This  can  lead  to  significant  increases  in  blood  flow  to 
certain tissues such as muscle and the skin [153]. However the increase in 
skin  tends  to  be  shortlived  once  the  exercise  stops  [153]  and  so  by 
incorporating  an  adaptive  phase  before  the  start  of  the  experiment,  the     100 
influence  of  pre-experimental  effort  induced  changes  in  laser  Doppler 
measured  blood flow can be minimised [153]. 
 
4.  Cognitive  activity  and  mental  stress  can  also  have  an  influence  on  the 
cutaneous circulation[163, 164].  
 
5.  Certain  vasoactive  substances  can  effect  laser  Doppler  measured  skin 
blood flow, for example vasoactive medications such as nitroglycerine and 
prazosine can have a prolonged influence [153, 158], as well as nicotine 
from smoking and nicotine patches and caffeine [153, 165]. 
 
6.  The optics of a patient’s wounds – a freshly debrided wound prior to TNP 
therapy will likely have a degree of bleeding from the wound bed. If a laser 
Doppler was used on this wound bed, the Brownian motion within any film of 
blood is likely to be a significant component of any recorded ‘blood flow’. In 
addition  the  optics  of  a  necrotic  aspect  of  a  wound  will  be  significantly 
different from that of an area with healthy granulation tissue. 
 
 
Clinical  observation  suggests  that  wound  beds  treated  with  TNP  usually  stop 
bleeding  by  the  second  TNP  dressing  change  (i.e.  at  least  4  days  after  initial 
debridement), and in most cases they have also begun to granulate by this stage. 
As a result it is intended that blood flow will be assessed in wounds after at least 4 
days of TNP therapy (i.e. at their second dressing change). 
 
 
4.1.2  Environmental Factors 
 
 
This relates primarily to temperature variation which was discussed in the previous 
chapter  but  also  includes  audiovisual  stimuli  and  mental  stress  which  are  both 
known to affect laser Doppler measured blood flow [153, 166]. European guidelines 
suggest that a draught free, quiet room be used and that patients/ volunteers adopt 
the position they will need to during the experiment, during an adaptive period of     101 
approximately thirty minutes[153]. All experiments therefore took place under these 
‘environmental’ conditions.  
 
 
 
4.1.3  Equipment factors 
 
 
Component degradation within the laser Doppler probe, lead or base unit can result 
in variation of the recorded signal. Regular calibration of the equipment is advised 
by the manufacturer (Perimed
© Uk) to detect any drift in laser Doppler signal that 
arises secondary to component degradation. In the current study this was done 
once  a  month  although  the  manufacturer  does  not  advise  any  strict  guidelines 
regarding the frequency of calibration [167].  
Practically  this  requires  the  testing  of  the  equipment  against  a  motility  standard 
(provided by Perimed
© Uk), which has a Perfusion Unit or Blood Flux rating of 250, 
and in addition against a zeroing disk, which as the name suggests has a PU rating 
of 0. 
In the first instance the LDF probe was immersed in a motility standard, with a 
Perfusion Unit rating of 250, for at least 5 minutes. The manufacturer recommends 
that the probe reads within 250 ± 5 %PU of this standard, Figure 20.   
 
 
 
 
 
 
 
Figure 20 An example of a recording from when the probe was immersed in a motility 
standard, performed monthly  
 
 
The LDF probe was then fixed within the zeroing disc, and laser Doppler output 
was  recorded  for  a  further  5  minutes.  The  manufacturers  recommend  that  the 
probe  read  within  ±  0.5  PU  of  this  standard.  The  probe  met  the  manufacture’s 
calibration requirements throughout the thesis.     102 
 
In addition, and prior to each experimental week, the laser Doppler was tested for 
its continued ability to detect changes in blood flow. In this thesis the validation of 
the  equipment  was  tested  by  two  methods.  Either  by  performing  a 
sphygmanometer occlusion test or an Allen’s test. In the latter the arterial supply to 
the hand was interrupted by occluding both the radial and ulna artery. The ulnar 
artery was then released whilst, in this thesis, recording blood flow changes in the 
pulp of the index finger. 
Alternatively a sphygmanometer occlusion test was performed in which blood flow 
was  recorded,  on  the  volar  aspect  of  the  forearm  for  1  minute,  the 
sphygmanometer was then inflated to 20mmHg above the systolic blood pressure, 
which was then released after 1 minute. When used in this thesis both these tests 
characteristically produced a trace similar to Figure 21. 
 
 
 
 
 
Figure 21 Example of occlusion test with tourniquet. Following a baseline period a 
tourniquet is applied, evidenced by the decrease in perfusion units during the second 
period, whilst following tourniquet release, a reactive hyperaemic response is recorded, 
in which PU rises immediately above baseline and then returns to pre-occlusion levels. 
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4.2  Further Sources of Variation and Validation 
 
 
Basal tissue perfusion, especially in the skin demonstrates variability in both time 
and variability in space [155,168]. Both these factors may lead to misinterpretation 
of data in this study and are therefore explored in a series of validation experiments 
in this section.  Although they were performed in non-wounded skin, it was intended 
where  possible,  to  draw  inferences  from  the  results,  which  would  aid  the  study 
design assessing wound blood flow.  
 
 
4.2.1  Temporal variation 
 
As already mentioned, the laser Doppler signal, which reflects the microcirculatory 
blood  flow,  has  two  major  components  namely  heart  synchronous  beats  and  a 
sinusoidal  pattern  known  as  vasomotion.  These  components  of  the  LDF  signal 
occur over seconds. Further variations, either slow drifts or stochastic changes can 
also occur, but do so over longer time periods.  
Although  LDF  is  a  sensitive  real-time  method  of  measuring  blood  flow  it  lacks 
absolute units and therefore changes in perfusion have to be determined relative to 
a baseline/ reference period. The protocol for this study intends to measure blood 
flow for a baseline period of 10 minutes during which time the TNP dressing is in 
situ but no SAP is applied (‘Dressing only’ or ‘Baseline’), and to then observe if any 
relative change occurs during a second twenty -minute period in which one of the 
SAP is applied (‘Dressing + suction’ or ‘experimental’ period). Clearly if there was 
significant changes in measurements between these two time periods as a result of 
the ‘normal’ temporal variation of blood flow, rather than as a result of applying a 
SAP then misinterpretation of data could occur, i.e. rises or decreases in blood flow 
could  be  attributed  to  the  application  of  a  SAP  but  actually  be  due  to  ‘normal’ 
temporal variation. 
 
 
 
 
     104 
4.2.1.1 Aims 
 
Therefore the aim of this validation study was to investigate the variation in blood 
flow that can occur in time (and independent of applying a SAP to a TNP dressing), 
over a 30 minute period. The intention was to compare blood flow in the first ten 
minute period (intended baseline period), with the following twenty minute period 
(intended period during which SAP would be applied). Further analysis of the data 
was performed to assess whether varying the periods – five minute baseline versus 
ten minutes experimental affected the temporal variation seen. 
   
 
4.2.1.2 Methods  
 
 
Healthy volunteers included if they met the following criteria 
 
1.  That they were 18 years or older 
2.  Able to lie relatively still for approximately a 1.5 hour period 
3.  Non smokers 
 
And excluded if 
 
1.  Volunteers  with  serious  medical  problems  such  as  diabetes  mellitus, 
hypertension. 
2.  Allergies to polyurethane adhesive/ foam 
3.  If the volunteer had any skin rashes in the intended area to be investigated 
4.  If the volunteer wore nicotine patches 
5.  If the volunteers were on vasoactive medications 
 
 
Twenty healthy non-smoking volunteers, mean age 34.2± SD 11.1 years, took part 
in the study. All experiments were performed in a dedicated draught free, quiet 
room  in  the  Medical  Physics  department  of  Salisbury  District  Hospital.  The     105 
temperature in this room was monitored with a thermometer and was controlled 
between 20-25ºC. 
Volunteers lay on standard hospital bed with a pressure relief mattress, in a semi –
recumbent position, with their lower limbs placed on the bed. Their knees were 
semi flexed with a single pillow placed under the knees for comfort. 
No caffeinated drinks were allowed during the testing. Volunteers were asked not to 
perform any physical activity prior to the experimental period, and were asked to lie 
as still as possible during the experiments. They were warned that any movement 
could jeopardise results 
After an adaptive period of 30 minutes, the LDF probe and Datalogger
© thermister 
were  placed  on  a  flat  surface,  in  between  in  between  the  tendons  of  Extensor 
Hallucis  Longus  and  Extensor  Digitorum  Longus,  Figure  22.  These  probes  were 
dressed with a 5 by 5cm piece of PU foam, such that the probes were in a central 
position  relative  to  the  foam.  After  being  sealed  with  an  adhesive  drape  that 
extended  5cm  beyond  the  foam  edge.  A  TRAC
©  pad  was  applied  but  was  not 
connected to a VAC
© ATS
© pump.  
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Figure 22 Position of Probes relative to tendons on dorsum of the foot 
 
 
 
 
After the temperature under the foam had plateaued blood flow recordings began 
and continued for a thirty minute period. An example of such a recording is given in 
Figure 23. 
 
Tendon of Extensor 
Digitorum Longus to 
second toe  
 
Tendon of 
Extensor 
Hallucis Longus 
Approximate Position of 
LDF and Temperature 
Probe (placed distal to 
Dorsalis Pedis Pulse)     107 
t 
Figure 23 An example of a LDF recording illustrating temporal changes in measured 
blood flow over a 30 minute period.  
 
 
4.2.1.3 Data analysis  
 
The mean and standard deviation of blood flow in the first ten minutes (the baseline 
period) and the following twenty minutes was calculated, for each volunteer. The 
mean blood flow for the periods is contained within Table 2. 
 
A  Wilcoxon  paired  samples  test  was  employed  to  assess  whether  there  was  a 
statistically significant change in blood flow between the baseline period and the 
subsequent twenty minutes. A p< 0.05 was deemed statistically significant. 
In  addition  the  percentage  change  in  mean  blood  flow  that  occurred  during  the 
twenty-minute period was calculated using the following formula. 
 
 
Mean blood flow (twenty minute period) – mean blood flow (First period)    * 100 % 
                                Mean blood flow (First period) 
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Using the same data the mean and standard deviation was calculated in the first 
five-minute of data collection (the baseline period), and the subsequent 10 minutes. 
The  mean  blood  flow  for  the  periods  is  contained  within  Table  3.  This  data  was 
analysed in a similar manner to above. 
 
 
4.2.2  Explanation of the use Non Parametric Tests 
 
The results in this section and in this thesis as a whole were subjected to a non-
parametric tests following evaluation of the data in conjunction with the hospital 
statistician at Salisbury District Hospital. 
The small sample size of n=10 in most experiments performed in this thesis was a 
major reason to use non-parametric test as was the use of the Alistair-Darling test 
of normality [169] (this is a statistical method of assessing whether data is normally 
distributed or not). 
When data from the use of TNP in non-wounded and wounded skin was subjected 
to this test it was clear that in the majority of experiments (five from nine), data was 
distributed in a non-Gaussian (normal) distribution, and therefore non parametric 
statistical analysis was used throughout.   
Both  the  Wilcoxon  paired  sample  test  and  the  Kruskal-Wallis  test  are  non-
parametric statistical methods. The Wilcoxon test assesses the difference between 
two  paired  groups  (i.e.  between  baseline  and  experimental  periods)  whilst  the 
Kruskal-Wallis test evaluates whether there is a difference between three or more 
independent  groups  and  in  this  thesis  is  used  to  assess  whether  there  is  a 
difference between the application of TNP in the different pressure cycles as set 
out in the null hypothesis. 
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4.2.2.1 Results  
 
 
4.2.2.1.1  Temporal variation over 30 minutes 
 
Overall there was no statistically significant difference in blood flow between the 10 
minute baseline period and the subsequent 20 minute period, p= 0.16.  However 
the LDF measured blood flow did exhibit a degree of temporal variation over this 
time  period,  with  the  range  of  observed  percentage  changes  being  between, 
approximately –15% and + 20% of the corresponding baseline blood flow. In 6/20 
subjects the blood flow rose during this period, otherwise there was a tendency for 
the LDF measured blood flow to decrease Figure 24. 
 
4.2.2.1.2  Temporal variation over 15 minutes 
 
The  results  for  a  15  minute  period  were  similar.  Once  again  there  was  no 
statistically significant difference in blood flow between the 5 minute baseline period 
and the subsequent 10 minute period, p= 0.12. The degree of temporal variation 
seen over this time period, ranged between approximately –10 % and 
+17  %  of  the  corresponding  baseline  blood  flow.  14/20  subjects,  showed  a 
decrease in blood flow relative to the baseline period over the course of the fifteen 
minutes Figure 24. 
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Figure 24 Dotplot of Percentage change in mean blood flow relative to baseline in n=20 
volunteers. On the superior dotplot 30 minutes refers to a baseline period of 10 minutes 
followed by an ‘experimental’ period of twenty minutes. Whilst on the inferior dotplot 15 
minutes refers to a baseline period of 5 minutes followed by an ‘experimental’ period of 
10 minutes 
 
. 
4.2.2.2 Conclusions 
 
•  Laser Doppler measured blood flow in the dorsum of the foot demonstrates 
temporal variation. 
•  There is a general trend for the measured blood flow to decrease with time 
relative to baseline levels. 
•  This change is not statistically significant, if one has a baseline period of 5 
minutes followed by an ‘experimental’ period of 10 minutes. 
•  Nor is it significant if one has a baseline period of 10 minutes followed by an 
‘experimental’ period of 20 minutes. 
•  Although it is not possible to infer that this is the case in wounds, it is useful 
to appreciate that changes in blood flow can occur in experimental situations 
that are independent of applying a SAP. Changes that are a feature of the 
temporal variation in the microcirculation.      111 
 
 
 
4.2.3  Spatial variation 
 
4.2.3.1 Aims 
 
To demonstrate the spatial variation that can be seen in adjacent areas of a tissue, 
millimetres apart. 
 
4.2.3.2  Methods 
 
Blood flow was recorded on the dorsum of the foot in the ten healthy volunteers, 
mean age 30.5 ± SD 11.4 years. The inclusion and exclusion criteria as well as the 
experimental conditions were the same as for the temporal experiments. 
After an adaptive period of 30 minutes, blood flow was recorded firstly in a central 
position,  and  then  the  LDF  probe  was  moved  in  succession  to  points  2mm 
proximal, 2mm medial, 2mm distal and 2mm lateral to the original position. In each 
position blood flow was recorded for five minutes.  An example of such a recording 
is given in Figure 25. 
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Figure 25 An example LDF recordings that illustrate spatial variation in perfusion, 2mm 
proximal (P), medial (M), Distal (D) and lateral (L) from a reference point on the dorsum 
of the foot 
 
4.2.3.3 Data analysis 
 
The mean and standard deviation of each period was calculated. The means are 
included in Table 4 and Table 5 .  
 
 
4.2.3.4 Results 
 
The  difference  in  mean  perfusion  between  the  probe’s  original  position  and  the 
subsequent areas in which it was placed is, is illustrated in Figure  26 for all ten 
volunteers.     113 
.  
Figure 26 Dotplot illustrating deviations in mean Perfusion Units following probe 
movement in n=10 volunteers 
 
 
4.2.3.5 Discussion 
 
These  results  confirm  the  findings  of  others  regarding  the  significant  spatial 
variations in blood flow seen in skin [168], a spatial variation of blood flow which 
undoubtedly also exists in the granulation tissue of open wounds. In the context of 
this  study  they  also  highlight  how  probe  movement,  particularly  during  the 
application and removal of suction, could lead to the misinterpretation of collected 
data.  
A number of factors are likely to minimise the risk of probe movement  
  
1.  Placing the probe on an even and flat surface as possible, which applies 
equally to use on intact skin or wounds.  
2.  Using tape to secure the probe to the skin surface. 
3.  The  selection  of  predominantly  two-dimensional  wounds,  i.e.  non-cavity 
wounds. From a practical point of view it is difficult to place the probe flat on 
the base of a cavity wound. This is because the first centimetre of the probe 
lead is relatively immobile, and therefore there is a tendency for the probe to 
tilt when placed in cavity wound.  
4.  Reducing patient movement during the course of the experiment.       114 
 
 
 
4.2.3.6 Conclusions 
 
•  Probe movement under the foam aspect of a TNP dressing could lead to 
misinterpretation of data in any blood flow study. 
•  Any  movement  is  likely  to  occur  during  the  application  and  release  of 
suction and therefore be greatest during the intermittent pressure regime. 
•   Securing the probe with tape may reduce this movement. 
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4.2.4  Probe movement 
 
Although the axial forces may well hold the probe in place prior to the application of 
a  SAP  or  indeed  after  the  application  of  a  SAP,  the  greatest  risk  of  probe 
movement,  in  this  study  is  likely  to  occur,  in  the  transition  between  the  two 
(although it may well be reduced by the fact that the system theoretically should not 
produce any shear forces- see chapter 7). 
It  is  clearly  not  possible  to  visualise  whether  probe  movement  has  occurred 
because  of  the  nature  of  the  foam  aspect  of  the  dressing.  However  an  indirect 
method  of  assessing  whether  probe  movement  has  occurred  can  be  used  by 
statistically comparing the mean blood flow during the baseline period and during 
the off periods, in the intermittent cycle. If the mean blood flow during these periods 
are similar one can infer that the probe has not moved.  
 
 
4.2.4.1 Aims 
 
To investigate whether probe movement occurs during the application and removal 
of a SAP. 
 
4.2.4.2 Methods  
 
Five healthy volunteer mean age 27.1 ± SD 8. 4 years took part in this study. Using 
the  same  experimental  conditions,  as  previously  outlined,  and  after  an  adaptive 
period of 30 minutes, the laser Doppler probe, and the Datalogger
© thermister were 
placed  in  the  reasonably  flat  surface  between  the  tendons  of  Extensor  Hallucis 
Longus  and  Extensor  Digitorum  Longus  to  the  second  toe.  The  probes  were 
secured to the skin surface with tape. 
The probes were then dressed with a nominal sized piece of TNP foam (5 by 5cm), 
and sealed with adhesive drape that extended by 5 cm in each direction beyond the 
foam  edge.  The  foam  was  then  connected  to  a  VAC
©  ATS
©  pump.  Blood  flow 
recordings began when the temperature under the foam plateaued.      116 
A baseline period of five minutes was recorded followed by a further 10 -minute 
period in which a 125mmHG SAP was applied intermittently every minute, giving a 
total  experimental  time  period  of  15  minutes.  It  was  assumed  that  if  no  probe 
movement occurred, then during the off periods of the intermittent cycle, blood flow 
would return to baseline levels. An example of recording is given in Figure 27. The 
mean and standard deviation blood flows are displayed in Table 6 . 
   
 
 
Figure 27 An example of a LDF trace investigating probe movement. The figures of 125 
and 0 refer to the SAP to which the TNP dressing was subjected 
 
 
 
4.2.4.3 Data analysis 
 
If  the  difference  in  the  mean  blood  flow  between  the  baseline  period  and  the 
subsequent off periods lay within 
 
    2.77  *                 (SD1)
2
 + (SD2)
2 
                            2 
                                          
where SD1 = standard deviation of baseline period 
           SD2= standard deviation of ‘off’ period 
     117 
It  was  assumed  that  the  probe  had  not  moved.  A  detailed  explanation  of  this 
statistical method known as a Delta check [169] [181] is provided in appendix 1. 
This delta check was repeated for every off period measured. 
 
 
4.2.4.4 Results 
 
For all five volunteers, and in all off periods during the intermittent cycle, the mean 
blood flow lay within this range. That is, no statistically significant change occurred 
in blood flow during the off periods relative to baseline blood flow. 
 
4.2.5  Discussion 
 
 
4.2.5.1.1  Probe movement in non -wounded skin 
 
If secured with tape the laser Doppler probe does not appear to move during the 
intermittent  application  of  a  125mmHG  SAP.  Similar  results  were  obtained  with 
when the experiment was repeated in the ‘medial Tibia’. 
One can therefore assume that if tape is used the laser Doppler probe is unlikely to 
move during the application and removal of suction, in ‘flat’ uniform surfaces such 
as the foot and medial Tibia.  
 
 
4.2.5.1.2  Probe movement in wounds 
 
 However even by selecting predominantly two-dimensional wounds there is still 
clearly a risk that the probe may move. In an effort to exclude such data from the 
results  within  wounds,  three  time  periods  of  blood  flow  measurement  were 
recorded. 
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1.  Period1 – a baseline of 10 minutes 
2.  Period  2  –  during  which  one  of  the  SAP  cycles  would  be  applied  – 
experimental period 
3.  Period 3 – ‘a return to baseline period’ or validation period 
 
If  Periods  1  and  3  were  not  statistically  significantly  different,  data  from 
wounds was included (see appendix 1).  If they were different statistically it was 
assumed that the probe had moved and the data was rejected. 
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4.2.6   Temporal variation Data 
 
 
BASELINE 10 minutes  NEXT 20 minutes  Change in Blood Flow 
in Perfusion Units 
Percentage change 
relative to baseline 
4.80  5.11  0.31  6.4583 
8.89  8.48  -0.41  -4.6119 
12.76  14.11  1.35  10.5799 
9.20  8.46  -0.74  -8.0435 
7.31  7.30  -0.01  -0.1368 
57.64  58.84  1.20  2.0819 
55.25  47.17  -8.08  -14.6244 
27.53  25.98  -1.55  -5.6302 
28.73  34.44  5.71  19.8747 
27.87  25.19  -2.68  -9.6161 
42.86  45.28  2.42  5.6463 
73.39  70.44  -2.95  -4.0196 
33.92  29.72  -4.20  -12.3821 
47.97  47.17  -0.80  -1.6677 
35.94  35.19  -0.75  -2.0868 
49.08  48.35  -0.73  -1.4874 
27.68  25.68  -2.00  -7.2254 
74.74  69.24  -5.50  -7.3588 
63.35  62.35  -1.00  -1.5785 
72.57  74.82  2.25  3.1005 
 
Table 2 Temporal variation over 30 minutes, with baseline of 10 minutes and experimental period of 20 minutes- mean values shown     120 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3 Temporal variation over 15 minutes, with baseline of 5 minutes and experimental period of 10 minutes- mean values shown   
 
 
 
 
BASELINE 5 minutes 
 
 
NEXT 10 minutes 
 
Change in Blood Flow in 
Perfusion Units 
 
Percentage change 
relative to baseline 
4.66  5.11  0.45  9.6567 
9.04  8.99  -0.05  -0.5531 
13.17  15.37  2.20  16.7046 
8.67  9.35  0.68  7.8431 
8.17  7.53  -0.64  -7.8335 
59.35  61.90  2.55  4.2965 
57.93  56.10  -1.83  -3.1590 
28.61  25.96  -2.65  -9.2625 
28.29  32.98  4.69  16.5783 
28.97  26.53  -2.44  -8.4225 
43.29  42.72  -0.57  -1.3167 
76.20  69.18  -7.02  -9.2126 
34.88  31.30  -3.58  -10.2638 
48.71  47.15  -1.56  -3.2026 
37.33  33.60  -3.73  -9.9920 
49.00  49.52  0.52  1.0612 
28.22  26.98  -1.24  -4.3940 
75.57  73.63  -1.94  -2.5672 
63.94  62.62  -1.32  -2.0644 
73.19  73.55  0.36  0.4919   121 
 
4.2.7  Spatial Variation Data 
 
 
Table 4 Spatial Variation in volunteers 1-5 
 
 
                     Volunteer 1  Volunteer 2 
 
                                      
Volunteer 3 
 
 
Volunteer 4 
 
 
Volunteer 5 
  Mean  SD  Mean  SD  Mean  SD  Mean  SD  Mean  SD 
Original 
Position  39.12  3.57  65.83  2.99  18.26  2.64  71.81  5  36.38  3.38 
Subsequent 
Positions  20.93  3.52  77.98  3.62  21.83  2.39  66.12  3.27  44.35  4.31 
  24.53  4.22  73.01  4.68  26.99  2.35  98.07  6.57  37.17  6.41 
  42.37  5.24  111  5.02  17.97  2.16  88.01  4.28  34.25  3.57 
  47.01  5.33  79.42  6.54  18.88  2.83  79.08  3.07  25.33  2.76   122 
 
 
 
Table 5  Spatial Variation in volunteers 6-10 
 
 
Volunteer 6  Volunteer 7 
                  
 
  
Volunteer 8 
                         
 
 
Volunteer 9 
 
 
 
Volunteer 10 
 
Mean Blood 
flow  SD 
Mean 
Blood flow  SD 
Mean Blood 
flow  SD 
Mean Blood 
flow  SD  Mean Blood Flow  SD 
Original 
Position  13.98  3.57  61.65  4.98  18.28  2.47  13.98  3.57 
 
 
38.86  4.11 
Subsequent 
Positions  18.51  2.39  55.59  4.7  21.84  2.4  18.51  2.39  20.91  3.52 
  15.65  3.73  64.2  5.46  26.62  2.89  15.65  3.73  25.4  7.98 
  19.08  2.55  31.44  4.67  17.98  2.17  19.08  2.55  42.33  5.23 
  16.34  3.16  33.43  3.6  18.9  2.24  16.34  3.16  47.04  5.32   123 
4.2.8  Probe Movement Validation Data 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                          
Table 6  Mean and standard deviation (SD) of blood flow during baseline periods and subsequent ‘off’ period
  Mean 
Blood 
Flow 
SD  Mean 
Blood 
Flow 
SD  Mean 
Blood 
Flow 
SD  Mean 
Blood 
Flow 
SD  Mean 
Blood 
Flow 
SD 
Baseline 5 
minutes 
26.22  1.87  21.69  1.89  23.74  1.93  18.45  1.22  19.49  1.26 
125mmHg SAP 
26  1.96  22.53  1.33  22.11  1.36  22.19  5.97  19.24  1.66 
0 mmHg SAP 
25.33  1.77  22.92  1.54  21.95  1.53  18.73  1.24  19.5  1.22 
125mmHg SAP 
25.18  1.77  22.28  1.12  22  1.72  18.69  1.69  19.33  1.64 
0 mmHg SAP 
25.6  2.8  21.83  1.55  22.11  1.41  19.86  2.01  19.45  1.22 
125mmHg SAP 
24.42  1.77  22.94  1.5  20.93  1.97  18.96  1.26  19.55  1.39 
0 mmHg SAP 
23.8  1.71  21.85  1.06  21.3  1.36  19.54  2.2  19.89  2.63 
125mmHg SAP 
24.89  1.63  21.64  1.06  23.3  1.4  19.33  2.05  20.91  1.93 
0 mmHg SAP 
24.72  1.62  22.57  1.37  23.29  1.9  19.78  1.22  21.66  2.11 
125mmHg SAP 
24.5  1.61  21.23  0.98  23.55  2.09  18.64  1.64  19.46  1.35 
0 mmHg SAP 
23.82  1.43  22.13  1.12  22.16  1.43  19.35  1.3  19.43  1.11 
Volunteer 1  Volunteer 2  Volunteer 3  Volunteer 4  Volunteer 5   124 
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5  The effect of TNP on blood flow in Skin 
  
5.1  Dorsum of the foot 
 
5.1.1  Aims  
 
To assess the effect on microvascular blood flow, in ten healthy volunteers, of 
applying  
 
1.  125mmHg SAP continuously 
2.  125mmHg SAP intermittently  
3.  150mmHg/ 100mmHg SAP in a profiled cycle 
  
to the dorsum of the foot. 
 
 
5.1.2  Methods 
 
Ten volunteers took part in the study; mean age  30.5  ±  SD  11.4  years, 5 
male, and 5 females. Volunteers were selected if they were non smokers and 
were able to lie relatively still for approximately an hour period at a time and 
excluded if they had any allergies to the polyurethane adhesive or foam, if 
there were any skin rashes on the dorsum of the foot, if they were wearing 
nicotine patches or if the volunteers were taking any vasoactive medication. 
All  experiments  were  performed  in  a  dedicated  room  within  the  Medical 
Physics  department  of  Salisbury  District  Hospital,  which  was  quiet  and 
draught free. Room temperature was monitored throughout (to be between 
20-25°C).   126 
Volunteers  were  asked  not  to  perform  any  physical  activity  prior  to  the 
experimental period. 
Volunteers lay on a standard hospital bed, in a semi-recumbent position, with 
a pillow placed under the knees, resulting in approximately 10-20º of knee 
flexion. No caffeinated drinks were allowed during testing.  Prior to recording 
blood flow volunteers were counselled that limb movement could jeopardise 
results. 
After  an  adaptive  period  of  30  minutes,  the  LDF  probe  and  Datalogger
© 
thermister were placed on a flat surface, in between the tendons of Extensor 
Hallucis  Longus  and  Extensor  Digitorum  Longus  of  the  volunteers.  The 
probes were secured to the skin using adhesive tape, and were then dressed 
with  a  5  by  5cm  piece  of  foam,  such  that  the  probes  were  in  a  central 
position relative to the foam.  
After being sealed with an adhesive drape that extended 5cm beyond the 
foam  edge.  A  TRAC
©  pad  was  applied  and  connected  to  a  VAC
©  ATS
© 
pump. A second temperature probe was placed 2cm from the TNP dressing, 
and was used to monitor the effect of room temperature on skin temperature.  
In each experiment the temperature under the foam was monitored until it 
had plateaued. Once it had done so, blood flow, using the laser Doppler, was 
recorded for a baseline period of 10 minutes (Period 1- ‘Dressing only’ or 
baseline  period).  One  of  the  SAP  cycles  (randomly  selected)  was  then 
applied for 20 minutes. Changes in blood flow and temperature (under the 
foam) were recorded during this period (Period 2- ‘Dressing + Suction’ or 
experimental period).  
The experiment was repeated on a weekly basis until all the SAP cycles had 
been assessed in all volunteers. 
Data was excluded if the room temperature varied beyond the 20-25ºC range 
set  for  this  study,  or  the  skin  temperature,  measured  by  the  second  skin 
temperature  probe  changed  by  more  than  an  arbitrary  figure  of  ±  2.5ºC 
during  the  course  of  the  experiment.  In  addition  data  was  excluded  if 
volunteers moved excessively during the experiment. 
   127 
 
 
 
5.1.3  Data analysis 
 
 
A  Wilcoxon  paired  samples  test  was  used  to  determine  the  statistical 
significance of any change in blood flow between having a TNP dressing in 
place  and  applying  a  SAP  to  it.  A  p<0.05  was  accepted  as  statistically 
significant. 
A non-parametric Analysis of Variance (Kruskal-Wallis test) was performed, 
to determine the statistical significance of any difference between the three 
SAP profiles. A p<0.05 was accepted as statistically significant. 
 
5.1.4  Results 
 
The  data  from  these  series  of  experiments  is  provided  in  tables  7-9  and 
presented  in  box  and  whisker  graphs  in  Figures  28-  31.  The  associated 
changes in temperature seen during the application of the SAP cycles are 
illustrated  as  interval  plots  in  figures  32-34  (an  explanation  of  box  and 
whisker graphs as well as interval plots is given in appendix 3). 
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5.1.4.1  Continuous Pressure Regime 
 
 
 
p = 0.92 
 
Figure 28 Box and Whiskers graph illustrating changes in blood flow seen during the 
application of a continuous of 125mmHg SAP in n=10 volunteers 
 
 
In the ten volunteers no statistically significant change in blood flow occurred, 
in the dorsum of the foot, when a continuous SAP of 125mmHg SAP was 
applied to the TNP dressing.  
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5.1.4.2    Intermittent Pressure Regime  
 
 
 
p= 0.54 
Figure 29 Box and Whiskers graph illustrating changes in blood flow seen during the 
application of a Intermittent 125mmHg SAP in n=10 volunteers 
 
 
In the ten volunteers no statistically significant change in blood flow occurred, in 
the dorsum of the foot, when an intermittent SAP of 125mmHg SAP was applied 
to the TNP dressing 
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5.1.4.3    Profiled Pressure Regime 
 
 
 
 
 
p=0.42 
Figure 30 Box and Whiskers graph illustrating changes in blood flow seen during the 
application of Profiled SAP in n=10 volunteers 
 
 
In the ten volunteers no statistically significant change in blood flow occurred, 
in  the  dorsum  of  the  foot,  when  a  profiled  SAP  was  applied  to  the  TNP 
dressing  
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5.1.4.4  Comparison of Pressure Regimes 
 
 
 
 
p=0.70 
Figure 31 Box and Whiskers graph illustrating changes in blood flow seen during the 
application of SAP cycles in n=10 volunteers  
 
 
 
No statistically significant difference could be demonstrated between the 
effects of the SAP cycles on blood flow, in the dorsum of the foot in the ten 
volunteers. 
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5.1.5  Conclusions 
 
 
In this preliminary study performed in ten individuals  
 
•  TNP delivered as either a 125mmHg Continuous SAP, 125mmHg 
Intermittent SAP, or as a 150mmHg/100mmHg Profiled SAP failed to 
significantly increase blood flow on the dorsum of the foot. 
•  There was no significant difference between the effects of any of three 
SAP on blood flow. 
• The null hypothesis is therefore accepted for the effects of the 
three pressure regimes on the dorsum of the foot blood flow  133 
5.1.6  Foot Data   Continuous SAP 
 
 
Dressing Only  (Baseline) 
 
 
Dressing + Suction  (Experimental) 
 
 
Mean 
 
Standard deviation 
 
Mean 
 
Standard deviation 
Volunteer 1  8.45  1.28  6.92  1.64 
Volunteer 2  9.25  1.29  26.44  3.55 
Volunteer 3  37.25  1.05  39.87  3.76 
Volunteer 4  17.12  1.25  24.22  3.44 
Volunteer 5  27.66  1.98  21.94  1.6 
Volunteer 6  9.19  0.45  8.42  0.37 
Volunteer 7  20.78  2.05  24.96  1.38 
Volunteer 8  36.97  0.95  24.22  3.17 
Volunteer 9  36  0.95  32.49  2.26 
Volunteer 10  4.51  0.37  4.86  0.53 
Table 7  Mean and SD blood flow using 125mmHg Continuous SAP  on foot   134 
Foot Data  Intermittent SAP 
 
 
Dressing Only  (Baseline) 
 
 
Dressing + Suction  (Experimental) 
 
 
Mean 
 
Standard deviation 
 
Mean 
 
Standard deviation 
Volunteer 1  7.76  1.78  8.67  2 
Volunteer 2  13.34  2.37  28.53  6.33 
Volunteer 3  36.99  0.86  37.29  1.31 
Volunteer 4  17.2  1.54  18.74  2.79 
Volunteer 5  54.72  1.02  35.44  7.84 
Volunteer 6  42.23  0.8  38.34  2.73 
Volunteer 7  59.89  2.58  26.9  7.08 
Volunteer 8  25.48  0.83  16.81  1.6 
Volunteer 9  18.12  1.08  20.45  1.73 
Volunteer 10  3.56  0.43  3.17  0.59 
Table 8 Mean and SD blood flow using 125mmHg Intermittent SAP  on foot   135 
Foot Data  Profiled SAP 
 
 
Dressing Only (Baseline) 
 
 
Dressing + Suction  (Experimental) 
 
 
Mean 
 
Standard deviation 
 
Mean 
 
Standard deviation 
Volunteer 1  14.59  2.09  16.82  3.94 
Volunteer 2  17.11  1.14  16.15  0.71 
Volunteer 3  36.51  0.95  37.62  1.86 
Volunteer 4  17.12  1.25  24.22  3.45 
Volunteer 5  18.14  0.66  17.99  0.81 
Volunteer 6  45.51  1.1  21.37  4.92 
Volunteer 7  21.49  1.36  10.04  2.56 
Volunteer 8  22.62  0.91  15.44  1.67 
Volunteer 9  15.56  1.28  13.17  1 
Volunteer 10  2.41  0.33  3.69  0.53 
Table 9  Mean and SD blood flow using 125mmHg Profiled SAP on foot   136 
5.1.7  Temperature Interval Plots for the Foot 
 
 
 
Figure 32 Interval Plot during the experimental period and after application of a 
125mmHG Continuous SAP 
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Figure 33 Interval Plot during the experimental period and after application of a 
125mmHG Intermittent SAP (5 minutes on: 2 minutes off) 
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Figure 34 Interval Plot during the experimental period and after application of a 
Profiled SAP (3 minutes 150mmHg: 3 minutes 100mmHg) 
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5.2   Medial Tibia  
 
 
5.2.1  Aims 
 
 
To assess the effect on blood flow, in ten healthy volunteers, of applying  
 
4.  125mmHg SAP continuously 
5.  125mmHg SAP intermittently  
6.  150mmHg/ 100mmHg SAP in a profiled cycle 
  
to the medial Tibia (the probe in all cases being placed on the medial aspect of 
the proximal tibia). 
 
 
5.2.2  Methods 
 
 
The same ten volunteers as in the in ‘dorsum of foot ’ experiments took part in 
this study and the same methods and environmental conditions were adhered 
to. 
After  an  adaptive  period  of  30  minutes,  the  LDF  probe  and  Datalogger
© 
thermister were placed on the flat aspect of the medial palpable tibia, Figure 35, 
approximately  a  hands  breadth  below  the  palpable  inferior  aspect  of  the 
patella. . The probes were secured to the skin using adhesive tape, and were 
then dressed with a 5 by 5cm piece of foam, such that the probes were in a 
central position relative to the foam.  
After  being  sealed  with  an  adhesive  drape  that  extended  5cm  beyond  the 
foam edge. A TRAC
© pad was applied and connected to a VAC
© ATS
© pump. 
A second temperature probe was placed 1-2cm from the TNP dressing, and 
was used to monitor the effect of room temperature on skin temperature.    140 
In each experiment the temperature under the foam was monitored until it had 
plateaued.  Once  it  had  done  so,  blood  flow,  using  the  laser  Doppler,  was 
recorded  for  a  baseline  period  of  10  minutes  (Period  1-  Dressing  Only  –
baseline period). One of the SAP cycles (randomly selected) was then applied 
for 20 minutes. Changes in blood flow and temperature (under the foam) were 
recorded  during  this  period  (Period  2-  Dressing  +  Suction-  experimental 
period). 
The experiment was repeated on a weekly basis until all the SAP cycles had 
been assessed in all volunteers. 
Data was excluded if the room temperature varied beyond the 20-25ºC range 
set  for  this  study,  or  the  skin  temperature,  measured  by  the  second  skin 
temperature probe changed by more than an arbitrary figure of ± 2.5ºC during 
the  course  of  the  experiment.  In  addition  data  was  excluded  if  volunteers 
moved excessively during the experiment. 
 
 
 
Figure 35 Approximate position of probe in medial Tibia experiments 
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5.2.3  Data analysis 
 
 
A  Wilcoxon  paired  samples  test  was  used  to  determine  the  statistical 
significance of any change in blood flow between having a TNP dressing in 
place  and  applying  a  SAP  to  it.  A  p<0.05  was  accepted  as  statistically 
significant. 
A non-parametric Analysis of Variance (Kruskal-Wallis) test was employed to 
determine the statistical significance of any difference between the three SAP 
profiles. A p<0.05 was accepted as statistically significant. 
 
 
 
5.2.4  Results 
 
The data from these series of experiments is provided in tables 10-12 and 
presented  in  box  and  whisker  graphs  in  Figures  36-39.  The  associated 
changes in temperature seen during the application of the SAP cycles are 
illustrated figures 40-42.  
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5.2.4.1 Continuous Pressure Regime 
 
 
 
 
                     
p=0.15 
 
Figure 36 Box and Whiskers graph illustrating changes in blood flow seen during the 
application of a continuous of 125mmHg SAP in n=10 volunteers 
 
In the ten volunteers no statistically significant change in blood flow occurred, 
in the medial Tibia, when a continuous SAP of 125mmHg SAP was applied to 
the TNP dressing. 
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5.2.4.2 Intermittent Pressure Regime 
 
 
 
 
 
p=0.19 
Figure 37 Box and Whiskers graph illustrating changes in blood flow seen during the 
application of a intermittent 125mmHg SAP in n=10 volunteers 
 
In the ten volunteers no statistically significant change in blood flow occurred, 
in the medial Tibia, when an intermittent SAP of 125mmHg SAP was applied 
to the TNP dressing. 
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5.2.4.3 Profiled Pressure Regime 
 
 
 
 
 
 
p=0.84 
Figure 38 Box and Whiskers graph illustrating changes in blood flow seen during the 
application of profiled SAP in n=10 volunteers 
 
In the ten volunteers no statistically significant change in blood flow occurred, 
in the medial Tibia, when a profiled SAP was applied to the TNP dressing  
 
 
 
 
 
 
 
   145 
5.2.4.4 Comparison of Pressure Regimes 
 
p=0.87 
 
Figure 39 Box and Whiskers graph illustrating changes in blood flow seen during the 
application of SAP cycles in n=10 volunteers 
 
 
 
No statistically significant difference could be demonstrated between the 
effects of the SAP cycles on blood flow, in the medial Tibia of the ten 
volunteers. 
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5.2.5  Conclusions 
 
 
 
In this preliminary study performed in ten individuals  
 
•  TNP delivered as either a 125mmHg Continuous SAP, 125mmHg 
Intermittent SAP, or as a 150mmHg/100mmHg Profiled SAP failed to 
significantly increase blood flow on the dorsum of the foot. 
•  There was no significant difference between the effects of any of three 
SAP on blood flow. 
•  The null hypothesis is therefore accepted for the effects of the 
three pressure regimes on medial Tibia blood flow.   147 
5.2.6  Medial Tibia Data  Continuous SAP 
 
 
Dressing Only  (Baseline) 
 
 
Dressing + Suction  (Experimental) 
 
Volunteer 1  18.96  2.64  17.4  2.8 
Volunteer 2  19.29  0.63  19.12  2.07 
Volunteer 3  29.42  1.07  27.72  1.78 
Volunteer 4  14.86  0.67  12.61  1.2 
Volunteer 5  13.9  2.17  15.42  2.46 
Volunteer 6  12.82  1.4  19.9  2.73 
Volunteer 7  17.39  1  24.86  3.92 
Volunteer 8  12.9  1.13  22.57  3.81 
Volunteer 9  22.65  1.08  27.9  2.82 
Volunteer 10  18.43  0.61  29.64  4.41 
 
Table 10 Mean and SD blood flow using 125mmHg Continuous SAP on medial tibia   148 
Medial Tibia Data  Intermittent SAP 
 
 
Dressing  (Baseline) 
 
 
Dressing + Suction  (Experimental) 
 
 
Mean 
 
Standard deviation 
 
Mean 
 
Standard deviation 
Volunteer 1  13.71  0.74  16.31  1.39 
Volunteer 2  34.9  1.69  29.29  4.29 
Volunteer 3  28.14  2.35  19.77  2.55 
Volunteer 4  11.71  0.47  25.78  9.71 
Volunteer 5  13.37  1.97  20.76  3.62 
Volunteer 6  21.26  0.99  20.53  1.8 
Volunteer 7  16.93  0.86  15.91  1.96 
Volunteer 8  30.98  2.41  55.6  8.68 
Volunteer 9  30.27  1.79  36.88  2.8 
Volunteer 10  24.61  3.92  36.34  5.07 
Table 11 Mean and SD blood flow using 125mmHg Intermittent SAP on medial tibia   149 
Medial Tibia Data  Profiled SAP 
 
 
Dressing  (Baseline) 
 
 
Dressing + Suction  (Experimental) 
Volunteer 1  37.91  5.51  33.91  3.42 
Volunteer 2  30.73  0.72  31.07  0.6 
Volunteer 3  110.28  14.01  38.38  6.77 
Volunteer 4  12.88  1.18  49.4  3.07 
Volunteer 5  22.2  1.75  34.89  4.67 
Volunteer 6  13.38  0.82  15.3  0.92 
Volunteer 7  24.73  1.12  22.6  1.67 
Volunteer 8  10.26  0.92  14.57  1.74 
Volunteer 9  63.88  1.89  43.93  7.37 
Volunteer 10  24.49  1.4  39.18  4.51 
 
 
Table 12Mean and SD blood flow using 125mmHg Profiled SAP on medial tibia   150 
5.2.7  Temperature Interval Plots for Medial Tibia 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 40 Interval Plot during the experimental period and after application of a 
125mmHG continuous SAP 
 
 
Medial Tibia – Continuous 
Pressure   151 
 
 
 
 
 
Figure 41 Interval Plot during the experimental period and after application of a 
125mmHG Intermittent SAP (5minutes on: 2 minutes off) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Medial Tibia – Intermittent 
Pressure   152 
 
 
 
 
 
 
Figure 42 Interval Plot during the experimental period and after application of a 
Profiled SAP (3minutes 150mmHg: 3 minutes 100mmHg) 
 
 
 
 
 
Medial Tibia – Profiled 
Pressure   153 
 
6  The Effect of TNP on Blood Flow in Wounds 
 
6.1.1  Aims 
 
 
To assess the effect on blood flow, in ten patients of applying  
 
1.   125mmHg SAP continuously 
2.  125mmHg SAP intermittently  
3.  150mmHg/ 100mmHg SAP in a profiled cycle 
  
to their wounds. 
 
6.1.2  Methods 
 
Patients were selected from in-patients treated by the General Surgical, 
Orthopaedic,  Vascular  and  Plastic  Surgery  Departments  of  Salisbury 
District Hospital, between December 2004 and June 2006. Patients were 
included  in  the  study  if  they  were  independently  mobile,  or  could  be 
transported  to  the  Medical  Physics  Department  in  a  wheelchair  and 
included if they could lie relatively still for periods of at least one and a 
half hours at a time. In addition only those patients who had 
 
1.  A wound that had been debrided and treated with TNP therapy 
2.  A  wound  that  had  a  non-bleeding  granulating  bed  4  days  after 
therapy had begun.  
3.  A wound in which it was possible to place the laser Doppler probe 
on an area of flat area granulation tissue (assessed subjectively) 
4.   A wound that could be dressed with a TNP dressing without the 
need for analgesia.   154 
5.  A  shallow  lower  limb  ulcer,  that  was  predominantly  two 
dimensional in nature 
 
 were included. 
These  assessments  were  made  on  the  General  Surgical  and  Plastic 
Surgery wards by consulting the notes of the patients and inspecting their 
wounds at their second dressing change. 
Patients  were  excluded  if  they  had  predominantly  necrotic  tissue  or 
slough  within  the  granulating  wound  bed,  had  allergies  to  the 
polyurethane adhesive/ foam aspect of the TNP dressing, if they were 
wearing nicotine patches, or taking regular medications that could not be 
delayed whilst the experiments were being performed, for example insulin 
injections, and if they were on intravenous drips. 
All experiments were performed in a dedicated room within the Medical 
Physics department of Salisbury District Hospital, which was quiet and 
draught  free.  Room  temperature  was  monitored  and  controlled  to  be 
between 20- 25 ºC. 
Patients lay on a pressure relieving mattress on a standard hospital bed, 
in  a  semi-recumbent  position,  with  a  pillow  placed  under  the  knees, 
resulting in approximately 10-20º of knee flexion. No caffeinated drinks 
were allowed during testing.  Prior to recording blood flow patients were 
counselled that limb movement could jeopardise results. 
After  an  adaptive  period  of  30  minutes,  the  patients’  existing  TNP 
dressing  was  removed,  and  the  laser  Doppler  probe  and  temperature 
probe were placed in the wound, on a flat surface as possible. The wound 
and the probes were then covered with a new TNP dressing that was 
applied after trimming an appropriate size of polyurethane foam to fit the 
geometry  of  the  wound.  This  was  sealed  with  an  adhesive  drape  that 
extended approximately 5cm beyond the margin of the wound margin and 
adhered to the surrounding skin. 
 A  TRAC
©  pad  was  then  applied  to  this  dressing  and  connected  to  a 
VAC
© ATS
© pump. A second temperature probe was placed 2cm from 
the  TNP  dressing,  and  was  used  to  monitor  the  effect  of  room 
temperature on the surrounding skin temperature.    155 
The temperature of the wound under the foam was monitored until it had 
plateaued. Once it had done so, blood flow, using the laser Doppler, was 
recorded for a baseline period of 10 minutes (Period 1- Dressing only- 
baseline period). One of the SAP cycles (randomly selected) was then 
applied for 20 minutes. Changes in blood flow were recorded during this 
period (Period 2- Dressing + Suction- experimental period).  
After the SAP was discontinued, the recording of blood flow continued for 
a third period, which lasted for 10 minutes (period 3- validation period).  
After this period the patient was allowed to readjust their position within 
the bed. When the patient was ready the above method, was repeated at 
the same sitting, for the remaining SAP. 
 
 
6.1.3  Data exclusion 
 
 
Data was excluded  
 
1.  If the room temperature varied beyond the 20-25ºC range set for 
this study, or 
2.   The skin temperature, measured by the second skin temperature 
probe changed by more than an arbitrary figure of ± 2.5ºC during 
the course of the experiment, or  
3.  If patients moved excessively during the experiment.  
4.  If all three SAP were unable to be assessed in the same patient 
 
6.1.4  Data inclusion 
 
A Delta check was performed. Data was included if the difference in the 
mean blood flow between the validation period -Period 3 and Period 1- 
baseline period lay within  
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    2.77  *                 (SD1)
2
 + (SD2)
2 
                            2 
                                          
Where SD1 = standard deviation of Period 1 (baseline) 
           SD2= standard deviation of Period 3 (validation) 
 
If this was the case it implied that no probe movement had occurred.  
 
 
6.1.5  Data Analysis 
 
A  Wilcoxon  paired  samples  test  was  used  to  determine  the  statistical 
significance of any change in blood flow between having a TNP dressing 
in place and applying a SAP to it. A p<0.05 was accepted as statistically 
significant. 
A  Kruskal-Wallis  test  was  employed  to  determine  the  statistical 
significance of any difference between the three SAP profiles. A p<0.05 
was accepted as statistically significant. 
 
 
6.1.6  Results 
 
Recordings from 10/23 patients met these criteria. They included, six men 
and four women, mean ± SD of age being 74.7± 17 years, all with lower 
limb wounds. Their data is shown in tables 13-15. Their relevant medical 
history is included in Table 16. 
The results are illustrated as box and whisker graphs in figures 43-47.The 
associated  changes  in  temperature  seen  during  the  application  of  the 
SAP cycles is illustrated in figures 48-50.  
Pictures of example wounds are contained in appendix 2. 
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6.1.6.1 Effect of Continuous Pressure Regime 
 
 
 
 
 
p=0.92 
Figure 43 Box and Whiskers graph illustrating changes in blood flow seen during 
the application of a continuous of 125mmHg SAP in n=10 wounds, in n=10 
patients 
 
 
No  statistically  significant  change  in  laser  Doppler  measured  blood  flow 
occurred  in  the  ten  wounds  included  in  this  study  when  a  125mmHg 
continuous SAP was applied to the TNP dressings. 
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6.1.6.2 Effect of Intermittent Pressure Regime  
 
 
 
 
p=0.05 
Figure 44 Box and Whiskers graph illustrating changes in blood flow seen during 
the application of a Intermittent 125mmHg SAP in n=10 wounds, in n=10 
patients 
 
 
The application of an intermittent SAP, produced a mean ± SD percentage 
increase in blood flow of 39 ± 60 % relative to the baseline recording of just 
having  the  TNP  dressing  in  place,  p=0.05.    The  individual  percentage 
changes are illustrated in Figure 45. When the two outlying data points are 
removed,  the  mean  ±  SD  percentage  change  in  blood  flow  is  reduced  to 
6.91±14.07 %, p=0.18. 
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Figure 45 Percentage change in blood flow produced by applying an intermittent 
SAP to n=10 wounds, in n=10 patients 
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6.1.6.3 Effect of Profiled Pressure Regime 
 
 
 
 
 
p=0.92 
 
Figure 46 Box and Whiskers graph illustrating changes in blood flow seen during 
the application of Profiled SAP in n=10 wounds, in n=10 patients 
 
 
No  statistically  significant  change  in  laser  Doppler  measured  blood  flow 
occurred in the ten wounds included in this study when the Profiled SAP was 
applied to the TNP dressings. 
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6.1.6.4 Comparison of Pressure Regimes 
 
 
p=0.27 
Figure 47 Box and Whiskers graph illustrating changes in blood flow seen during 
the application of SAP cycles in n=10 wounds, in n=10 patients 
 
 
No statistically significant difference could be demonstrated between the 
effect of the SAP cycles on blood flow, in n= 10 wounds in n=10 patients. 
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6.1.7  Discussion  
 
 
The possibility of probe movement, under the foam aspect of the TNP 
dressing, and in particular during the intermittent pressure regime, was of 
primary  concern  when  designing  a  protocol  for  this  study.  In  the  non-
wounded skin sites that were examined in this thesis, it was possible to 
secure the probe with tape to the skin and validate that probe movement 
did not occur. 
Clearly  this  was  not  possible  in  wounds,  however  in  an  attempt  to 
minimise  the  risks  of  probe  movement  occurring,  predominantly  two- 
dimensional wounds, i.e. lower limb ulcers, with as ‘flat and even wound 
surfaces’ as possible were selected. It was envisaged that there would be 
sufficient axial forces to hold the probe in place, both during suction ‘on’ 
and suction ‘off’ periods, in these types of wounds (see chapter 7). 
In addition, 3 periods of blood flow were recorded in wounds. Period 1 – 
baseline  blood  flow,  period  2  –  experimental  period  and  period  3- 
validation period. Period 3 was included so as to exclude data in which 
probe  movement  occurred.  This  ‘quality  control’,  using  a  delta  check, 
allowed only those recordings in which blood flow returned to (statistically 
comparable) baseline levels to be included.  
It could be argued that this would exclude patients in whom a hyperaemic 
response was seen in period 3. However, although there was a possibility 
of this, no hyperaemic responses were seen in the 13 patients who were 
excluded  from  this  study  (based  on  periods  1  and  3  not  being 
comparable). 
All three SAP regimes were tested in a single sitting in wounds, which 
involved  recordings  of  at  least  4  hours.    The  pressure  regimes  were 
randomly selected, in an attempt to prevent biasing of the results, and 
recordings of a new SAP only began when the temperature under the 
foam had returned to ‘baseline levels’.   163 
Using  these  protocols,  this  preliminary  study  of  the  effect  of  TNP  in 
wounds found, that neither a continuous SAP of 125mmHg nor a Profiled 
SAP of 150mmHg/100mmHg increased blood flow significantly. 
However, the application of an intermittent SAP did produce a mean ± SD 
increase  in  blood  flow  of  39±60  %,  relative  to  baseline  levels,  which 
approached statistical significance with p=0.05. With only 10 patients in 
the  study  group,  these  results  were  significantly  influenced  by  two 
individuals in whom blood flow increased by > 125 % with the application 
of intermittent SAP (one of these patients showed similar responses to 
the application of the continuous SAP and profiled SAP). 
When these two ‘outliers’ were removed the intermittent pressure regime 
did  not  produce  any  significant  change  in  blood  flow,  6.91±14.07  % 
change relative to baseline, p= 0.18. 
Even when they were included no significant difference between the three 
different  pressure  regimes  could  be  demonstrated  in  the  ten  wounds 
included in this study. 
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6.1.8  Conclusions  
 
 
In this preliminary study performed in ten individuals  
 
•  TNP  delivered  as  either  a  125mmHg  Continuous  SAP,  or  as  a 
150mmHg/100mmHg Profiled SAP failed to significantly increase 
blood flow in the ten wounds tested. 
 
•  The intermittent SAP did increase blood flow by a mean ± SD of 39 
±  60  %  (p=0.05),  but  this  was  significantly  influenced  by  two 
patients  who  had  outlying  responses  to  the  application  of 
intermittent  SAP.  There  was  no  significant  response  in  the 
remaining 8 patients (p= 0.18). 
 
•  With  the  greatest  risk  of  probe  movement  occurring  during  the 
intermittent  pressure  regime,  and  the  small  number  of  patients 
included  in  this  study,  the  results  for  the  intermittent  pressure 
regime need to be treated with caution. 
 
•  There was no significant difference in the effect on blood flow of 
the three pressure regimes. 
 
•  The  null  hypothesis  is  therefore  accepted  for  the  effects  of  the 
Continuous  pressure  regime  and  Profiled  regime  in  the  wounds 
tested.  In  a  limited  number  of  patients,  in  this  thesis,  an 
Intermittent SAP increased blood flow but this was not statistically 
significant.   165 
Table 13 – Mean and SD of Blood flow in Periods 1-3 for the application of Continuous 125mmHg SAP 
 
Continuous SAP 
 
 
Period 1 (Baseline) 
 
Period 2 (Experimental) 
 
Period 3 (Validation) 
6.1.9  Wound Blood 
Flow Data 
 
Mean 
 
Standard deviation 
 
Mean 
 
Standard Deviation 
 
Mean 
 
Standard Deviation 
 
Patient 1  12.731  5.0195  46.954  8.8481  14.303  7.0065 
 
Patient 2  73.145  8.0326  85.215  11.0943  86.634  5.5343 
 
Patient 3  94.747  11.0763  136.192  22.4878  116.229  10.7149 
 
Patient 4  76.731  3.4744  80.968  5.4681  84.091  4.9102 
 
Patient 5  191.483  12.2942  199.042  11.1927  184.551  6.9053 
 
Patient 6  131.964  12.8369  153.138  7.4918  143.564  6.9143 
 
Patient 7  469.673  28.4153  354.188  70.4851  418.516  49.7755 
 
Patient 8  56.442  6.5933  51.194  7.3945  55.747  3.7832 
 
Patient 9  36.763  5.0954  114.387  18.1669  44.049  21.4243 
 
Patient 10  2.997  2.3363  2.379  0.6296  2.708  0.6178   166 
 
Period 1 (Baseline) 
 
Period 2 (Experimental)  Period 3 (Validation)   
 
Mean 
 
Standard deviation 
 
Mean 
 
Standard Deviation 
 
Mean 
 
Standard Deviation 
 
Patient 1  15.745  1.8415  37.155  11.4226  16.977  4.6202 
 
Patient 2  85.694  5.6206  86.788  15.5521  74.685  12.0789 
 
Patient 3  136.292  11.291  164.45  19.7666  154.302  6.7914 
 
Patient 4  135.547  6.5588  151.446  15.3214  152.144  18.607 
 
Patient 5  182.921  15.4593  220.937  16.3168  193.076  30.2557 
 
Patient 6  101.251  6.1646  135.105  25.6086  101.934  4.7709 
 
Patient 7  218.074  12.667  208.461  22.9213  238.926  35.2971 
 
Patient 8  55.816  4.5484  53.585  6.8602  62.326  5.3363 
 
Patient 9  48.638  8.3861  124.095  49.6819  62.692  9.6402 
 
Patient 10  2.847  1.1687  2.551  0.9565  2.748  1.071 
Table 14 Mean and SD of Blood flow in Periods 1-3 for the application of Intermittent 125mmHg SAP 
Intermittent SAP 
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Period 1 (Baseline) 
 
Period 2 (Experimental)  Period 3 (Validation)   
 
Mean 
 
Standard deviation 
 
Mean 
 
Standard Deviation 
 
Mean 
 
Standard Deviation 
 
Patient 1  18.447  1.6054  53.235  12.7325  20.166  3.6895 
 
Patient 2  59.86  6.6128  52.624  5.7781  67.72  4.5188 
 
Patient 3  160.745  6.6955  164.195  11.7307  151.568  6.7542 
 
Patient 4  150.624  19.9491  167.44  16.0618  176.046  19.6394 
 
Patient 5  150.762  10.9691  167.126  14.5593  167.233  19.5256 
 
Patient 6  124.551  6.2491  90.962  10.7638  115.791  4.2377 
 
Patient 7  282.691  13.3682  165.747  27.8282  257.94  29.7261 
 
Patient 8  62.798  4.7874  41.659  6.8771  57.846  6.516 
 
Patient 9  130.948  17.7584  145.988  21.1745  139.264  24.9572 
 
Patient 10 
2.674  1.0322  2.204  0.5879  2.311  0.6264 
Table 15 Mean and SD of Blood flow in Periods 1-3 for the application of Profiled SAP 
 
Profiled SAP 
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6.1.10 Patient 
Details 
Sex  Age  Cause of 
Lower Limb 
Wound 
Relevant Medical History 
Patient 1  Female  80y 3 
months 
Wound 
breakdown 
following long 
saphenous 
vein harvest 
for CABG 
Angina, Hypertension, 
Previous Myocardial Infarction  
Patient 2  Male  34y 5 
months 
Non- healing 
area in 
Latissimus 
Dorsi Free flap 
None significant 
Patient 3  Female  94y 1 
month 
Haematoma  None significant 
Patient 4  Female  79y 3 
month 
Mixed Venous/ 
Arterial Ulcer 
Angina, Hypertension 
Patient 5  Female  89y 1 
month  
Venous Ulcer   Hypertension 
Patient 6  Female  64y 7 
months 
Venous Ulcer  CABG, Diet Controlled 
Diabetes Melllitus, Previous 
Myocardial Infarction 
Patient 7  Male   69y 2 
months 
Following 
Incision And 
Drainage of 
Abscess 
Bitten by insect  
Nil else significant 
Patient 8  Male   71y 4 
months 
Venous Ulcer  Atrial Fibrillation, Gout, 
Hypertension 
Patient 9  Male  89 years  Venous Ulcer   Hypertension, High 
Cholesterol 
Patient 10  Female   75y 4 
months 
Ischaemic 
Ulcer 
None Significant 
 
 
Table 16 Details of patients 
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6.1.11 Temperature Interval Plots for Patient Wounds 
 
 
 
 
 
 
Figure 48 Interval Plot during the experimental period and after application of a 
125mmHg Continuous SAP 
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Figure 49 Interval Plot during the experimental period and after application of a  
125mmHg Intermittent SAP (5 minutes on: 2 minutes off)  
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Figure 50 Interval Plot during the experimental period and after application of a 
Profiled SAP (3minutes 150mmHg: 3 minutes 100mmHg) 
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7  A Proposed Concept of the Physical Forces 
Produced by TNP 
 
 
 
 
7.1  Introduction 
 
In contrast to the literature the experiments of this thesis failed to show 
that applying a SAP increased blood flow significantly in either skin or 
predominantly two-dimensional wounds. This may in part be due to the 
fact that previous studies (bar that of Timmers [29]) have measured blood 
flow  adjacent  to  the  wound  or  skin  surface  being  ‘treated’  with  TNP, 
whereas this thesis has attempted to measure blood flow under the TNP 
dressing  or  it  may  be  simply  due  to  the  small  number  of  individuals 
studied in this thesis. 
However  other  possible  explanations  for  not  observing  significant 
changes  of  blood  flow  include  that  the  environment  created  under  the 
TNP dressing may not ‘physically’ permit significant increases in blood 
flow  to  occur  or  that  the  conditions  created  by  TNP  application  may 
comprise the technique used to measure blood flow, which in this thesis 
was Laser Doppler Flowmetry. This is particularly relevant given LDF is a 
technique that lacks absolute units. 
To gain a better understanding of the ‘environment’ created by applying a 
TNP  dressing  to  a  skin  or  shallow  wound  an  attempt  is  made  in  this 
chapter to explain the macroscopic physical forces at work during TNP 
application. 
It is hoped that by trying to explain these forces (as a proposed theory/ 
concept) a clearer picture of mechanisms of action may become apparent 
as  well  as  possible  limitations  in  techniques  used  to  investigate  any 
proposed mechanism(s). 
As the literature review in this thesis has shown, several mechanisms of 
action of TNP have been proposed, including the reduction of oedema 
(excess tissue fluid) [2, 3], increasing blood flow[3, 16, 26-28] and the   174 
creation of mechanical forces that have positive effects on wound healing 
[16, 24, 25]. 
 The  reduction  of  oedema  is  often  quoted  [2,  3,  11,  28,  170]  with  the 
assumption  that  TNP  ‘sucks  out’  excess  tissue  fluid,  but  the  literature 
review  has  failed  to  reveal  any  quantative  evidence  to  suggest  TNP 
removes  any  more  wound  fluid  than  is  normally  produced,  nor  any 
physical explanation of how TNP might remove excess tissue fluid. 
Nevertheless  both  Morykwas  [16]  and  Wackenfors  [26,  27]  have 
suggested  that  the  removal  of  oedema  surrounding  wounds  by  TNP 
reduces  microvasculature  compromise  and  consequently  leads  to  an 
increase  in  laser  Doppler  measured  blood  flow.  Both  investigators 
measured immediate increases in blood flow as soon suction was applied 
to TNP dressings, which would suggest that the removal of oedema by 
TNP is itself immediate. However clinical observation suggests that this is 
not the case. 
A secondary cause of the changes seen in blood flow, was alluded to in 
the Wackenfors  study [27]. Interestingly when measuring blood flow at 
varying distances from the wound edge Wackenfors [27] demonstrated a 
discrepancy  between  increases  in  blood  flow  seen  in  muscle  and  in 
subcutaneous fat. They suggested that these differences could be due to 
‘pressure transduction’ from the TNP system and that pressure from the 
TNP  system  was  transduced  in  a  ‘differing  manner  to  soft  and  dense 
tissues’. 
This  proposed  mechanical  effect  of  TNP,  on  the  surrounding  tissues 
appears a more plausible explanation for the immediate changes in blood 
flow, measured by both Morykwas [16] and Wackenfors [26, 27], as one 
would  expect  any  mechanical  effects  to  occur  in  tandem  with  the 
switching on or off of suction. However at present there is no quantative 
or qualitative data examining the mechanical effects of applying TNP to 
either non- wounded skin or wounds. 
In  chapters  five  and  six  of  this  thesis,  and  in  contrast  to  the  work  of 
Morykwas  [16]  and  Wackenfors  [16,  26,  27] , blood  flow  changes 
underneath the foam of TNP,  was investigated in non wounded skin and 
wounds.  In  contrast  to  previous  studies  no  significant  change  in  laser   175 
Dopplered measured blood flow was seen when TNP was applied to non-
wounded skin. Although the application of an intermittent SAP in wounds 
did cause an increase in blood flow that was approaching significance 
overall  no  statistical  significant  change  in  laser  Dopplered  measured 
blood  flow  was  seen  when  TNP  was  applied  to  predominantly  two 
dimensional wounds, 
In an effort to gain an understanding into the discrepancy between the 
existing  literature  regarding  the  measurement  of  laser  Dopplered 
measured blood flow changes and the results in this thesis this chapter 
aims to explain the (macro) mechanical forces created in applying TNP. 
It is envisaged that an understanding of the mechanical properties of the 
TNP system, and of where and how the forces produced under the drape 
aspect  of  the  dressing  are  disposed,  would  also  aid  in  sorting  out 
probable  mechanisms  of  action  from  speculative  ones,  as  any 
mechanism, for example, removal of oedema or a mechanical effect of 
TNP, would have to have to operate within the constraints of the TNP 
system 
Whereas  Saxena  [25]  have  investigated  the  micromechanical  forces 
operating at the wound/ foam interface using finite element analysis, their 
study concentrated on forces evident at the ‘microscopic’ level. To date 
no overall description of the mechanical properties of the TNP system, or 
of the likely balance of physical forces, at a macroscopic level has been 
described.  
This chapter explores the physical forces that are produced by the TNP 
system, and uses Magnetic Resonance Imaging (MRI), to visualise the 
TNP system in operation, The aim is to clarify the physics of the system 
and provide an aid in understanding how TNP may exert an influence on 
the wound environment, in particular blood flow or its measurement.  
The physics of the system are presented as a concept/ theory. 
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7.2  Aims of Concept 
 
 
The concept has been set to address a number of key questions pertinent 
to the application of TNP to either normal skin or a non-cavity wound. 
These are 
 
1.  What are the balance of forces and how are they distributed, when 
a TNP dressing is in-situ but no suction is applied, and how do 
these forces change when a suction force/ SAP of 125mmHg is 
applied?  
2.  What effect do these forces have on the skin/ wound surface under 
the TNP foam dressing? – These first two questions are dealt with 
in sections 7.3, and investigated using MRI in section 7.6. 
3.  How the TNP system might produce any change in blood flow in 
the skin or the underlying tissues? 
4.  How is exudate removed from the wound by the TNP system? – 
I.e. is there a physical basis for TNP ‘sucking out’ excess tissue 
fluid? This is dealt with in section 7.5. 
 
The concept is described through the use of cross sectional diagrams 
and accompanying photographs. In the diagrams the foam is illustrated in 
green,  whilst  white  lines  represent  the  skin  and  adhesive  drapes. 
Pressures  are  stated  in  millimetres  of  mercury  (mmHg),  where 
760mmHg  represents  atmospheric  pressure,  and  635mmHg 
represents a pressure of 125mmHg below atmosphere.  
  
 
7.3  The System 
 
The concept will be based upon the V.A.C
©. ATS
© system. This consists 
of as previously mentioned:   177 
 
1.   Black Polyurethane ester foam – this is open cell in nature, with a 
pore size of 400-600 microns. It is insulating, provides wound infill 
and  acts  as  a  spacer  between  wound  and  adhesive  drape.  In 
applying a TNP dressing the foam is cut to the geometry of the 
wound and placed in contact with the wound surface. 
 
2.  Polyurethane adhesive drape – this is placed over the foam and 
extends by several centimetres beyond the wound edge to adhere 
to  normal  intact  skin.  Its  application  serves  to  seal  the  wound 
converting an open wound into a closed one. 
 
3.  A non-collapsible tube that connects to a T.R.A.C.
 © (Theurapuetic 
Regulation Accurate Care) pad – an aperture is cut in the middle of 
the foam dressing, which is then resealed with the non-collapsible 
tube/ T.R.A.C
© pad. 
 
4.  A collection canister that connects to the non-collapsible tube. It 
serves to collect wound fluid, and is housed within, 
 
5.   V.A.C.
©  ATS
©  suction  pump-  through  which  the  wound  can  be 
subjected to a range of partial pressures. 
 
 
7.4  Concept 
 
7.4.1  Application of Dressing 
 
In the first step of TNP application the foam is cut to the geometry of the 
area being treated and placed on the skin/ wound surface. In this concept 
the foam is nominally square in shape.   178 
 
Figure 51 Placing of foam on wound/ skin surface 
 
Therefore prior to the application of the adhesive drape the pressure at the foam / 
skin/ wound interface is atmospheric i.e. 760mmHg, Figure 51. 
 
 
7.4.2  Sealing the foam with adhesive drape 
 
 
 
Figure 52Application of the adhesive drape 
 
The  next  step  in  the  application  of  TNP  is  sealing  the  foam  with  an 
adhesive drape. This drape extends beyond the margins of the foam by 
760 mmHg   179 
approximately 5cm in clinical practice, but importantly for the purposes of 
the  concept,  this  extension  of  drape  is  assumed  to  be  equal  in  all 
directions, Figure 52 and Figure 53 (This is followed by the attachment of 
the  T.R.A.C
©  pad/non  collapsible  tube,  collection  canister  and  suction 
pump. For simplicity sake these are not illustrated). 
 
 
Figure 53 Photograph of foam sealed with adhesive drape 
 
 
7.4.2.1 Creation of axial and tangential forces  
 
The  application  of  the  adhesive  drape  results  in  both  an  axial  and 
tangential force being created, which are represented by the green and 
red arrows respectively Figure 54.  
Figure 54 Axial and tangential forces 
 
760 mmHg   180 
 
 
 
 
7.4.2.1.1  Mathematical description of theses forces 
 
Both the axial and radial forces created by the drape on the foam and the 
structures  underlying  the  foam  can  be  described  mathematically.  The 
radius of curvature that the drape creates, directly influences both these 
forces Figure 55. 
 
Figure 55 Mathematical expression of forces 
 
 
  represents the radius of curvature of the drape on the underlying foam. 
When   tends to zero the radial force diminishes and the resultant force 
becomes entirely tangential in nature. In effect this means that where the 
drape is flat the axial force acting on the foam and in turn the skin/ wound 
surface approaches zero 
T= R Cos  
 
A= R Sin  
 
Resultant Force = T+A  
 
Or   Resultant Force= R 
(Cos  + Sin ) 
 
 
 
or   181 
The greatest radius of curvature of the drape is at the foam edge where 
  is approximately 45°, therefore the axial forces will be greatest here. 
 
 
Figure 56 Force evident at wound/ skin surface 
 
 
As a result of the open cell nature of the foam, the sum of these forces, 
defined as x mmHg is transmitted to the foam/ skin/ wound interface, 
Figure 56. 
 
 
 
7.4.2.2 The  effect  of  this  pressure  on  the  foam  and  skin/  wound 
surface 
 
The effect this pressure produces on the underlying foam and skin/wound 
will depend on its magnitude and the energy required to deform these 
structures, i.e. their bulk moduli. In the TNP concept it is assumed that 
the bulk modulus of the skin/wound surface is greater than that of the 
foam, i.e. the energy required to deform the skin/wound surface is greater 
760mmHg + x mmHg 
760 mmHg   182 
than  the  energy  required  to  deform  the  foam.  As  a  result  the  foam  is 
compressed somewhat by the application of the drape, particularly at the 
foam edges (where the axial forces are greater). However because the 
skin/ wound surface has a high bulk modulus little or no compression may 
be expected in these structures. 
 
7.4.3  Application of Suction 
 
If one ignores the pressure x mmHg, then the application of suction to 
the system will create a sub-atmospheric environment of 635 mmHg at 
the foam/ skin/wound interface as well as in the non collapsible tube, and 
in the collection canister Figure 57. 
 
 
Figure 57 Application of a 125mmHg SAP 
 
 
7.4.3.1 Pressure Differential and collapse of the foam 
 
This  results  in  a  pressure  differential  between  the  atmosphere  gas 
pressure and the sub-atmospheric gas pressure under the drape. These 
760 mmHg    183 
gas  pressures  would  under  normal  circumstances  equilibrate  but  are 
prevented from doing so by the drape itself and the air tight seals of the 
non collapsible tube/ collection canister. However the pressure gradient 
causes the atmosphere outside the drape to  exert a mechanical force 
across  these  structures  of      +125mmHg.  This  mechanical  force  of 
125mmHg is sufficient to cause the foam to collapse but because of their 
high bulk moduli, this force is insufficient to cause collapse of the non-
collapsible tube and the collection canister.  
 
7.4.3.2 Pressure at foam/ skin/wound interface 
 
The  pressure  gradient  and  the  mechanical  force  it  exerts  across  the 
drape on the foam results in the overall pressure at the foam/ skin/ wound 
interface  to  return  atmospheric  i.e.  760  mmHg.  This  pressure  of 
760mmHg  is  compromised  of  a  sub-atmospheric  gas  pressure  of  635 
mmHg created by the suction pump and a positive mechanical pressure 
of 125mmHg created by the pressure differential Figure 58. 
 
 
 
Figure 58 Forces evident a wound/ skin surface when 125mmHg SAP 
applied 
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However the drape will also produce a force on the underlying structures. 
 
 
7.4.3.3 Force created by the Drape when foam collapsed 
 
 
When the foam collapses it becomes both thinner and flatter in nature 
Figure 59. This has the effect of reducing the radius of curvature of the 
drape on the foam. Along the majority of the length of the foam the radius 
of curvature approaches zero. Therefore little to no axial force is exerted 
along the length of the foam, except at the foam edge, where greater 
axial  forces  can  be  expected,  as  the  radius  of  curvature  of  the  drape 
approaches 90 degrees).  
 
 
 Figure 59 Photograph of collapsed form 
 
The sum of these axial forces is for the purposes of the concept defined 
as y mmHg, Figure 60,  (it is assumed that this pressure is less than x 
mmHg principally because along most of the length of the foam no axial 
force will be created by the flat drape). 
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Figure 60 Additional Force produced by drape 
 
 
 
 
7.4.3.4  The  effect  of  this  pressure  on  the  foam  and  skin/  wound 
surface 
 
As a result of pressure y < x mmHg less compression of the underlying 
foam, skin/ wound surface, and subcutaneous fat and muscle can be 
expected. Any compression that does occur could be expected to be at 
the foam edge. 
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7.5  Wound Fluid 
 
Wound  fluid  is  essentially  a  transudate  that  is  similar  in  biochemical 
constituents to plasma and is produced largely by the capillaries of the 
wound  bed  [171].  Under  normal  circumstances  the  exchange  of  fluid 
across  capillaries  is  influenced  by  number  of  forces  that  includes  the 
hydrostatic pressure within the capillaries, the major driving force causing 
fluid and dissolved solutes to be filtered, and the oncotic pressure within 
the  vasculature  that  leads  to  reabsorption  of  fluid  [172].  This  oncotic 
pressure tends to return approximately 90 % of filtered fluid back into the 
capillary vasculature with the remaining fluid (and leaked proteins) being 
returned to the circulation by the lymphatic system[172]. In wounds this 
lymphatic  circulation  is  lost  and  instead  of  fluid  being  returned  to  the 
vasculature,  it  is  lost  to  the  exterior.  The  various  forces  involved  in 
transcapillary exchange are summarised below. 
 
7.5.1  Starling Hypothesis of Transcapillary Exchange 
 
Qf = Kf  (Pc-Pi ) –  ( c-  i) 
Qf = Total fluid flow across capillary membrane 
 Kf = Fluid filtration coefficient Lp*S 
[where Lp is the hydraulic conductivity- this describes how rapidly fluid 
can pass through the capillary membrane 
and S is the capillary surface area available for exchange]   
Pc = capillary hydrostatic pressure 
Pi = interstitial hydrostatic pressure 
 c= capillary oncotic pressure 
 i= interstitial oncotic pressure 
 = osmotic reflective coefficient – this defines the capacity of the capillary 
membrane to prevent the translocation of proteins 
if  =1 then the membrane is totally impermeable to proteins if  =0 then 
there us no impedance to protein translocation   187 
 
7.5.2  Does the system ‘suck out wound’ fluid? 
 
 
Figure  61  illustrates  a  theoretical  scenario  in  which  the  non-collapsible 
tubing  of  a  V.A.C.
©  ATS
©  is  placed  in  a  beaker  of  fluid.  The  non-
collapsible  tubing  is  then  connected  to  a  collection  canister,  which  is 
placed within the VAC
© ATS
© suction pump. When the suction pump is 
set to create a SAP of 125mmHg, fluid is sucked up into the tubing and 
then onto the collection canister. 
This  happens  because  a  pressure  differential  is  created  between  the 
atmosphere  and  the  sub  atmospheric  pressure  within  the  tubing,  as  a 
result,  and  because  there  is  no  barrier  preventing  it  doing  so  the 
atmosphere pushes fluid into the tubing – allowing the tubing to ‘suck up’ 
the fluid. 
 
 
 
 
 
        Figure 61 Pressure differential driving fluid movement in open system 
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Figure 62 The passage of wound fluid into the tubing under hydrostatic pressure 
from the capillaries, green arrows indicating mechanical force causing collapse 
of the foam, blue arrows showing movement of wound fluid. 
 
 
 When  there  is  a  barrier,  such  as  the  adhesive  drape,  preventing 
equalisation  of  the  gas  pressures,  this  cannot  happen.  The  125mmHg 
pressure differential can collapse the foam and contribute to the pressure 
evident at the wound/ skin surface but it cannot drive fluid into the non-
collapsible tubing because it is excluded physically by the drape Figure 62. 
In effect this means that TNP cannot suck wound fluid (blue arrows) out 
of  the  wound  bed  and  into  the  collection  canister.  Instead  the  major 
driving  force  for  the  movement  of  wound  fluid  in  TNP  systems  is  the 
hydrostatic  pressure,  within  the  capillaries  of  the  wound  bed.  This 
pressure pushes wound fluid into  
channels  within  the  collapsed  foam,  Figure  63  and  Figure  64.  Although 
some of the pores within the foam may close completely when the foam 
collapses, it is proposed that sufficient numbers remain patent, offering 
little  to  no  resistance  to  the  passage  of  wound  fluid,  driven  by  the 
hydrostatic pressure of the capillaries. Fluid eventually migrates into the   189 
canister as it is displaced through the foam by more fluid entering the 
system from the wound surface. 
 
 
 
Figure 63 Image of foam taken prior to the application of suction using a 
hand held ‘transcutaneous’ microscope, *200 magnification 
 
 
 
 
 
 
Figure 64 Corresponding image taken after the application of suction (125mmHg 
SAP)   190 
 
7.6  MRI study  
 
7.6.1  Aim of study 
 
 The validity of the TNP concept, was investigated using MRI in human 
volunteers, In particular the study was aimed at visualising the system in 
operation and appreciating the mechanical effects of TNP on the skin and 
soft tissues underlying the foam. 
7.6.2  Materials and Methods 
 
MRI is a non-ionising, non-invasive diagnostic tool that can be used to 
provide high resolution images of soft tissues [173]. The technique relies 
upon  the  use  of  magnetic  fields  and  radiowaves  to  generate  cross 
sectional  images  of  body  structures[173].  MRI  works  in  the  following 
manner. 
When placed in a magnetic field the axis of rotation of protons, within the 
nuclei of hydrogen atoms, (mainly to be found in water), align along the 
long axis of he MRI scanner. This alignment is known as the magnetic 
vector [174]. 
Coils placed around the anatomical area being scanned can then be used 
to  expose  these  aligned  protons  to  radiowaves  [175].  This  exposure 
results in the deflection of the magnetic vector, but the vector returns to 
its resting state when the emission of radiowaves is stopped [174]. 
The  return  of  the  magnetic  vector  to  its  resting  state,  is  itself 
accompanied by the emission of a radiowave which is detected by the 
coil [174]. The intensity of the received signal is processed and plotted 
against a greyscale, allowing cross sectional images to be produced. The 
signal  from  different  tissue  types,  for  example  fat  and  muscle,  varies 
according to its water content, and this allows tissue planes to be defined 
but images can also be ‘weighted’, allowing fat within structures to be   191 
highlighted  (T1 weighted images) or suppressed  (T2 weighted images) 
[174]. 
For the purposes of this study, a 1 Tesla (a measure of magnetic field 
strength)  General  Electric  Signa  MRI  scanner,  based  in  the  Radiology 
Department of Salisbury District Hospital was used. The effects of TNP, 
on the skin and soft tissues of the right thigh in four healthy volunteers, 
two male, 2 female, mean age of 30. 6, was investigated by taking axial 
and sagittal cross sectional images with  
 
1.  PreDressing – No TNP dressing applied 
2.  Dressing only – but no suction applied 
3.  Dressing +  suction (i.e. the application of 125mmHg SAP) 
 
Volunteers  were  asked  to  wear  shorts  so  as  to  expose  the  lower  two 
thirds of the thigh, the knee and the proximal third of the shin. Lying flat in 
the scanner their right lower limb was placed in a padded MRI coil. When 
closed  this  held  the  knee  in  approximately  10  degrees  of  flexion,  and 
together  with  the  application  of  a  ‘corset’  at  the  ankle  prevented 
movement of the knee in either a coronal or sagittal plane. Rotational 
movement of the hip were prevented by the application a corset about the 
pelvis. Volunteers were asked to lie as still as possible throughout the 
MRI scans. 
In the first series of scans T1 weighted images were taken that included 
the distal 30cm of femur and the proximal 10 cm of tibia. 
Following  these  scans,  the  top  of  the  knee  coil  was  opened  (it  opens 
much like the manner of a clam shell) and a nominally sized 8 by 8cm 
piece  of  foam  was  applied  to  the  distal  thigh,  in  a  position  that  had 
already been marked with an indelible marker pen. This was arbitrarily 
measured as 8cm from the palpable superior edge of the patella, Figure 
65. The intention was to be proximal to the quadriceps tendon and with 
respects to the overall study design, in an anatomical area that contained 
muscle and fat ‘bulk’.   192 
Next the adhesive drape was applied to the foam, extending 5cm beyond 
the foam edge in all directions. The TRAC
© pad/ non collapsible tubing 
was then attached, and in turn connected to a VAC ATS
© suction pump. 
The coil lid was replaced and two further series T1 weighted scans were 
performed, firstly with the dressing in place, but without the application of 
suction,  and  secondly  with  the  application  of  a  125mmHg  SAP  to  the 
dressing 
From these series of scans, sagittal and axial sections through the middle 
of  the  foamed  area  were  selected  for  comparison  against  the 
corresponding anatomical sections. 
Dimensions of the skin, subcutaneous fat and muscle layers in the scans 
were measured by using the General Electric MRI software. This allows 
measurements to the nearest millimetre. 
 
 
 
 
Figure 65 ‘Birds eye view’ illustrating the position of the TNP dressing relative to the 
right patella 
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7.6.3  Results 
 
 
7.6.3.1 Change in Overall Tissue Thickness 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 17  Measurements in millimetres of the overall thickness of tissues 
 
 
 
 
 
In  all  four  volunteers  application  of  the  TNP  dressing  produced  tissue 
compression  of  the  underlying  tissues.  The  data  for  each  volunteer  is 
shown in Table 17, and illustrated as a line graph in Figure 66. The overall 
thickness of the tissues was reduced by a mean ± SD of 11 ± 1.4 mm. 
This compression was diminished by the application of suction, but there 
was still a mean ± SD compression of tissues of 2.75 ± 1.7 mm. 
 
  No Dressing  Dressing 
Only 
Dressing+ 
Suction 
 
Volunteer 1 
46mm  36mm  43mm 
Volunteer 2  44mm  31mm  43mm 
Volunteer 3  55mm  44mm  50mm 
Volunteer 4  54mm  44mm  52mm   194 
 
 
 
Figure 66 Changes in total soft tissue thickness seen after TNP application. The 
terms x mmHg and y mmHg refer to forces that were described in the TNP 
concept 
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7.6.3.1.1  Muscle 
 
 
 
 
 
 
 
 
 
 
 Table 18 Measurements in millimetres of the muscle ‘layer’ 
 
 
The compression of soft tissues occurred predominantly in the muscle 
layer. The data for each volunteer is shown in Table 18, and illustrated as a 
line graph in Figure 67. The muscle ‘layer’ was reduced in thickness by 
9.75 ± 0.5 mm when the dressing was in- situ but no suction applied. The 
degree  of  compression  was  reduced  when  suction  was  applied  to  the 
dressing to 3.75 ± 2.1 mm. 
 
 
Figure 67 Change in muscle thickness 
  No Dressing  Dressing 
Only 
Dressing+ 
Suction 
 
Volunteer 1 
37mm  27mm  33mm 
Volunteer 2  26mm  16mm  25mm 
Volunteer 3  39mm  29mm  33mm 
Volunteer 4  35mm  26mm  31mm   196 
 
 
 
7.6.3.1.2  Fat 
 
 
 
Table 19 Measurements in millimetres of the fat ‘layer’ 
 
The fat layer was compressed by the application of the dressing by 1.25 ± 
1.26 mm, but increased from its original thickness by 1.25 ± 1.26 mm 
when suction was applied. The data for each volunteer is shown in Table 
19, and illustrated as line graph in Figure 68. 
 
 
 
 
 
 
 
 
  No Dressing  Dressing Only  Dressing+ Suction 
 
Volunteer 1 (Body mass index – 18) 
6mm  6mm  7mm 
Volunteer 2 (Body Mass Index – 25)  15mm  12mm  15mm 
Volunteer 3 (Body Mass Index – 22)  13mm  12mm  14mm 
Volunteer 4 (Body Mass Index – 30)  16mm  15mm  18mm   197 
 
 
                        Figure 68 Change in fat thickness 
 
 
 
7.6.3.1.3  Skin 
 
 In all volunteers the skin did not demonstrate any measurable change in 
thickness throughout the MRI study, as shown in Table 20. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 20 Measurements in millimetres of the skin ‘layer’ 
 
 
  No Dressing  Dressing 
Only 
Dressing+ 
Suction 
 
Volunteer 1 
3mm  3mm  3mm 
Volunteer 2  3mm  3mm  3mm 
Volunteer 3  3mm  3mm  3mm 
Volunteer 4  3mm  3mm  3mm   198 
7.7  MRI images 
 
 
The MRI images of one of the volunteers are included in this section to 
illustrate the changes in tissue thickness that occurred Figures 69-77. 
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Figure 69 T1 saggital section of right thigh prior to dressing application. Skin layer is 
visible as grey. Fat is highlighted in T1 sections,therefore the subcutaneous fat layer 
appears white (as does the bone marrow). Muscle appears as grey. 
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Figure 70 Zoomed in image of Figure 69, showing skin, fat and muscle layers   201 
 
Figure 71 Axial section prior to TNP dressing application, taken at the midpoint 
of where the foam dressing will be placed 
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Figure 72  T1 saggital section after application of the TNP dressing but without the 
application of suction, taken through the midpoint of the foam 
DRESSING ONLY   203 
Figure 73  Zoomed in image of Figure 72 
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Figure 74 Corresponding axial section  
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Figure 75 Saggital section after the application of suction, taken at midpoint of 
foam 
 
DRESSING + SUCTION   206 
 
 
Figure 76 Zoomed in image of Figure 75 
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Figure 77 Corresponding axial section 
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7.8  Discussion 
 
The aim of this chapter was to firstly clarify the physical forces evident 
during the application of Topical Negative Pressure in a predominantly 
two-dimensional  wound  or  in  non-wounded  skin,  and  to  secondly 
visualise the mechanical effects this produces. In doing it was hoped to 
gain an insight into the mechanism(s) of action of TNP, in particular how 
TNP may produce changes in blood flow. 
It is evident from the theoretical concept presented in this chapter, that by 
simply applying a TNP dressing (without a SAP being applied), a positive 
force  is  produced  at  the  wound/skin  surface.  It  is  suggested  that  this 
positive  force  is  entirely  defined  by  the  radius  of  curvature  that  the 
adhesive drape produces relative to the foam. For example, a greater 
radius of curvature and therefore force would be expected at the skin/ 
wound interface when a TNP dressing is applied to the forearm or lower 
limb compared to when a dressing is applied to a planar surface. 
When a suction force, i.e. a SAP is applied, rather than the wound being 
subjected to a ‘Topical Negative Pressure’, a positive force will still exist 
at  the  skin/  wound  surface,  albeit  a  reduced  one.  Again  the  radius  of 
curvature, that the drape produces relative to the foam, will entirely define 
this force. In a two-dimensional wound or on the skin surface this force 
will  be  greatest  at  the  foam  edge.  The  generic  term  Topical  Negative 
Pressure therefore appears a misnomer. 
The concept also proposes that, because the TNP system is in essence a 
closed system, it is unable to actively ‘suck’ wound fluid out of a wound. 
Rather, the driving force behind fluid movement through the foam and 
into  the  collection  canister  is  suggested  to  be  principally  the  positive 
hydrostatic pressure within the capillaries. 
The foam itself probably does not hinder the movement of fluid and may 
itself promote it. The foam offers little no resistance to the passage of 
wound fluid, even in its collapsed state, because sufficient open lacunae 
exist for fluid movement. It therefore provides an effective means of fluid 
management. In addition, the switching ‘on’ of suction collapses the foam   209 
and reduces the forces evident at the wound surface. In so doing the 
positive pressure working against fluid production by the wound is in itself 
reduced. 
In  clinical  practice  further  ‘sweeping’  of  wound  fluid  into  the  non-
collapsible tubing may occur by a number of means. For example,  by 
gases leaking from the edges of the drape along the upper surface of the 
foam and driving fluid along. Whilst during intermittent SAP application 
there  may  be  a  ‘bellow’  effect,  i.e.  wound  fluid  absorbed  by  the  non-
collapsed foam may be driven into the tubing when suction is switched on 
and the foam collapses.  
Clinical  observation  suggests  that  this  is  the  case  when  TNP  is  first 
applied to a wound in which wound fluid has pooled. As soon as suction 
is switched on fluid is seen ‘gushing’ into the tubing. However with the 
continuous  application  of  a  SAP  the  concept  suggests  that  the  major 
driving  force  for  fluid  movement  is  the  hydrostatic  pressure  within  the 
capillaries. 
The  removal  of  oedema,  nevertheless  has  been  proposed  by  several 
investigators [16, 26-28] as the primary cause by which the immediate 
changes in blood flow occur. Blood flow changes which tend to occur in 
tandem with the switching ‘on’ and ‘off’ of suction.  
In light of the concept this explanation appears unlikely, as the switching 
‘on’ of suction will not actively ‘suck’ fluid out of the wound. In addition in 
most of these studies [16, 26, 27] blood flow tends to return to ‘baseline’ 
levels immediately after suction is switched off. This cannot be readily 
explained  if  one  assumes  increases  in  blood  flow  are  secondary  to 
oedema removal from the tissues. 
The  (limited)  MRI  study  in  the  second  half  of  this  chapter  however 
provides  visual  evidence  that  the  mechanical  effects  of  TNP  occur  in 
tandem  with  the  switching  ‘on’  and  ‘off’  of  suction.  In  addition  they 
illustrate how these mechanical effects are disproportionately distributed 
in the tissues underlying the foam. 
With just a TNP dressing in place (and no suction applied), the tissues 
under the foam are significantly compressed by the axial forces described 
in the TNP concept, by a mean ± SD of 11 ± 1.4 mm. This compression   210 
occurs predominantly in the muscle compartment, 9.75±0.5 mm of the 
overall compression occurring in the muscle compared to 1.25 ± 1.26mm 
in  the  fat.  Whilst  no  discernable  compression  occurs  in  the  skin  layer 
(however  because  the  MRI  was  only  able  to  measure  changes  to  the 
nearest  millimetre,  any  change  in  this  tissue  may  not  have  been 
detectable). 
When a 125mmHg SAP is applied the tissues become less compressed, 
as predicted by the TNP concept. The muscle becomes less compressed, 
from  a  mean  ±  SD  of  9.75  ±  0.5  to  3.75±2.1  mm.  The  fat  actually 
increases in thickness by 1± 0.88 mm, however this may well be in the 
error of measurement of the MRI. Alternatively this may be due to greater 
forces  at  the  foam  edge  causing  bulging  of  the  fat  layer.  The  skin 
however does not change in thickness. 
With  the  findings  of  the  concept  and  MRI  studies  in  mind  it  is  not 
unreasonable to assume, that if blood flow in tissues, whose dimensions 
changed significantly during the switching ‘on’ and ‘off’ of suction, was 
measured one might well see significant changes in blood flow.  
This is discussed in more detail in the final chapter of this thesis with 
particular relevance to the blood flow studies performed in chapters four 
and five and the existing literature. 
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7.9  Conclusions 
 
 
•  Two-dimensional  wounds  and  intact  skin  are  subjected  to  a 
positive pressure when both a TNP dressing is in situ, and when a 
SAP is applied to this dressing. 
•  This positive pressure is entirely defined by the radius of curvature 
that  the  adhesive  drape  produces  relative  to  the  foam,  and  is 
reduced when a SAP is applied. 
•  Wound fluid is not ‘sucked out’ of the wound bed, but is driven into 
the canister by the hydrostatic pressure within the capillaries. 
•  The  mechanical  effects  produced  by  the  TNP  system  are 
distributed disproportionately, according to the tissue type. 
•  The mechanical effects occur in tandem with the switching ‘on’ and 
‘off, of suction. 
•  These  mechanical  effects  may  explain  the  blood  flow  changes 
seen by investigators to date, rather than the removal of oedema. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   212 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   213 
8  Thesis Discussion  
 
8.1  Introduction 
 
 
The application of suction forces- ‘Topical Negative Pressure’ to a wound 
that has already been dressed with foam and sealed with an adhesive 
drape  is  a  relatively  new  concept  in  wound  care  having  only  been 
introduced in the mid 1990s. In a short period of time this technique of 
wound  management  has  become  both  widely  used  and  accepted 
amongst wound carers both in the hospital and community settings.   
It has enjoyed considerable success in the management of acute, chronic 
and difficult to heal wounds across a wide range of clinical specialities [1-
18],  suggesting  that  the  application  of  TNP  to  wounds  positively 
influences the wound healing process. 
Based on clinical observation, early series reported that TNP increased 
the  rate  of  granulation  tissue  formation  and  wound  healing  in  acute 
wounds [3, 4] findings which have been confirmed in a number of small 
animal  [16-18] and emerging controlled clinical studies [19] [12, 20]. The 
evidence from more recent well designed RCT[21] [22], has also begun to 
suggest,  together  with  previous  observational  studies[2-6],  that  these 
benefits  may  also  be  evident  in  chronic  wounds  and  difficult  to  heal 
wounds,  but  clearly  further  large,  well  designed  RCT  are  needed  to 
confirm these findings and in so doing provide stronger evidence for TNP 
use,  not  only  to  wound  carers  but  also  to  the  manufacturers  of  TNP 
systems and indeed patients. 
If TNP does therefore benefit the wound healing process, it is important to 
ask the question by what mean(s) it does so, because if a clearer picture 
of  its  mechanism  of  action(s)  or  how  it  might  affect  the  wound 
environment were to emerge then the clinical parameters of its use, for 
example the SAP or cycle setting used would become evidence based, 
focused and more compelling to current users of TNP systems and even 
to sceptics of TNP.   214 
There is however a paucity of studies investigating the mechanism(s) of 
action  of  TNP,  particularly  in  human  experimental  situations.  Several 
mechanisms have been proposed including decreasing the bacterial load 
of wounds [5, 12, 16], decreasing oedema [3, 23], mechanical effects that 
promote wound healing [16, 24, 25], and increasing blood flow [16, 26-
29]. 
Although several investigators had evaluated the effect of TNP on blood 
flow  in  animal  studies,  at  the  beginning  of  this  thesis,  no  studies  in 
humans evaluating blood flow could be found (one study was published 
during the thesis however[29]) . 
This  thesis  was  therefore  aimed  at  investigating  the  effect  of  TNP  on 
microvascular blood flow in humans, and in particular three SAP setting/ 
cycles.  Current  clinical  parameters  with  regards  to  SAP  settings  and 
pressure cycles are primarily based on the work of Morykwas  [16]. They 
used a porcine acute wound model to derive that 125mHg SAP applied 
continuously, and 125mHg SAP applied intermittently in a timed cycle (5 
minutes  on:  2  minutes  off)  increased  blood  flow  optimally  in  tissues 
immediately adjacent to the wound edge. 
The aim of this thesis was to evaluate these two SAP regimes and also a 
third that KCI
© (Ferndown, UK), manufacturers of the VAC
© TNP system, 
was attempting to introduce into the market place. This they termed a 
‘profiled’ SAP cycle, which involves applying a 150mmHg SAP and then a 
100mHg  SAP  in  a  timed  cycle  (3  minutes  at  150mmHg:  3  minutes  at 
100mHg). The aim was to evaluate the effect on blood flow of these three 
SAP  regimes  in  both  intact  human  non-  wounded  skin  and  in  human 
wounds. In contrast to the published animal studies investigating blood 
flow the aim was to investigate blood flow under the foam aspect of the 
TNP dressing. 
Having  investigated  these  SAP  regimes  an  attempt  was  made  at 
describing  the  macroscopic  forces  evident  during  TNP  application  (to 
intact skin and predominantly two dimensional wounds), and the effect of   215 
these  forces  on  tissues  was  visualized  in  a  small  number  of  healthy 
volunteers using MRI. 
It was envisaged that by describing the physical forces involved in TNP 
application a greater understanding of how TNP might effect changes in 
microvascular blood flow might become apparent.  
  
 
8.1.1  Blood flow Studies 
 
8.1.1.1 Non-wounded skin 
 
Although  a  number  of  methods  exist  for  the  measurement  of 
microvascular  blood  flow,  the  ethical  approval  granted  for  this  thesis 
permitted only the use of non-invasive techniques, as such Laser Doppler 
Flowmetry  was  chosen  because  of  its  ability  to  provide  a  real  time 
continuous measurement in a non-invasive manner. 
 As  well  as  being  an  established  technique  in  monitoring  blood  flow, 
Laser  Doppler  Flowmetry  was  used  by  both  Morykwas  [16]  and 
Wackenfors [26] [27] in their animal studies examining the effect of TNP 
on blood flow. In their studies filament Laser Doppler needle probes were 
inserted into the tissue surroundings wounds treated with TNP. 
 Rather than using filament probes, which are generally designed to be 
inserted  into  tissues,  a  single,  specially  designed  ‘surface’  probe  was 
used throughout this thesis and was placed at the foam/ skin interface 
during the blood flow experiments. This low profile probe was less bulky 
than others produced by (Perimed
©, Sweden), and it was envisaged that 
its dimensions would allow blood flow to be measured without perturbing 
the TNP system itself, or the application of a variety of SAP regimes. A 
single probe was used because of cost implications with the use of more 
than one probe.   216 
The continuing ability of this probe to detect changes in blood flow was 
checked  prior  to  each  recording  period.  In  addition  the  probe  was 
calibrated as per manufacture guidelines. 
Experiments were performed in a dedicated room that was draught free 
and  temperature  controlled,  so  as  to  reduce  the  likelihood  of 
environmental factors affecting blood flow in the areas being tested. 
Prior to performing the blood flow experiments in non- wounded skin, a 
number  of  sources  of  variation  were  investigated.  The  intention  in  so 
doing  was  to  gain  familiarity  with  the  equipment  being  used  and  in 
addition  highlight  potential  problems  that  could  be  encountered  in  the 
study.  
The initial protocol for the study was to measure ‘baseline’ blood flow for 
a period of ten minutes and to compare the change in blood flow over the 
next twenty minutes during which one of the three SAP regimes would be 
applied –‘experimental period’. If any change in blood flow did occur it 
would be assumed that this would be due the application of the SAP, 
however  with  blood  flow  in  skin  exhibiting  temporal  variation  another 
possible explanation for blood flow changes might simply be the passage 
of time.  
This was investigated in twenty healthy volunteers, mean± SD 34.2±11.1 
years for both the dorsum of the foot and on the ‘Medial Tibia’ sites, by 
measuring blood flow under a TNP dressing for thirty minutes (without 
suction being applied).   
Blood flow recordings only began after an adaptive period and when the 
temperature under the foam aspect of the dressing had plateaued – as 
measured by a temperature probe placed at the foam / skin interface. No 
significant temporal variation was seen (although there was a tendency 
for a decrease in blood flow) and this allowed the initial protocol of a 10 
minute baseline period followed by a twenty minute experimental period 
to be used. 
Spatial variation was also investigated in the dorsum of the foot, in ten 
healthy volunteers, mean age 30.5 ± SD 11.4 years.  Blood flow was 
recorded in a ‘central position’ – between the two tendons of EHL and 
EDC  and  then  2mm  proximal,  distal,  lateral,  and  medial  from  this   217 
reference  position.    The  results  of  this  experiment  demonstrated  the 
significant spatial variation seen in blood flow and highlighted one of the 
major concerns throughout this thesis, which was that if the laser Doppler 
probe moved even by as little as 2mm then erroneous results could arise. 
It was therefore clear that every effort needed to be made to ensure and/ 
or demonstrate that probe movement did not occur during the blood flow 
experiments in non-wounded skin and for that matter in wounds.  
In non-wounded skin this was achieved by selecting sites which it was felt 
could reduce the likelihood of probe movement and by taping the probes 
to the skin using an adhesive tape. 
It was felt that the skin sites, which were chosen, represented areas in 
which  the  laser  Doppler  probe  could  be  placed  on  a  reasonably  flat 
surface.  In  the  case  of  the  dorsum  of  the  foot  this  was  between  the 
tendons of EHL and EDC, with the cable and the laser Doppler probe 
being placed parallel to the direction of these tendons. With the ‘Medial 
Tibia’ the probe was placed on the flat aspect of the medial palpable tibia, 
approximately a handbreadth inferomedial to the palpable inferior aspect 
of the patella, with the cable and the probe lying parallel to the direction of 
the limb. It was also envisaged that in these sites sufficient axial forces 
could be created by application of the adhesive drape aspect of the TNP 
dressing,  which  certainly  during  ‘baseline’  blood  flow  recordings  could 
hold the laser Doppler probe ‘in situ’. 
The greatest risk of probe movement was likely to occur however during 
the switching on or off of suction, and with the SAP being tested in mind 
the  risk  was  perceived  to  be  greatest  during  the  application  of  the 
intermittent SAP cycle.  
The  laser  Doppler  probe  was  therefore  secured  to  the  skin  using 
adhesive  tape  in  an  attempt  to  prevent  it  moving  during  ‘pressure 
changes’. Furthermore an attempt was made to validate that the adhesive 
drape prevented probe movement. 
Five healthy volunteers mean age 27.1 ± SD 8. 4 years took part in this 
study. With the laser Doppler probe secured to the skin with adhesive 
tape a TNP dressing was applied to the ‘dorsum of he foot’. When the   218 
temperature under the foam had plateaued blood flow was recorded for a 
baseline period of five minutes.  
A 125mmHG SAP regime was then applied intermittently to the dressing 
in a one minute ‘on’, one minute ‘off’ cycle for a total of ten minutes. The 
intention was to compare baseline blood flow to blood flow during the ‘off’ 
periods. Probe movement was felt not to have occurred if there was no 
statistical  difference  between  the  baseline  period  and  the  ‘off’  periods. 
This was determined indirectly by the use of a delta check, a statistical 
method that is used to assess biological variation [181] and which allows 
two results from the same patient to be compared, i.e. it allows an intra-
patient comparison of data.  
This proposed method of checking if probe movement occurred during 
‘pressure changes’ made an important assumption however and that was 
if applying a 125mmHG SAP did produce a change in blood flow (during 
the one minute on period) then blood flow would return to baseline during 
the one minute off period. At the beginning of this thesis the studies that 
has used laser Doppler to investigate blood flow using TNP had all shown 
that laser Doppler measured blood flow returned to baseline levels on 
switching  off  of  suction.  This  assumption  was  therefore  deemed  a 
reasonable one to make. 
Using  a  delta  check  no  statistically  significant  difference  could  be 
demonstrated  between  the  baseline  period  and  the  subsequent  off 
periods and from this it was assumed that the laser Doppler probe had 
not moved. This therefore allowed the blood flow experiments evaluating 
the three SAP cycles in non-wounded skin to be performed with a degree 
of confidence in the methodology being used. 
For the blood flow experiments therefore, blood flow was recorded for a 
‘baseline’ period of 10 minutes with recordings only beginning once the 
temperature under the foam had plateaued, one of the SAP was then 
applied  (selected randomly) for a twenty minute period.  
 Ten healthy volunteers (subject to inclusion / exclusion criteria), mean 
age 30.5 ± SD 11.4 years, took part in the study. Each SAP was tested at 
weekly intervals in both the ‘dorsum of the foot’ and medial Tibia. Data 
was excluded if the room temperature varied beyond the 20-25ºC range   219 
set  for  this  study,  or  the  skin  temperature,  measured  by  a  skin 
temperature probe placed adjacent to the TNP dressing changed by more 
than an arbitrary figure of ± 2.5ºC during the course of the experiment. In 
addition data was excluded if volunteers moved excessively during the 
experiment. 
Using this protocol no significant change in blood flow was seen when 
TNP  was  applied,  nor  was  there  a  significant  difference  between  the 
three  SAP  tested.  This  held  true  for  both  the  non-wounded  skin  sites 
tested.  The  hypothesis  that  TNP  applied  to  non-wounded  skin  and 
delivered  as  a  125mmHG  continuous  SAP  regime,  a  125mmHG 
intermittent  regime  (5minutes  on:  2  minutes  off)  or  a  profiled  SAP  (3 
minutes  150mmHG:  3  minutes  100mmHG)  increases  blood  flow  was 
therefore rejected based on these results. Importantly this thesis did not 
demonstrate any significant decrease in blood flow with the use of the 
three SAP tested. 
 
 
 
 
8.1.1.2 Comparison to Previous studies 
 
These results in non- wounded skin are in contrast to a study that was 
published  during  this  thesis  evaluating  the  effect  on  blood  flow  in  the 
forearms of healthy volunteers [29].   
This study [29] investigated the effect of a range of SAP, on blood flow, 
under  the  foam  aspect  of  TNP  dressings,  which  were  applied  to  the 
forearm  of  healthy  volunteers.  Three  laser  Doppler  needle  filament 
probes  were  used  and  were  incorporated  into  the  foam  aspect  of  the 
dressing.  
In the Timmers study [29] a 25mmHg continuous SAP was applied for 
twenty minutes. The mean± SD of blood flow was calculated in this period 
and acted as the baseline blood flow to which any changes were relative 
to.  Continuous  SAP  of  100,  200,  300,  400,  500  mmHg  SAP  were   220 
successively applied, each for twenty minutes. The pressures were not 
tested independently of each other.  
Although blood flow was measured throughout each 20 minute period, in 
which the 100mmHg, 200mmHg, 300mmHg, 400mmHg and 500mmHg 
SAP  were  applied,  only  data  from  the  last  5  minutes  was  used  to 
calculate the mean± SD blood flow. The authors justified this by claiming 
that only after 10 minutes of raising the pressure, did measured blood 
flow reach a ‘steady state’. However they did not elaborate on how blood 
flow changed prior to reaching a ‘steady state’ or how the overall results 
of the study would change if this data were included. 
In this thesis however each pressure regime was tested on a separate 
day, using the same experimental conditions, rather than in succession, 
so  as  to  prevent  biasing  of  results.  During  each  experiment  baseline, 
blood flows were recorded with a TNP dressing in place but no suction 
applied and then compared to a subsequent ‘experiment’ period in which 
one of the SAP pressure regime were applied. The effect on blood flow of 
temperature rises under the foam (due to its insulating nature) were taken 
into account, and as a result baseline blood flow recordings only began 
when the temperature rise had plateaued.   
Unlike the Timmers study [29] the mean ± SD of the entire ‘baseline’ and 
‘experimental’ periods were calculated.  
It is difficult to compare the results of the Timmers study directly with the 
results  of  this  thesis  in  non-wounded  skin,  because  of  the  different 
methodologies used, and the different sites tested, however the closest 
comparison between the results in this thesis and the Timmers study [29] 
can be drawn from the continuous application of SAP. 
When applying a 100mmHg continuous SAP to the forearm, Timmers at 
al showed a change in blood flow from a mean ± SD, of 13.63 ± 4.27 
(baseline  25mmHg  SAP  applied)  to  39.53  ±  28.7,  p=0.02.  They 
suggested that this increase might have been due to irritation of the skin 
by the foam dressing. In contrast, in this thesis, no significant change in 
blood flow occurred after applying a 125mmHg SAP to the dorsum of the 
foot or ‘medial Medial Tibia’ (baseline TNP dressing in place- no suction). 
There may be several reasons for this discrepancy in results.    221 
 
1.  Laser Doppler Flowmetry is only able to measure blood flow from a 
single spot [149], under the probe and from a 1mm
3   volume of 
tissue(ref).  Three  probes  were  used  in  the  Timmers  study  [29] 
whilst only one was used in this thesis. If the effect of TNP on skin 
blood flow was not uniform then using only one probe may have 
reduced the likelihood of detecting any significant change in blood 
flow.  
 
2.  There  was  a  difference  in  the  probe  geometries  used  in  the 
Timmers study [29] and this thesis, which can effect the volume 
tissue sampled [149]. 
  
3.  Timmers  [29] suggested that blood flow rises seen in their study 
were due skin irritation by the foam. The probe used in this thesis 
excluded contact between the foam and the skin. The area under 
the probe was therefore not exposed to the foam, and blood flow 
rises may therefore not have occurred in this area whilst occurring 
in the surrounding areas. 
 
4.  Timmers  [29] only used the last 5 minutes (from 20 minutes) of 
the period during which a SAP was applied, to calculate the mean 
and  SD  of  blood  flow.  It  is  not  stated  in  their  paper  how  the 
significance of the blood flow rises they observed would change, if 
the first 15 minutes were included. Inclusion of this data may have 
reduced the clinical significance of their results. 
 
5.  If one assumes that the blood flow rises seen with the use of TNP 
are due to mechanical effects, as described in the third part of this 
discussion, then it is reasonable to assume that the axial loading of 
the skin will be dependent on a number of factors including the site 
being  tested,  the  foam  size,  and  the  distance  to  which  the 
adhesive  drape  extends  beyond  the  edges  of  the  foam.  In  the 
Timmers  study  [29]  the  axial  forces  created  during  ‘baseline’   222 
conditions may well have been greater than those created on, the 
dorsum of the foot and the medial Tibia.  
In the forearm and under ‘baseline’ conditions, these forces may 
well have decreased blood flow. Relative rises in blood flow would 
then be seen when higher than ‘baseline’ SAP were applied. 
The axial loads created by ‘baseline’ conditions in this thesis may 
well not have been sufficient to alter ‘baseline’ blood flow. As a 
result, reduction in the axial load, by the application of for example 
a 125mmHg SAP, did not produce any relative change in blood 
flow. 
 
  
 
In summary of this section 
 
•  TNP did not produce any significant change in blood flow, in the 
dorsum  of  the  foot  or  the  medial  Tibia,  when  a  125mmHg 
continuous,  125mmHg  intermittent,  or  a  150:100  mmHg  profiled 
pressure  regime  were  used  in  a  small  sample  size  of  n=10 
volunteers.  
 
•  This is in contrast to a previous study investigating the effect of a 
range of continuous SAP on blood flow in the forearm.  
 
•  This  study  showed  a  significant  rise  in  blood  flow  compared  to 
baseline when a 100mmHg continuous SAP was applied. 
 
•  These conflicting results may be due to methodological differences 
between the two studies or differences in the mechanical effects 
produced by ‘baseline’ conditions in both studies 
 
•  The  studies  on  non-wounded  skin  in  this  thesis  therefore 
provide evidence that the mechanical effects of TNP, in the   223 
skin sites tested, are not significant and importantly do not 
compromise blood flow.  
 
 
8.1.2  Wound studies 
 
 
 
 
No previous studies evaluating the effect of TNP on blood flow in human 
wounds  could  be  found  in  the  literature  review.  The  experiments  on 
wounds  were  therefore  one  of  the  first  of  their  kind.  The  aim  as 
mentioned earlier in this discussion was to evaluate the effect of TNP, 
delivered  in  three  different  SAP  regimes;  on  laser  Doppler  measured 
blood flow in a variety of human wounds. 
All  patients  receiving  TNP  from  within  the  Plastic  Surgery,  General 
Surgery,  Vascular  and  Orthopaedic  Surgery  wards  of  Salisbury  district 
hospital  between  December  2004  –  June  2006  were  considered  for 
inclusion into the study if they had shallow predominantly two dimensional 
wounds whose wound base was ‘flat’ and non bleeding in nature at the 
first  dressing  change  (i.e.  forty  eight  hours  following  debridement). 
Further  inclusion  criteria  are  cited  in  chapter  6.  Experiments  were 
performed in the same dedicated room as previously mentioned. 
The dimensions of the wound were of significance because the primary 
concern in using laser Doppler flowmetry in wounds was that the probe 
would  move.  To  reduce  the  likelihood  of  probe  movement  shallow, 
predominantly two-dimensional wounds with a flat surface as possible (a 
subjective assessment) were selected. From a practical point of view this 
allowed the laser Doppler probe to be placed on a flat surface and by 
applying  the  adhesive  drape  aspect  of  the  TNP  dressing  beyond  the 
wound by approximately 5cm it was envisaged that sufficient axial forces 
would  be  created  to  hold  the  laser  Doppler  probe  against  the  wound 
surface during baseline blood flow recordings.   224 
In non-wounded skin the issue of probe movement was addressed by 
selecting skin sites that allowed the laser Doppler probe to be placed on a 
flat surface as possible, and by taping the probe to the skin surface. The 
highest  risk  of  probe  movement  was  envisaged  to  be  during  the 
intermittent SAP regime but it was possible to validate that in the skin 
sites selected, this did not occur. To tape the laser Doppler probe to the 
testing surface was clearly not possible in wounds. It was also thought 
that given the heterogeneous nature of wound geometry as well as their 
position  on  the  body  any  tests  that  demonstrated  a  lack  of  probe 
movement in one individual, or in one wound could not be accepted in a 
different individual or wound. An intra-individual validation demonstrating 
that probe movement had not occurred during testing of a SAP regime 
was  therefore  needed  otherwise  it  would  be  impossible  to  defend  the 
validity of any of the results seen.  
In the experiments in wounds, blood flow was therefore recorded over 
three periods. Period1 – was a baseline period of 10 minutes. It began 
after  an  adaptive  period  and  when  the  temperature  under  the  TNP 
dressing  (measured  by  a  probe)  had  plateaued.  Period  2  –  an 
experimental period, lasting twenty minutes, during which one of three 
SAP regimes to be tested would be applied and Period 3 – a validation 
period in which blood flow would be recorded for a further 10 minutes. 
All the pressure regimes were evaluated at one sitting, and to prevent 
bias,  were  selected  at  random  to  be  applied  to  the  wound.  After  a 
pressure  regime  had  been  evaluated,  and  following  period  3,  the 
temperature  under  the  foam  was  monitored  (until  it  had  returned  to 
‘baseline  levels’,  and  the  experimental  protocol  was  repeated  for  the 
other SAP regimes. 
For each pressure regime tested, data was only accepted if a delta check 
performed on periods 1 and 3, showed no significant difference in blood 
flow (i.e. between the baseline period and the validation period). A delta 
check is a statistical comparison of the mean of two measurements in the 
same individual. If there was no statistical difference in the mean blood 
flows in Period 1 and 3, this implied that that the probe had not moved. 
Data  was  therefore  rejected  if  periods  one  and  three  failed  the  delta   225 
check, and testing abandoned in any individual in whom that occurred 
(further exclusion criteria are cited in Chapter 6). Using these criteria data 
was excluded in 13 out of 23 patients (solely on failing delta checks).  
In using this technique to validate whether the laser Doppler probe moved 
however a fundamental assumption was made which is that, when any of 
the SAP regimes were stopped i.e. suction switched off blood flow would 
return  to  baseline  levels  near  enough  immediately.  This  has  been  the 
case  in  the  all  of  the  studies  evaluating  blood  flow  in  animal  wound 
models, in which Laser Doppler Flowmetry has been used [16, 26, 27], 
and so it was not felt to be an unreasonable assumption to make. 
Nevertheless any results from the study in this thesis on wounds, would 
have  to  be  considered  in  light  of  this  method  of  data  exclusion.  It  is 
accepted that if TNP produced changes in blood flow, that persisted after 
suction was switched off then the methodology used would exclude these 
results. Given the equipment and techniques used in this thesis no other 
non-  invasive  method  could  be  could  be  thought  of  to  assess  probe 
movement.  
Ten  patients  all  of  whom  had  lower  limb  ulcers  met  the  criteria,  they 
included, six men and four women, mean ± SD of age being 74.7± 17 
years.  
For  both  the  continuous  SAP  regime  and  the  profiled  regime  no 
significant  changes  in  blood  flow  were  seen  relative  to  baseline 
recordings. Application of the intermittent SAP regime however produced 
a rise in blood flow of 39 ± 60 % (mean± SD), which approachedd but did 
not  achieve  statistical  significance  (p=0.05).  This  was  significantly 
influenced by two patients (patients 1 and 9) who had outlying responses 
to the application of intermittent SAP (their ulcer aetiology is contained in 
table 16. There was no significant response in the remaining 8 patients 
(p= 0.18). 
In both these patients there was an immediate increase in blood flow after 
the  application  of  suction,  that  continued  throughout  period  2,  and 
returned  to  ‘baseline’  levels,  during  the  ‘off’  periods  of  the  intermittent 
cycle and during period 3 (Similar responses were seen in both patients   226 
for  the  continuous  and  intermittent  regimes,  and  in  patient  1  for  the 
profiled regime (but not patient 9 – it is not clear why this is the case)). 
This is analogous to the responses seen by Morykwas  [23] [26, 27], (and 
may produced by mechanical effects as described later in this discussion- 
as they occur in tandem with the switching on and off of suction), but it is 
not clear why they should occur in only these two patients and not the 
other patients with lower limb ulcers 
Clearly an alternative explanation would be that these apparent changes 
in  blood  flow  were  as  a  result  of  probe  movement,  the  probe  moving 
when suction was switched on and returning to its original position when 
suction was switched off. Certainly the greatest risk of probe movement 
was likely to be in the intermittent regime, the only regime whose results 
were approaching clinical significance, but a similar explanation could be 
given for all blood flow changes seen (in the other regimes too). 
A certain degree of caution therefore needs to be used when interpreting 
these results because of the methodological difficulty in both preventing 
and assessing whether probe movement occurs under the opaque foam 
of a TNP dressing. 
With  this  caution  in  mind  and  given  the  small  sample  size  of  n=10 
patients the hypothesis is rejected for all three SAP regimes in human 
wounds,  although  there  was  a  tendency  for  an  increase  in  blood  flow 
using the intermittent SAP regime.  
Importantly though there was no significant comprise in blood flow shown 
overall by any of the SAP regimes. Nor when compared with one another 
was there any difference between the SAP tested. 
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8.2  TNP concept 
 
 
Although this thesis failed to show any significant changes in blood flow 
caused by TNP application a number of investigators have demonstrated 
immediate changes occurring in tandem with switching on[16, 26-28]and 
off of suction [16, 26, 27] All of these studies evaluated blood flow either 
immediately adjacent to the wound edge or at varying distances from it.  
In contrast in this thesis an attempt was made to assess blood flow under 
the foam aspect of the TNP dressing. The failure to show any significant 
changes in blood flow may be due to a number of factors including small 
sample  size,  methodological  failures,  or  simply  that  the  physical 
conditions created under the foam/ drape aspect of the dressing do not 
allow for changes in blood flow to occur. 
Chapter 7 of this thesis was aimed at trying to understand the physical 
forces produced by TNP application. It was thought that by providing a 
description  of  the  macroscopic  forces  created  by  TNP,  as  well  as 
visualizing the mechanical effects on the underlying tissues then possible 
mechanisms of action of TNP, and possible mechanisms of increasing 
blood flow may become clearer. 
A  proposed  TNP  concept,  giving  a  detailed  description  of  the  forces 
evident in predominantly two- dimensional wounds or non-wounded skin 
was therefore set out in chapter 7. These were investigated in a limited 
MRI study. The concept suggested 
 
 
•  Two-  dimensional  wounds  and  intact  skin  are  subjected  to  a 
positive pressure when both a TNP dressing is in-situ, and when 
a SAP is applied to this dressing. 
•  This positive pressure is entirely defined by the radius of curvature 
that  the  adhesive  drape  produces  relative  to  the  foam,  and  is 
reduced when a SAP is applied.   228 
•  Wound fluid is not actively ‘sucked out’ of the wound bed, but is 
driven  into  the  canister  by  the  hydrostatic  pressure  within  the 
capillaries. 
•  The  mechanical  effects  produced  by  the  TNP  system  are 
distributed  disproportionately,  according  to  the  tissue  type.  This 
was illustrated by the MRI study. The mechanical effects are likely 
to  be  disproportionate  in  non  symmetrical,  non-homogeneous 
surfaces such as wounds. 
•  The mechanical effects occur in tandem with the switching ‘on’ and 
‘off, of suction, once again confirmed by the MRI study. 
 
There are several implications of these results, particularly in reference to 
the published literature regarding TNP’s effect on blood flow.  
 
 
8.2.1  Mechanical effects of TNP 
 
8.2.1.1 As an explanation of changes in blood flow 
 
 
To date most investigators have suggested that the removal of oedema 
by TNP is the primary method by which TNP might produce changes in 
blood  flow  [16,  26-28].  This  explanation  was  initially  proposed  by 
Morykwas  [16].  They  suggested  that  chronic  wounds  and  to  a  lesser 
extent acute wounds were characterized by localized peripheral oedema, 
which  they  compared  to  the  zone  of  stasis  surrounding  burn  injuries 
[176]. They postulated that the immediate rises in blood flow seen after 
the  application  of  SAP,  seen  in  their  study,  were  due  to  the  active 
removal  of  oedema  or  excess  interstitial  fluid  from  the  tissues 
immediately surrounding wounds. This removal of oedema they claimed 
resulted in decompression of previously compromised blood vessels and 
therefore the restoration of blood flow in them.   229 
Clearly this theory is based upon TNP actively sucking wound fluid out of 
a wound, however this seems an unlikely explanation for a number of 
reasons 
 
•  The concept proposed in this thesis suggests that wound fluid is 
not actively removed by the TNP system; rather the major driving 
force  is  the  hydrostatic  pressure  within  the  capillaries  of  the 
wound. 
•  A consistent finding in three of the existing blood flow studies [16, 
27, 28, 128] is that observed changes in blood flow are immediate, 
occurring in tandem to the switching ‘on’ and ‘off’ of suction. These 
changes are not readily explained by the removal of oedema. For 
example, if the removal of oedema causes increases in blood flow 
when  suction  is  switched  on,  why  does  blood  flow  return  to 
baseline levels, immediately after suction is switched off [16, 26, 
27] ? This has not been answered in any of the studies to date. 
 
•  The  removal  of  oedema  does  not  readily  explain  zones  of 
hypoperfusion  seen  by  Wackenfors  [26,  27]  immediately 
surrounding wounds treated with TNP. 
 
 
A more plausible explanation, in light of the TNP concept and MRI study 
of chapter 7, is that the changes in blood flow occur as a result of the 
mechanical effects of TNP on tissues. 
The mechanical effects will be affected by a number of factors including 
the  wound  dimensions,  wound  site,  the  foam  thickness  and  the 
composition of the tissues being treated, however, what is clear from the 
TNP concept is that, the mechanical effects are immediate and occur in 
tandem with the switching ‘on’ and ‘off’ of suction. 
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8.2.1.2 Relevance to previous blood flow studies 
 
 
The MRI study, which was performed in a limited number of volunteers 
(due to a lack of available MRI ‘time’ at Salisbury District Hospital), and 
the concept also offer an insight into the mechanisms by which previously 
reported blood flow changes may have occurred.  
 In  Morykwas  [23]  study,  full  thickness  circular  defects  were  created, 
down  to  the  deep  fascia  of  the  muscle  over  the  dorsal  spine.  Laser 
Doppler needle probes were then inserted, via the wound and into the 
surrounding  subcutaneous  tissue  and  deep  muscle  of  the  back 
(approximately  1-2mm  from  the  wound  edge-  personal  communication 
Morykwas 2005 TNP symposium –Salisbury).  
Blood flow was recorded with a TNP dressing in place (but no suction 
applied)  and  then  recorded  after  the  application  of  a  continuous  SAP. 
They observed an immediate rise in laser Doppler measured blood flow 
in both the subcutaneous tissue and muscle. Blood flow responses were 
bell shaped in nature. However after 5-7 minutes the increase declined. 
In addition blood flow measurements were immediately depressed below 
baseline when SAP of 400mmHg or above were applied.  
If  one  applies  the  findings  of  Chapter  7  of  this  thesis  to  these 
observations, then it is possible that with just the TNP dressing in place, 
occlusion  of  blood  flow  occurred  in  the  muscle  and  fat,  because  they 
were compressed by the axial forces created by the drape. When a SAP 
was applied these axial forces were immediately reduced (because the 
foam collapsed), less compression of the fat and muscle occurred, and as 
a result blood flow increased immediately. 
The fact that blood flow increases lasted for only 5-7 minutes suggests 
that  the  increases  in  blood  flow  were  possibly  reactive  hyperemic 
responses.  
Reactive hyperemia, or a reactive increase in blood flow, Figure 78, is the 
reperfusion  that  occurs  in  the  arterial  vasculature  following  periods  of   231 
occlusion [177]. The response is seen across the arterial tree from large 
arteries to single arterioles [178], and takes the form of an immediate rise 
in  blood  flow  above  baseline  levels  (approximately  5  times  baseline  – 
[172]), following release of the vascular occlusion, and a gradual return to 
baseline  levels.  Although  the  mechanism(s)  controlling  reactive 
hyperemia are incompletely understood [177-179], the magnitude of the 
reactive hyperemia is known to vary between tissues and to be influenced 
by the length of the vascular occlusion [179]. 
Following  the  initial  experiments  on  blood  flow  Morykwas  [16] 
investigated the effects of applying intermittent SAP, in a timed cycle. The 
period of time during which SAP was applied, the ‘on cycle’, ranged from 
1-10 minutes whilst the ‘off cycle’ ranged between 1-5 minutes.  
The fact that Morykwas [16] observed increases in blood flow during the 
‘on’ cycle (i.e. in a period during which it is proposed that there was a 
release from vascular occlusion), which were influenced by the length of 
the ‘off’ cycle (i.e. the length of vascular occlusion), adds further support 
to the theory that Morykwas [16] observed hyperemic responses in their 
study Figure 79. 
Although  the  Zhoa-Chen  study  [28]  measured  blood  velocity,  they 
showed a similar response in blood velocity which increased immediately 
after  the  application  of  suction  and  then  gradually  decreased  over  a 
twenty -minute period.  
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Figure  78  An  example  of  a  reactive  hyperaemic  response,  seen  after 
tourniquet occlusion of blood flow to the forearm. Three periods are shown. 
The  first-  baseline  levels.  The  second  -occlusion.  The  third-  reactive 
hyperaemia. The response is an immediate rise followed by a slow decline to 
baseline levels. The length of occlusion is known to influence the length of 
the  hyperaemic  response  [179].  It  is  suggested  in  this  discussion  that 
Morykwas [16] observed only the last two periods- occlusion with suction ‘off’ 
– release of occlusion with suction ‘on’. 
 
 
 
 
Figure  79  Laser  Doppler  tracing  of  the  effects  of  applying  intermittent 
125mmHg SAP in the Morykwas study[16]. Morykwas did not record blood 
flow in the tissues prior to applying a TNP dressing. The suggestion in this 
discussion  is  that  the  ‘baseline’  in  Morykwas  study  [16]  refers  to  the 
occlusive  period  of  Figure  78.  In  this  tracing  the  steady  decline  of  the 
hyperemic  response  is  interrupted  by  switching  ‘off’  of  suction,  which  is 
suggested to cause occlusion of blood flow and a return to ‘baseline’.   233 
 
The TNP concept also suggests that axial forces are greatest at the foam 
edge,  when  the  foam  is  collapsed  and  increase  when  subatmospheric 
pressures are applied. This edge effect, together with the creation of a 
dense, non pliable foam when high SAP are applied, may explain the 
decreases in blood flow seen after continuous SAP of 400mmHg were 
applied by Morykwas  [16].  
 As the concept and the MRI study of this thesis apply to predominantly 
two-dimensional wounds and non-wounded skin it is difficult to comment 
on the studies of Wackenfors [26, 27]. These studies were in inguinal 
cavity  wounds  (at  least  10cm  deep)  and  median  sternotomy  wounds, 
which were dressed with foam one and a half times broader than the 
wound  dimensions.  However,  a  similar  edge  effect  (at  all  SAP  they 
tested)  may  explain  the  zones  of  hypoperfusion  seen  adjacent  to  the 
wounds in this study. 
 
 
 
 
8.2.1.3 Implications for the use of LDF 
 
 
LDF lacks absolute units. As a result, its use relies on the measuring of 
blood  flow  during  a  baseline  period,  and  then  observing  any  change 
relative  to  this  baseline,  during  an  experimental  period  (in  which  the 
physiological circumstances are changed by the investigator) [151].  
In most of the blood flow studies to date [16, 26-28] ‘baseline’ blood flow 
has been recorded with a TNP dressing in place, but no suction applied. 
As  the  TNP  predicts  and  the  MRI  study  illustrates,  simply  having  a 
dressing in place, can significantly compress certain tissues under the 
foam (and could also have an effect on the dimensions of surrounding 
tissues also).   234 
This compression is as a result of the axial forces generated by drape, 
whose magnitude will be dependent on a number of factors that include 
foam  thickness,  the  tension  in  the  drape,  the  wound  dimensions 
especially  wound  depth  and  wound  site.  In  our  limited  MRI  study  the 
effect  of  this  axial  force  on  the  underlying  tissues  was  greater  in  the 
muscle  compartment  compared  to  the  fat  layer,  whilst  no  discernable 
compression occurred in the skin layer. 
Depending on the magnitude of the axial forces, and depending on the 
tissue in which blood flow is being recorded there are a number of effects 
that having a TNP dressing in place could have 
 
 
1.   No effect on blood flow- this may occur in the skin/ or wound 
base, which has a high bulk moduli and is not easily compressed 
(however this is likely to be site dependent – pressures as low as 
15mmHg  are  known  to  interrupt  blood  flow  in  the  finger  [151], 
whilst pressures in the region of 42± 8 mmHg have been shown to 
interrupt blood supply in the skin over the tibia, and pressures of 
71±16mmHg have been shown to occlude blood flow over tibialis 
anterior.  This  suggests  that  higher  pressures  are  required  to 
interrupt blood supply in skin over muscle compared to skin over 
bone [175, 180].  
 
2.  Occlusion of blood flow  
 
3.  A reduction in blood flow 
 
 
When  suction  is  switched  ‘on’  less  compression  of  certain  tissues  will 
occur. If blood flow was occluded when suction was ‘off’, then as has 
been suggested a reactive hyperemia might be seen.  
If blood flow was reduced, when suction was ‘off’, the switching ‘on’ of 
suction is likely to result in an increase in blood flow. However although 
this increase is relative to a ‘baseline’ of having a TNP dressing in place,   235 
it may not represent a true increase in blood flow. In this situation, blood 
flow would have to be recorded in the tissues before the application of a 
TNP  dressing,  after  the  application  of  a  TNP  dressing,  and  after  the 
application of suction, in order to differentiate between true and relative 
rises in blood flow. 
This has not been considered in previous studies. For example, in their 
study Timmers [29] evaluated the effect of TNP on cutaneous blood flow 
in healthy intact forearm skin. In each volunteer, the forearm was dressed 
with a single piece of 10*15cm foam sized foam (10*15 cm). Skin blood 
flow was measured using 3 filament probes (Perimed, Sweden) that were 
incorporated into holders and placed within the foam.  
Despite ‘baseline’ recordings being taken with a 25mmHg SAP applied to 
this dressing, the axial load on the skin and the underlying tissues was 
likely to be high in this study. Principally because of the size of foam used 
and the site, i.e. the forearm, essentially a cylindrical structure.  
This  study  showed  a  significant  increase  in  blood  flow  (relative  to 
‘baseline’), when SAP of up to 300mmHg were applied, these increases 
were  significantly  greater  with  the  use  of  PU  foam  compared  to  PVA 
foam. These results could be explained by firstly considering, that both 
foams became thinner with increasing SAP, reducing the axial load on 
the skin, and therefore any compression of blood flow, and secondly by 
the fact that PU foam collapses more readily than PVA foam for any given 
SAP, because of its larger pore size. 
A rise in blood relative to ‘baseline’ would therefore be expected to be 
seen with increasing SAPs for both foams, and in particular in the PU 
foam. However without having a recording of blood flow prior to the foam 
application, it is impossible to comment on whether the increases seen in 
this study, actually represent true rises in blood flow. Ideally this would 
have been performed in the blood flow studies of this thesis, in which a 
laser  Doppler  probe  was  placed  at  the  foam/  skin/  wound  interface, 
however there was a real risk of laser Doppler probe movement under the 
foam, especially in wounds if this was attempted.  
As well as potentially changing the blood flow within tissues, the axial 
loads  described  above  could  also  influence  blood  flow  measurement   236 
using  a  laser  Doppler  probe  at  the  foam  /  skin  surface.  There  is  a 
possibility that with a TNP dressing in place, the axial load brings the 
probe closer to the blood vessels within the dermal plexi of the skin. A 
reduction in axial load, when suction is applied, would then change the 
position of this probe relative to the blood vessels, potentially resulting in 
an apparent decrease in blood flow. This possibility was not considered 
during the experimental blood flow studies, principally because the MRI 
study,  which  visualized  the  effects  of  TNP  application  on  tissues 
underlying the foam, had not at that stage been performed.  
In conclusion of this section it is important to consider how conditions set 
up during ‘baseline’ recordings influence the measurand, i.e. blood flow 
within the tissues, and its ability to be measured using LDF. Chapter 7 a 
description of the mechanical forces created by TNP application, in non-
wounded  skin  and  two  dimensional  wounds,  provides  an  aid  in 
understanding these conditions. 
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8.3  Future Work 
 
 
This thesis set out to evaluate the effects of TNP on microvascular blood 
flow  in  human  experimental  conditions  using  laser  Doppler,  and  in 
particular  the  effect  of  applying  TNP  using  three  different  pressure 
regimes on blood flow under the foam aspect of TNP dressings.  
This was extremely difficult especially in wounds where one of the major 
weaknesses  of  using  laser  Doppler  was  exposed,  namely  that  this 
technique of blood flow can only be used to measure an approximate 
1mm
3   volume of tissue and that the technique lacks absolute units. 
In not being able to visualise the laser Doppler probe under the black 
foam  the  overriding  concern  throughout  the  thesis  was  of  probe 
movement. As such and in wounds the statistical method of Delta checks 
was  employed  to  evaluate  if  probe  movement  had  occurred  (in  non 
wounded skin it was
  possible to validate that probe movement did not 
occur). 
This  reliance  on  the  Delta  check  represents  a  major  weakness  in  the 
study of wound blood flow but represented the only means of attempting 
to rationalise the data, however it may well have excluded ‘genuine’ data. 
This situation in retrospect would probably not have arisen if blood flow 
had been measured at the foam edge / wound edge. The probe would be 
fixed  by  the  adhesive  drape  and  could  be  visualized  through  the 
transparent dressing and be easily validated. This represents a potential 
area of further work. 
Despite  these  weaknesses  this  thesis  represents  a  significant 
investigation of the effect of TNP on blood flow in human experimental 
situations. The results however did not demonstrate significant changes 
in blood flow. Were these findings related to the small sample sizes of the 
experiments? Were they due to exclusion of data because of the use of 
Delta checks? Is an increase in blood flow a plausible explanation of how 
TNP works? 
These questions led to investigating the physics of TNP application in an 
attempt to understand how TNP might effect blood flow.   238 
In contrast to this thesis a number of investigators have shown that TNP 
has the ability to significantly increase blood flow in wounds and non-
wounded  skin,  principally  they  argue  by  the  removal  of  oedema,  with 
blood flow changing in tandem with the switching on and off of suction  
In clinical practice however oedema removal is not instantaneous, nor is 
wound fluid, collected in the suction pump canister, returned to the wound 
bed once suction is switched off.  
This thesis (Chapter 7) suggests and illustrates that TNP has the ability to 
create  mechanical  forces  that  can  have  marked  effects  on  tissues 
underlying the foam aspect of the dressing, especially muscle, and that 
these mechanical effects change with the switching on and off of suction. 
Is  this  a  more  plausible  explanation  of  blood  flow  changes  seen  by 
others? Probably, but to prove this would require in the first instance a 
larger study MRI study to confirm the findings seen in the four volunteers 
(of  the  MRI  study)  and  beyond  that  an  effective  means  of  evaluating 
blood flow in the tissues affected by the mechanical forces created. 
What Chapter 7 and in particular the MRI images illustrate is that one 
cannot truly term having a TNP dressing in place (but no suction applied), 
as  ‘baseline’  conditions.  This  is  particularly  true  when  using  LDF  to 
measure  blood  flow  changes.  Any  future  work  needs  therefore  to 
measure  truly  baseline  blood  flow  prior  to  the  application  of  a  TNP 
dressing, blood flow after the application of a dressing and blood flow 
after the application of a SAP (a 125mmHg continuous SAP would be the 
most pertinent as anecdotally this is the most commonly used in clinical 
practice). 
To do this using LDF is fraught with difficulties. A major concern would be 
probe  movement  (as  mentioned  above  and  has  been  highlighted 
throughout  the  experiments  in  this  thesis).  A  novel  method  of 
investigating blood flow as well as blood vessel morphology and calibre 
under the foam aspect of the dressing is the use of Magnetic Resonance 
Imaging  Angiography  [182][183].  This  is  emerging  as  a  technique,  in 
Plastic  Surgery,  in  visualising  subcutaneous  blood  vessels  and  their 
morphology,  to  aid  flap  design  and  planning  [183].  This  evolving 
technique  offers  a  means  to  dynamically  assess  blood  flow  under  the   239 
(entirety of the) foam aspect of a TNP dressing (and potentially beyond 
the dressing).  
It is entirely feasible that a laser Doppler probe could also be used in any 
such study and its movement be ‘tracked’ with the MRI, however the LDF 
probe would only be measuring a 1mm
3  volume as stated previously. By 
tracking the LDF probe, one could be certain that the LDF probe had not 
moved especially in wounds. As a result there would not be a need for 
validation periods or delta checks to assess probe movement 
      
If one were to consider MRI angiography on its own merits then it offers a 
non-ionising  and  potentially  non-invasive  technique  of  assessing  blood 
flow and the mechanical effects of TNP application, in both non-wounded 
skin and wounds. As such it has the ability to confirm the suggestion in 
this  thesis  that  any  blood  flow  changes  are  likely  due  to  mechanical 
effects, and to visualize and quantify these mechanical effects.  
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9  Appendices 
 
 
 
9.1  Appendix 1 
 
 
DELTA CHECK 
 
In biological systems Delta checks are used as a means of quality control 
[169]  [181].  The  Delta  check  is  based  on  observing  the  difference 
between two separate test results in the same patient/ volunteer. It asks 
the question  
 
‘is the mean of result 1 ( X 1 ) significantly different to the mean of 
result 2 (X 2)’  
 
 
but it allows you to do this in the same patient/ volunteer. 
In a cohort of patients/ volunteers this question would be answered by 
performing a t –Test, however to answer the same question in only one 
individual, requires an external estimate of the spread of data, i.e. the 
standard deviation (SD). Given the standard deviation a Delta check can 
be performed. 
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Delta check  =    2.77  *                    (SD1)
2
 + (SD2)
2 
       
                                         2 
 
 
 
therefore if the x2-x1 is   >     Delta check  
 
 
then result 1 and result 2 are significantly different 
(p=0.95) 
 
 
 
In this thesis the Delta check allows an assessment to be made as to 
whether two mean blood flows (in the same patient) are the same, by 
taking into account a measure of the spread of the data, i.e. the SD. 
 Using the Delta checks allows a statistically assessment of whether the 
blood flow in any two periods, within the same patient/ volunteer, are in 
fact statistically similar. 
If the difference between the two means falls within the Delta check, the 
blood flows are statistically the same. 
This is used in the thesis to infer that the probe has not moved. In effect it 
is used as a quality control, and is used to accept or reject data.   
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9.2   Appendix 2 
 
 
 
 
 
 
Picture of patient 1 wound 
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Picture of patient 9 wound 
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9.3  Appendix 3 
 
 
9.3.1  Boxplots 
 
 
 
 
 
A boxplot typically consists of a box, its ‘whiskers’ and an asterisk. Values 
beyond the whiskers represent outlying data points, either an unusually 
large or small observation.  
The top of the box is the third quartile (Q3) - 75% of the data values are 
less than or equal to this value. 
The bottom of the box is the first quartile (Q1) –25 % of the data are less 
than or equal to this value.  
The horizontal line within the box refers to the median of the data. 
The upper whisker extends to the highest data point (excluding outliers). 
The lower whisker extends to the lowest data point (excluding outliers). 
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9.3.2  Interval Plot 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
An interval plot is used to illustrate both a central tendency and variability 
in the data set. In this case the blue spots show the mean temperature at 
various times for all patients who had their wounds subjected to a profiled 
SAP. At 1 minute in the ten individuals there was an approximate 1.25 °C 
mean temperature drop. 
The whiskers illustrate 95% confidence intervals for the mean value. 
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